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ABBREVIATIONS
ACAT AcyI-<:oA cholesterol acyltransfera.se
ACC Acetyl CoA carboxylase
om Congestive heart disease
CPT Camitine palmitoyltransferase
CPTi Camitine palmitoyltransferase.inner mitochondrial membrane
CPTo Camitine palmitoyltransferase-outer mitochondrial tnembrane
CPTp Peroxisomal camitine palmitoyltransferase
CVD Cardiovascular Disease
OHA Oocosahexaenoic acid (22:6, n-3)
EDL Extensor digitorum longus
EPA Eicosape:ntaenoic acid ems, n-3)
ETF Electron-transferring flavoprotein
FABP Fatty acid binding protein
HOL High density lipoprotein
HSL Hormone-sensitive lipase
IDL Int:ennediate density lipoprotein
LOL Low density lipoprotein
Lp(a) Lipoprotein a
LPL Lipoprotein lipase
PC Phosphatidylcholine
PI:X;F Platelet: derived growth factor
PE Phosphatidylethanolamine
PGI Prostaglandin
PI Phosphatidylinositol
iii
PPAR Peroxisome proliferator activated receptor
PS Phosphatidylserine
SM Sphingomyelin
TAG Triacylglycerol
Tx Thromboxane
VLDL Very low density lipoprotein
iv
ABSTRACT
We hypothesized that EPA is preferentially metabolized in peripheral
tissues thus making less of this acid available for storage. The three proposed
mechanisms investigated to explain how EPA is preferentially utilized included;
1) EPA is oxidized at a greater rate relative to DHA in skeletal and cardiac
muscle, Z) EPA is preferentially hydrolyzed from ciI\...-u1ating triacylglycerols,
and/or 3) EPA is selectively secreted in bile by the liver.
To investigate the first proposal, fatty acid oxidation studies
conducted using soleus muscle homogenates, intact soleus muscle and cardiac
myocytes. Our findings indicated that even though the rate of oxidation of EPA
over DHA was doubled. in the experiments which employed soleus muscle
homogenates, there was no differential oxidation between EPA and DHA in
muscle when these fatty acids were incubated with either the intact soleus
muscle or cardiac myocytes. Since the latter two experiments are more
representative of the physiolOgical state, it appears that these results do not
support our first postulated mechanism that EPA is preferentially oxidized
compared to DHA by muscle.
We also suggested that EPA is preferentially hydrolyzed compared to
DHA from circulating triacylglycerols by muscle LPL with the hypothesis that if
more EPA is released to the peripheral tissues for metabolism then less would be
available for storage in adipose tissue. 'Therefore, chylomicrons were incubated
with cardiac lipoprotein lipase (LPL) to determine if there was selective release of
EPA. 1his study demonstrated no difference in the hydrolysis pattern of the
two n-3 fatty adds. Thus, preferential release of EPA from chylomicrons by LPL
does not appear to explain the lower storage of EPA in adipose tissue.
The third mechanism examined the proposal that supplementation of fish
oil in the diet results in more EPA compared. to DHA being available for hepatic
phospholipid synthesis. Consequently, more EPA is secreted in bile by the liver.
In this' part of the investigation, we determined the fatty acid profile as well as
the proportion of fatty acids of phospholipids secreted in the bile of rats being
fed a diet containing MaxEPA oil as its primary fat source. Even though biliary
phospholipids were enriched. in the long chain n-3 fatty acids found in dietary
fish oils, no significant difference in the relative proportion of EPA and OHA was
observed.. The differential storage of DHA compared to EPA is thus, not due to
the selective secretion of EPA into bile by the liver.
From our data, we were able to conclude that the suggested mechanisms
are not responsible for the preferential metabolism of EPA relative to DHA. We
found that EPA was oxidized at a greater rate than ORA in soleus muscle
homogenates. However, when more physiological models were used, Le.,
cardiac myocytes or the intact skeletal muscle, there were no differences in the
oxidation of either of these fatty acids. Furthermore, we determined that EPA
vi
and OHA were released from. triacylglycerols in lymph-derived chylcnnicrons at
si.m.ilar rates and that both fatty acids were secreted in bile to the same extent.
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CHAPTER 1.0
DIfFERENTIAL MEl'ABOUSM OF FATIY AaDS
1.1 lNTRODUcnON
The focus of this thesis is to examine the differential metabolism. of the
two long chain n-3 fatty acids found in marine oils, eicosapentaenoic acid (20;5,
n-3) and docosahexaenoic acid (22:6. n-3). For simplication these two fatty acids
will be referred to as EPA and OHA, respectively, throughout the text. In order
to better understand the metabolism. of these two fatty acids, a general overview
of fatty acids and their role in metabolism are discussed in this chapter.
Fatty acids are a class of compounds that contain a long hydrocarbon
chain with a carboxyl group on one end and a methyl group on the terminal end
(Figure 1.1). In biological systems, fatty acids usually contain an even number of
carbon atoms, typically between 14. and 24. They are either saturated or
unsaturated, containing one or more double bonds that generally exist in the cis
configuration.
,
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Figune 1.1 Structure of a Saturated Fatty Acid
Fatty acids play two major physiological roles in mammalian tissues; a
structural role and a role in energy storage and production. First, they are
building blocks of phospholipids and glycolipids, and thus, important
cornponents of biological membranes. In fact, the fatty acyl chains account for
more than half the mass of most major phospholipids and are primarily
responsible for the apolar nature of the membrane bilayer (Goodridge. 1991).
Consequently, fatty acids influence many membrane properties and functions
such as membrane fluidity, ion transport and the activities of membrane-
associated proteins. In addition, polyunsaturated fatty acids found in
phospholipids may serve as substrates for production of biologically potent and
versatile compounds, the eicosanoids (Cook, 1991). The eicosanoids are involved
in the modulation of a host of physiological or pathophysiological processes
including tissue perfusion, immune response, thrombosis, inflammation and
atherosclerotic disease.
Second, as part of triacylglycerols, fatty acids are involved in energy
storage and fuel production in animals. During meals, fatty acids may be
incorporated into triacylglycerols and stored mostly in adipose tissue which
represents the largest reservoir of these storage lipids. Triacylglycerols are
highly concentrated stores of metabolic energy because they are reduced and
anhydrous. The yield from the complete oxidation of fatty acids is about 37
kJ/g, in contrast to about 17 kJ/g for carbohydrate and protein. In situations
such as fasting or between meals. fatty acids are mobilized from stores and
transported to the tissues where they are required for energy (tin and Connor,
1990; Halperin and Rolleston,. 1990).
Individual fatty adds are acquired through the diet, tU nooo synthesis and
via elongation and/or desaturation. All mammals can synthesize saturated fatty
adds tU 11000 from simple precursors such as glucose or amino adds. The cells of
most tissues can synthesize fatty adds. However. the liver and adipose tissue are
the most important organs for fatty acid biosynthesis. Acetyl CoA carboxylase
(ACe), the key regulatory enzyme in the conversion of citrate to long chain fatty
acids. catalyzes the carboxylation of acetyl CoA to malonyl CoA. The synthesis
of long chain fatty acids from acetyl CoA and malonyl CoA involves a sequence
of six reactions for each two carbon addition and this sequence is repeated
several times until the long chain fatty acid is produced. These reactions are
catalyzed by the fatty acid synthase complex which consists of two
multifunctional polypeptides (Figure 1.2). The end product of these reactions in
mammals is usually 16:0 and. to a lesser extent.18:0. Many eucaryotic cells have
the capacity for two carbon chain elongation,. both of endogenously synthesized
adds and of exogenous dietary adds (Cook. 1991; Thompson. 1992). In tissues
such as brain and liver there are two systems for elongation. one in endoplasmic
reticulum and the other in the mitochondria. The enzymes involved in fatty acid
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biosynthesis are active when high carbohydrate. low fat diets are eaten but
suppressed when the consumption of fat is high.
Unsaturated fatty acids must be supplied by dietary acids of plant and
animal origin or by oxidative desaturation (Figure 1.3). Monounsaturated. fatty
acids (i.e.• 18;1(n-9» are either obtained ftom·-the diet or fonned by direct
oxidative desaturation of preformed long chain saturated fatty acids via the
enzyme, .::19--desaturase. For the polyunsaturated. fatty acids, animals are
dependent on plants for the two major precursors of the n-6 and n-3 fatty acids,
18:2(n--6) and 18:3(n-3), respectively (Thompson.. 1992).
Enzym. Biosynthesis Diet Diet
0'
I
Diet
~
18:0
Stearic
9-0."""'.--1
'f
18;1 n-9 18:2 n-6 18:3 n·3
Oleic Unoleic Alpha linolenic6-0...'.....--1 ~ ~
18:2 n-9 18:3 n-6 18:4n-3
Elong".----i
Gamma ~linolenic~
20:2 n-9 20:3n-6 20:4 n-3
5-0·'·'·...·4 Oihomogamma ~linolenic~
20:3 n-9 20:4n.-6 20:5 n-3
'Mead" Arachidonic Eicosapentaenoic
~ (EPAIElongase .. ~
22:4 n-6 22:5 n-3
Adrenic ~?4-Desaturas~ ~
22:5 n-6 22:6 n-3
Docosapentaenoic Docosahexaenoic
(OPA) (OHAI
Figure 1.3 Biosynthetic Pathway of Long Chain Polyunsaturated Fatty Acids
(Adapted from British Nutrition Foundation, 1992).
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The predominant wuaturated. fatty acid families are the n-6 fatty acids
derived. from 18:2(n-6), the n-3 fatty adds derived. from 18:3(n-3), and the n-9
fatty acids derived. from 18:1(n-9). All three parent compounds compete for the
enzymes responsible for elongation and d..esaturation. For instance, these 18-
carbon unsaturated. fatty acids require d6-desaturase for the introduction of a
double bond at position 6. Each of these fatty adds can compete for the same
enzyme and therefore influence the metabclism of fatty acids of other families.
The re~ction rates for the enzyme are different, with 18:3(n-3) being preferred to
18:2(n~ which is preferred to 18:1(n-9). SirlCe the North American diet has more
18;2(n-6), the predominant pathway is that of the n-6 series in which 18;2(n-6) is
converted to 20:4(n-6) (Lands, 1992; Cook, 1991). IT 18:2(n-6) is low in the diet,
then the other two 18-<:arbon unsaturated fatty acids compete for the .o.~
desaturase. Usually, 18:1(n-9) is more ab<undant than 18:3(n-3), and thus, its
desaturation and elongation is enhanced, resulting in an accumulation of the
'Mead acid', 2O;3(n-9). "This fatty acid con.tributes to the structur.tl integrity of
membranes; however, it is not a precursor for the eicosanoids as are 20:4(n-6) or
20:5(n-3) and it does not alleviate the signs of essential fatty add deficiency
(Cook. 1991; British Nutrition Founrlati<lI\, 1992). As a consequence of the
competition for the enzymes involved in .e1ongation and desaturation.. 18:3(n-3)
appears to be poorly converted to the long chain fatty acids produced in its
pathway; Le.,ORA and EPA (Lands, 1992) .
1.2 DIFFERENTIAL METABOUSM OF FATI"Y AODS
As a constituent of triacylglycerols and phospholipids, fatty acids are to
some extent positionally restricted. with a saturated fatty acid usually found in
the sn-1 position and an unsaturated acid in the sn-2 position. However, the
actual fatty acids incorporated into phospholipids and triacylglycerols may differ
depending on tissue variation, species variation, or environmental factors such as
diet. Depending on the degree of WlSaturation or the chain length, fatty acids
may behave differently with respect to their involvement in metabolic processes
resulting in differential metabolism.
It has been found that dietary lipids can induce extensive modifications in
the fatty acid composition of tissue membranes. Such modifications have been
shown to lead to a variety of functional changes, including membrane fluidity,
ion tran.sport, cellular responses as well as the biosynthesis of eicosanoids. For
instance, upon fish oil supplementation in human and animal feeding trials
(Careaga-Houck and Sprecher, 1989; Abeywardena et al, 1987; Urakeze et al,
1987; Schick et al. 1990; Gibney and Bolton-Smith, 1988; Marl et al,1987), it was
observed that EPA can replace, in part, 20:4(n-6), the major precursor of
eicosanoids (Figure 1.4), in platelet phospholipids. This outcome has a major
impact on platelet functions such as platelet aggregation. Figure 1.5 illustrates
the synthesis of different thromboxanes from different fatty acid substrates. The
presence or absence of one double bond in the side chain can make a significant
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Figure L4 Synthesis of Ei(OAl'l.oids From AradUcionic Acid (20:4. n-6)
(Adapted from. Marl et aI, 1987).
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Figure L5 Synthesis of Thromboxanes From Fatty Acid Substrates
<Athpted from Mascioli, 1989).
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difference in the physiological function of a particular eicosanoid (Mascioli.
1989). When 2O:4{n--6) is the substrate. thmmboxane A2 (TxAz) is synthesized by
platelets. TxA2 has two double bonds in its side chain and is a potent
vasoconstrictol: and platelet aggregator. However. thromboxane A3 (TxA3).
synthesized from EPA, has three double bonds and is a platelet antiaggregatory
agent. Consequently, it has been suggested that diets high in fish oils may lead
to a synthesis of the 3-series eicosanoids, replacing the plateiet·reactive
eicosanoids of the 2-series. The resultant shift in the balance of proaggregatory
to antiaggregatory compounds could then lead to a decrease in thrombotic
tendency (Moti et ai, 1981). However, the extent to which the membrane
composition must be aItered in order to affect platelet function (i.e.. the
EPA/20:4(n-6) ratio) remains unknown.
Differential metabolism with respect to fatty acids' involvement in energy
produ.ction has also been demonstrated. Figure 1.6 shows the process of
activating fatty acids in the cytosol to their correspondent fatty acyl CoAs prior
to being transport across the mitochondrial membrane into the mitochondrial
matrix. Once inside the matrix these fatty acyl CoAs participate in £H>xidation.
Long chain fatty acyl CoAs require the camitine enzyme system for transport
across the mitochondrial membrane. However, McGarry et al (1977) observed
that the transport of medium chain fatty acyl CoAs. containing 8-10 carbons was
carnitine independent.
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Figure 1.6 lrltercol\version of Fatty Acyl Coenzyme As and Fatty Acyl
Camitines (Adapted. hom Huperin and Rollestoft, 1990).
AbbreviatioM are: FF_Free Fatty Acid.; CYfo-<:amitine palmitoyl
transferase outer mitocltondrial meD\brane; cm._Cunitine
palmitoyl transferase inner mitochondrid membrane.
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Many investigations have examined preferential oxidation of fatty adds
(Leyton et al,. 1987; Mead et aL 1956; Cenedel.la and Allen. 1969; Jones et al.
1985; Willebrands, 1964; Jones, 1994). Leyton and coworkers (1987) reported
preferential oxidation of 18:1(n-9) and 18:3(n-3) over other long chain fatty adds
such as 18:2(n-6) and the 20 carbon unsaturated. fatty adds. This group of
investigators examined whole body fatty add oxidation in rats by comparing the
tracer appearance rates in the form of expired CO2 from the labelled fatty acid.
Rats that were previously fed chow received an oral dose of 5-6 ).lG of a labelled
fatty acid dissolved in olive oil The animals were then placed in metabolic
chambers and the expired 14<:02. was collected for a period of 24 hows. From
their data, Leyton and coworkers (1987) observed more expired 14caz from rats
that received either 18:1(n-9) or 18:3(n-3) than the other fatty acids examined.
Consequently, they concluded that these two fatty acids were preferentially
oxidized. However, this study has been criticized for not correcting for the
specific activity of the labelled precursor, resulting in a variation in the
enrichment of the endogenous fatty acid pools. In essence, this study did not
measure the absolute rates of oxidation of each fatty acid and thus, the data
cannot be used to assign relative rates of oxidation.
In order to rectify this problem, Jones (1994), in a recent study, determined
whole body fatty acid oxidation but he controlled the amount of dietary fatty
acids the rats consumed as well as the endogenous pools. He did this by feeding
13
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animals for ten weeks diets that rontained. identical amounts of the three 18-
carbon unsaturated fatty adds; i.e., 18:1(n-9), 18:2(n-6), and 18:3(n-3). After the
ten week feeding period, he gave the rats 20 )lO of the labelled fatty add in
question in a bolus dose of oil also containing identical amounts of these three
fatty adds. Jones (1994) observed no difference among the oxidation of these
fatty acids. In fact, the curves were almost superimposed. upon each other and
thus, he concluded that there was no preferential oxidation with regards to the
18-carbon unsaturated fatty acids.
1.3 n-3 FATTY ACIDS
1.3.1 WHY THE INTEREST IN n-3 FATlY ACIDS?
A great deal of interest has been generated concerning dietary fish and
fish oils since epidemiological evidence suggested a high intake of fish correlated
with a low incidence of cardiova.scu1ar disease (CVD) and thrombotic disorders.
The beneficial effects of fish oils have been a.ttributed to the actions of the long
chain n·3 fatty acids, EPA and DHA.
In addition.. evidence suggests that feeding dietary fish oil favours energy
substrate oxidation reducing the fraction of metabolizable energy partitioned for
storage Oones, 1988). Jones (1988) further states that this finding supports the
notion that the selection of dietary fat alters the efficiency of energy substrate
deposition and may playa role in the pathogenesis of obesity.
..
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EPA and OHA have been reported to have a wide range of important
biological and. physiological effects. rn their classic:: epidemiological studies.
Bang and Oyerberg (1972. 1986) noted. that the preva1enc::e of evo in the Inuit
community of West Greenland was lower than that of the Oanes despite a diet as
high in fat and cholesterol as that of the Oanes. 1he most striking difference
between the diets was in the type of fats consumed (Table 1.1). The authors
evaluated. the diet of 130 Inuits and found that their diets had high levels of long
chain polyunsaturated n-3 fatty acids (Bang and Oyerberg, 1972). Interestingly,
the Oanes' diet contained twice as much saturated fat and more n-6 poly-
unsaturated fatty acids than the Inuit diet (Dyerberg, 1972). It was observed that
the Greenland Inuit had lowered levels of serum cholesterol. LOL, and VLOL,
high HDL COncentratiON. prolonged b1eed.ing times, easy bIUisability, decreased
number of platelets as well as a reduction in platelet aggregation.. All of these
factors have been linked to a low rate of coronary thrombosis.
Hirai et a1 (1980) found similar results as Bang and Oyerberg (1972) when
they compared the diet and blood lipids of Japanese fishermen who consumed
2.6 g EPA/d with those of Japanese farmers (D.9 g EPA/d). They found a lower
mortality rate from ischemic heart disease and cerebrovascular disorders in the
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Table Ll Dietuy Fats in lnuit and. Danish Food Intake Computed on a
Daily Energy Consumption of 3000 kcal (Ad.ia.pted hom Oyuberg..
1986).
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Dietarv Fats
Fatene
Saturated.:
Monoenes:
Polvenes:
PIS Ratio
Ololesterol(~/dav)
%
12:0
14.-0
16:0
18:0
20:0
0/0 Total fats
16:1
18;1
20:1
2H
0/0 Total fats
182n-6
18:3n-3
20:5 n-3
22:5 n-3
22:6n-3
0/0 Total fats
Inuit
39
1.1
3.7
13.6
4.0
0.1
23
9.8
24.6
14.7
8.0
58
5.0
0.6
4.6
26
5.9
19
0.84
14
0.79
16
D~..
42
5.9
75
255
95
43
53
3.8
29.2
0.4
1.2
34
10.0
20
0.5
o
03
13
0.24
10
0.42
fishing village than the farming village and related this to a higher consumption
offish.
Retrospective epidemiological studies from some Western countries
during World Wax II infer that a high intake of fish and fish products was
associated with a reduction in thrombotic disorders. rn Norway, Jensen and
colleagues (1952) reported that mortality from coronary heart disease (CHO) as
well as the incidence of thrombotic and embolic diseases decreased dramatically
during' the wax At the same time, due to food. shortages, people had a reduced.
caloric intake and were forced to eat fish and fish products which resulted in an
estimated three to four fold increase in intake of this particular food. Thus, the
authors concluded. that the fall in cardiovascular mortality was due to the
cholesterol lowering effect of fish in the diet. In agreement, Bang and Dyerberg
(19B1) presented retrospective evidence of a relationship between long chain n-3
fatty acids and CVD in Oslo during the second world wax. These authors
calculated that this population consumed about 4-5 g of EPA a day. After the
wax, when the nutritional situation returned to normal, the prevalence of
thrombotic diseases in Oslo increased to the pre-wax level.
In a longitudinal study of risk factors and their relationship to chronic
diseases, Kromhout et al (l985a, 1985b) recorded the dietary habits of a group of
men in the town of Zutphen. Netherlands and followed its mortality over a 20
yeax period. They examined risk ratios for mortality from aiD in relation to the
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amount of fish "eaten and found. that an inverse dose-response relationship was
observed. between fish consumption in 1960 and death from am during the 20
years of follow-up. Mortality from am was more than 50% less among those
who consumed. at least 30 g fish/d (less than 0.5 g EPA) than among those who
did not eat fish. suggesting that the consumption of as little as one or two dishes
per week may be of preventive value with regards to CHD. However, these
investigators concluded that some element other than 0·3 fatty adds was
cardioprotective since there was such a low consumption of EPA by this
population. In a critical review of the literature, Harris (1989) co=ented. that
there were drawbacks to this report such as the failure to continue prospective
dietary surveys, the use of a single dietary survey without follow-up, and failure
to report the fish intake of those with preexisting coronary disease who died.
The results of the Western Electric Study demonstrated. the same inverse
relationship between coronary death and the amount of fish eaten, supporting
the observation by Kromhout et al (1985a, 1985b). Shekelle et al (1985) carried
out this cohort study among 2000 middle-aged men employed by the Western
Electric Company in Chicago, starting in 1957 and following this population for
25 yean. The authors remarked that ~although a biologic explanation for this
association is not yet clearly established., the evidence supports the hypothesis
that something associated with regular consumption of fish may be helpful in
preventing CHD".
I. l
However, studies done in Norway (VoU$et et al. 1985; Nordey et u. 1987)
and Hawaii (Curb and Reed, 1985) did not find this relationship. Vollset et a1
(1985) noted no such relation in the analysis of their follow-up study in Norway
of 17,000 respondents to a postal delivery survey. Curb and Reed (1985)
examined the relationship of reported fish consumption to total and fatal aro
over a 12 year follow.up period. on 7615 Japanese men without prevalent
atherosclerotic disease, as part of the Honolulu Heart Program. 1be apparent
trends were not statistically Significant when loolcing at the 12 year incidence rate
for total and fatal aiD in relation to fish consumption. In rebuttal, Kromhout
(198Sb) commented that there was variation in the results of these studies
because of the methods used to obtain the fish. consumption data.. The dietary
reporting methods were similar in the Western Electric Study and the Zutphen
Study. The investigators used extensive c:ross-<heck dietary histories, providing
information on usual food. intake. rn contrast, Vollset et a1 (1985) collected.
information from a postal survey. They collected the information on the basis of
responses to 3 questions about fish. intake. From these questions a fish index was
derived. but, as Kromhout (198Sb) remarks, it is not clear what amount of fish.
was consumed by the persons in the different categories of fish consumption.
Curb and Reed (1985) conducted food frequency questionnaires along with 24
hour dietary recall surveys. These methods can result in errors in the collection
and recording of food consumption data including respondent biases, Le., over-
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reporting 'goo~.' foods and under-reporting those foods considered bad',
memory lapses, and incorrect estimation of portion sizes.
Nordey and coworkers (1987) commented. that in a coastal community in
Northern Norway, a traditionallyhigh intake of fish was not sufficient to induce
platelet and plasma lipids similar to what had been reported from Greenland
and Japan. These investigators conducted a study in Northern Norway investi-
gating the mortality from am and comparing the dietary lipid. and hemostatic
parameters in subgroups of the population in two communities. One group was
located. on the coast where the majority of the population was employed. in the
fishing industry and the other was a typical inland farming community. The fish
consuznption was approximately 2.5 times higher in the coastal area with two
thirds of the intake being of a lean variety. The daily intake of EPA was 0.25 g
for the inland area and 0.90 g for the coastal community. They found that the
coastal region had higher plasma triacylglycerol levels and no significant
differences in the other lipid fractions when compared to the inland group.
Bleeding times were also similar in the two groups. In addition, a higher
mortality for both. men and women was observed. in the coastal community.
Nordey et al (1987) concluded that "unknown potent thrombogenic factors may
mask possible effects of a rather high intake of n-3 fatty acids." However, the
coastal group's EPA intake in this study was not quantitatively different from the
intake of the farmers in Japan (Hirai era!, 1980) or that of the Danish population
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studied by Bang and Dyerberg (1972). Therefore, it is not surprisirLg that Nordsy
and coworkers observed similar results in the coastal and inland populations.
The epidemiologica1evidel'lce for the beneficial CVD effects of dietazy fish
oils has been supported by data obtained by numerous animal and human
feeding trials. The underlying mec:hanistns for reduced incidence of CVD by n-3
fatty acids have focused on lipid and lipoprotein metabolism.
A number of reports have shown that the consumption of fatty fish.
marine oils rich in n-3 fatty acids or n-3 fatty acid supplements lower serum
triacylglycerol concentrations compared to control diets in both human and
animal investigations (Weiner et aL 1986; Garg et a.l 1989; Singer et aL 1986;
Fehily et aI. 1983; Goodnight et aI. 1982; Saynor et ai, 1984; Sdu:nidt et aI, 1993;
Phillipson et aI, 1985; Harris et al.. 1990; Harris et aI. 1991; Simons et a.L 1985).
Lipoproteins that transport triacylglycerol. especially VLDL and lOr... have
likewise been lowered (Weiner et aI. 1986; Sayner et ai, 1984; Nestel et ai, 1984;
Harris et ai, 1991). There is overwhelming evidence that fish oils decrease both
triacylglycerol and VLDL concentrations in a clear dose dependent fashion in
normolipidemic as well as hyperlipidemic subjects. According to Neste! (1993),
the average reduction in triacylglycerols seemed to be 40-50% auld the minimal
effective dose of n-3 fatty acids appeared to be about 1 g daily with a plateau in
the concentration reached when the dose was between 5-10 g.
II
The triac,ylglycerol-Iowering effect of n-3 fatty adds appears to be due to a.
decrease in fatty acid synthesis (Herzberg and Rogerson, 1988; Iritani et al, 1979;
Iritani et aL 1980; Yang and W1lliams, 197B), a reduction in hepatic synthesis of
triacylglycerols and the secretion of VLot (Herzberg and Rogerson, 1988; Wong
et al, 1984; Mizuguchi et al, 1993; Nestel et al. 1985; Harris et al, 1984; Nestel et
al, 1984; Sanders et al, 1985; Connor, 1986), an increase in the clearance of
triacylglycerol~ntaininglipoprot'eim (Herzberg and Rogerson. 1989; Baltzell et
al, 199i; Herzberg et al, 1990; Mizuguclti et al, 1993; Goodnight et al. 1982), and
pem.aps, to a lesser extent, an increase in fatty acid oxidation in the liver (Wong
et al, 1984) as well as the peripheral tissues. Decreased absorption of dietary fish
oil does not appear to contribute to its hypotriacylglycerolemic effect (Q\emenko
et al, 1989; Herzberg et aL 1991; Thomson et al, 1988).
There is more uncertainty about the effects of EPA and DHA on plasma
cholesterol, LOL, and HDt. LOL cholesterol has been found either to increase
(Weiner et al. 1986; Saynor et al, 1984; Harris et ai, 1991), decrease (Singer et al,
1986; Nestel et a.l. 1985), or not change (Fehily et al, 1983), despite diminished
cholesterol absorption, decreased cholesterol synthesis, and increased sterol
excretion (Mizuguchi et al, 1993). A minor increase in HOt cholesterol could
generally be demonstrated (Singer et al. 1986; Sdunidt et at. 1993; Harris et at.
1991), but could a.Jso decrease (Davis et ai, 1987) or not change (Fehily et a.L 1983;
Goodnight et al, 1982; Sayner et ai, 1984).
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Studies have also examined. the role of n-3 fatty acids in reducing the
development of thrombotic disorders. Since thrombotic events include platelet
activation as well as the explosive biosynthesis of the eicosanoid. thromboxane.
investigations have focused on changes in fatty acid content of phospholipids
following dietary fish oil supplementation (Abeywardena et al, 1987; Careaga-
Houck and Sprecher. 1989; Heemskerk et aI. 1989; Urakeze et aI. 1987; Schick et
at 1990; Gibney and Bolton-Smith. 1988; Morl et aI. 1987; Piche and
Mahadevappa, 1990) as well as the effects of dietary fish oils on total
phospholipids in platelet membranes (Abeywardena et aI. 1987; Careaga-Houck
and Sprecher. 1989; Heemskerk et aI.. 1989; Aukema and Holub, 1989).. platelet
function (Urakaze et ai, 1987; Schick et at 1990; Salonen et aI. 1987; Gibney and
Bolton-Smith, 1988; Nagakawa et aI. 1983) and mechanisms which may alter
platelet function (Heemskerk et aI. 1989; Gilmey and BoLton-Smith, 1988;
Sanders et al1980; Lands et at 1973; Culp et al..1979; Corey et aI. 1983; Hwang
et al..1988; Swann et al1989).
Evidently.. diet manipulation with fish oils has a definite effect on platelet
membrane fatty acid composition and, more than likely. platelet function. Fish
oil supplementation does not seem to affect the relative proportions of the
individual platelet phospholipids; i.e., total phosphatidylcholine (PC).. phospha-
tidylethanolamine (FE), phosphatidylinositol (PO, phosphatidylserine (PS), and
sphingomyelin (SM) (Abeywardena et al, 1987; Careaga-Houck and Sprecher,
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1989; Heemskerk et al. 1989). Aukema and Holub (1989) also found that there
was no marked change in the relative proportions of phospholipid subda.sses,
alkeny1acy1 PE and diacyl PE, in platelets over a 12 week experimental period.
However, in both animal and human feeding trials. there is a change in the fatty
acid composition of these phospholipids upon fish oil supplementation
(Careaga-Houck and Sprecher. 1989; Abeywardena et al. 1987; Ucleze et ai,
1987; Schick et aI. 1990; Gibney and Bolton-Smith. 1988; Morl et aI. 1987). A
decrease in 20:4(n-6} with a concomitant rise in EPA in total phospholipids was
seen upon fish oil supplementation. However, contradictory results were found
with the accumulation of OHA or other n-3 polyunsaturated fatty acids in PC
and PE; the fatty acid content of PS. PI, and SM; and the effect of diet-induced
changes on platelet function.
The relationship between fish oil supplementation and platelet aggrega-
tion has been studied using platelet-rich plasma to which various concentrations
of aggregating substances (i.e.• collagen, ADP. and thrombin) have been added
(Urakaze et aI. 1987; Schick et aI. 1990; Salonen et aL 1987; Gibney and Bolton-
Smith, 1988). The results of several reports have shown that the conswnption of
fish oil can significantly decrease platelet aggregation (Uralcaze et aI. 1987;
Schick et ai, 1990; Nagakawa et aI, 1983). These observations are of interest
because platelet aggregation is considered. to be involved in the development of
arterial thrombosis after the formatioit of atherosclerotic plaques.
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Several .mechanisms have been proposed to explain diet-induced.
alterations in platelet function. First, many authors have suggested that fish oil
feeding may alter membrane fluidity, and changes in fluidity may have a role in
the activation process of blood platelets (Heemskerk et ai, 1989; Gibney and
Bolton-Smith, 1988). However, these investigations did not show any significant
effects of fish oil supplementation on membrane fluidity measured by
fluorescence polarization. In fact, Heemskerk et al (1989) suggested their results
indicated that changes in platelet responsiveness to thrombin and TxAz.. rather
than membrane fluidity, may be responsible for the effects of dietary fatty acids
on rat platelet aggregability. Second, n-3 fatty acids may serve to promote
platelet disaggregability through substrate competition, displacing 20:4(n-6) from
tissue phospholipid pools and consequently, reducing the availability of 20:4(n-6)
for thromboxane synthesis. It has been suggested. that a decreased 20;4(n~)/
EPA ratio in platelet phospholipids may be responsible for decreased platelet
aggregation after the consumption of fish oil (Sanders et al, 1986; Schick et al,
1990; von Schacky et al, 1985). A third mechanism involves the ability of EPA
and DHA to competitively inhibit cyclooxygenase which would result in a
decrease in TxA2 synthesis. It has been shown that n-3 polyunsaturated fatty
acids can bind to the active site of this enzyme with affinities equal to or greater
than that for 2O:4(n-6) and therefore are effective inhibitors (Lands et al, 1973;
Culp et ai, 1979). Additional mechanisms that may explain the effect of fish oils
on platelet lipid composition and function include 1) the possibility that Long
2S
chain n-3 fatty acids inhibit 46-desaturase and. thus, the conversion of 18:2(n-6) to
2f):4(n-6) (Hwang et aI.. 1988) and/or 2) that EPA and ORA may interfere with
the binding of TxA2 to the TxA receptor in platelets (Swann et ai, 1989).
1.3.2 EICOSAPENTAENOIC ACID [EPA,. 2o-.s(n-3)1 AND
OOCOSAHEXAENOIC ACID [DHA, :u,6{n-311
The long chain n-3 fatty acids, EPA and OHA., appear to favourably
modify more than one factor implicated in the pathogenesis of atherosclerosis
and thrombosis. These fatty adds are involved in hypolipidemic effects, platelet
,
.I effects. viscosity effects, blood pressure effects, and so on. However. questions
still remain involving the nature and metabolism of these two fatty acids.
The n-3 fatty acids belong to a series of polyunsaturated fatty acids
characterized by the first double bond at the third position from the methyl end
whereas the n-6 fatty acids' first double bond is at the sixth position. Figure 1.7
illustrates the structural formula of the main n~3 and n~ fatty acids in the human
body. n-3 and n-6 fatty acids are not interconvertible (Figure 1.3). They form a
Significant part of cell membranes.
18:3(n-3) is found in some vegetable oils especially linseed,. flaxseed and
soybean oils. Fatty fish like mackereL herring and salmon that live in the North
Atlantic and marine mammab such as seal are particularly rich in OHA and EPA
(Nordey, 1991). The n-3 fatty acids in marine animals are exclwively 20 and 22
carbon fatty acids, probably because of the low temperature of the animal's
environment which demands that their lipids include more highly unsaturated
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molecules (Dyerberg, 1986). Table 1.2 summarizes the amount of n-3 fatty acid
in different varieties of fish oil. A few terrestrial plants (some mosses and ferns)
and range-fed nonruminant game animals are also sources of EPA and DRA
(Tinoco, 1982).
The n-3 fatty acids are primarily found in biological tissues esterified to
phospholipids, triacylg1ycerols, and cholesterol. In humans, n-3 fatty acids are
present in all cell membranes but brain,. retina, and reproductive organs are
particularly rich in DRA, accounting for 15-25% of the total amoWlt of DRA
found in the body (Benolken et al, 1973; Lampty, 1976; TInOCO, 1979; Salem et
al, 1986). DHA appears to be the principal n-3 fatty acyl component found in
cells; 18:3(n-3) and EPA are usually only found in trace amounts in most tissues,
often as metabolic intermediates (Salem et al, 1986). Of special interest, it
appears that the removal of n-3 fatty acids from the diet of adult rats has little
effect on the DHA content of the brain or retina. Since adult brain is resistant to
DHA content loss, a deficient state can only be achieved by depriving an animal
of n-3 fatty acid sources at an early stage of development or by depriving the
female during pregnancy. Studies have shown that tissues high in DHA
tenaciously retain it in the face of dietary challenge and replace it with other 20
or 22 carbon polyunsaturated fatty acids only when necessary (Salem et ai, 1986).
These investigations suggest that there is a critical period. early in development
when DHA is taken up from the diet and incorporated into phospholipids and
l
IbC~COOH
a -IiI:IIcni: acii (CIS:3. n ·3)
ELC~COOH
Ei::osapencaemic acid (C205,n--3)
DocosaheJl:aemi:: acn (C22;6,n-3)
fLC~COOH
AraclJi10nic acid (C20:4.n-6)
H,C~COOH
Lixlici:: acil (C182.n-6)
Figure 1.7 Structures of the Main n-3 and. n-6 Fatty Acids.
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Table 1.2 n-3 Fatty Acid Content in Common Marine Oils (g/100 g fat).
Oils 18:3(n-3) EPA (20:5, n·3) ORA (22:6, n·3)
Cod Liver 0.7 9.0 95
Herring 0.6 7.1 4.3
Menhaden 1.1 12.7 7.9
Salmon 1.0 8.8 11.1
maxEPA (concentrate from 2.4 17.8 11.6
Menhaden)
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possibly that elongation and desaturation systems are more active during fetal or
early developmental stages.
EPA and DRA have not only been shown to have similar biological
actions such as their role in reducing platelet aggrega.bility but, in addition,. have
been found to individually possess unique properties or functions. For instance,
OHA clearly inhibits prostaglandin synthesis and has its own platelet·modifying
actions separate from EPA but has little influence, unlike EPA, over leukotriene
pathways (Gorlin. 1988). However, it is apparent that ORA has specific roles in
visual acuity and brain development in the growing infant. It has been generally
assumed that the various cardioprotective effects attributed to dietary fish and
fish oils are due to EPA because it acts as a precursor of some of the eicosanoids.
L4 TIlE PROBLEM STATEMENT·EPA IS PREFERENTlALLY
METABOLIZEO RELATIVE TO ORA.
L4.1 RATIONALE
Many investigators have suggested. that EPA is preferentially metabolized
compared. to DHA, thus, implying that EPA may be the principal component in
marine oils responsible for the beneficial CVO and antithrombotic effects. In
addition. EPA may alter energy substrate utilization in such a way that it has a
possible role in long term energy balance. Studies have shown an enridu:nent of
OHA in tissues such as adipose tissue or skeletal muscle relative to EPA
(Sheppard and Rettberg.. 1992; Lin and Connor, 1990; Jandecek et al, 1991;
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Raclot and Groscolas. 199'). Sheppud and Henberg (1992)~ the effect
of dietary fish oil and com oil on the fatty acid composition in adipose tissue,
muscle and liver for a period of seven weeks in young, growing rats. Their
results dearly showed that the triacylglycerol composition of the tissues studied
was influenced by the fatty add composition of the dietary fat. They
demonstrated that OHA was deposited in adipose tissue at a concentration
similar to that at which it is absorbed. Figure 1.8 shows that the proportion of
DHA absorbed is similar to the amount that is deposited. in the epididymal fat
pads of rats fed diets that contain fish oil (Herzberg. 1991). EPA, in adipose
tissue. is considerably less than DHA and in the lymph during fish oil
absorption.
Consequently, EPA is greatly underrepresented in adipose tissue
compared. with. the amount of EPA absorbed. from the diet. Similar results were
observed in adipose tissue of rats studied. by]andecek et aJ (1991) and Radat and
Groscolas (1994) as well as in zdipose tissue of rabbits (Un and Connor. 1990).
This difference in the n-3 fatty add content of triacylglycerols is also seen in
skeletal muscle and liver but it is most dramatic in the liver where OHA is
present at nearly twice its content in the diet and nearly SO'Yo more than EPA
(Sheppard and Herzberg.. 1992). These results are consistent with those reported
by Yeo and Holub (1990) for liver triacylglycerols.
31
C 100 Lymph FAs as % of MaxEPA
.. 90 Iwi 8070 +a 80
.:. 50 tI 4030
""
20 --<>- "'A
:£ 10 """0i- 0 80 120 180 240 300 360
! Time (min after bolu. infusion)
60
Epididymal FAs-MaxEPA-% diet
8 T50
I 140
e 300
"~ 20
a 10 --<>- EPA
... DtlA
0
0
w_
./
figure L8 Lymph Fatty Acids as Percentage of MaxEPA uul EpididyuW
Fatty Acids-MaxEPA-Percenlaglt of Diet. (Acb.pted hom
Herzberg.. 199U.
32
L4.2 OVERALL HYPOTHESIS
The reason for the underrepresentation of EPA in adipose tissue is still
unknown. This underrepresentation is not due to differential intestinal
absorption because, previously in our laboratory, it has been shown that both of
these fatty acids are absorbed to the same extent in rats (Chernenko et al, 1989).
We hypothesize that EPA is preferentially utilized relative to ORA by peripheral
tissues and that is why relatively less EPA is stored. Three possible mechanisms
to explain this overall hypothesis of preferential utilization include:
Mechanism #1: EPA is preferentially oxidized relative to ORA in muscle.
Mechanism #2:. EPA is preferentially released relative to OHA from
circulating triacylglycerols.
Mechanism #',3: EPA is preferentially secreted into bile relative to OHA.
1.4.3 PRIMARY OBJECTIVES OF THE STUDY
Mechanism Itl: EPA is preferentially oxidized relative to ORA in muscle.
Objectives:
1.1 To examine the oxidation of EPA and OHA by soleus muscle
homogenates from rats fed fish oil containing diets.
1.2 To examine the oxidation of EPA and OHA by the intact soleus
mwcle of rats fed fish oil containing diets.
1.3 To examine the oxidation of EPA and OHA by cardiac myocytes of
rats fed fish oil containing diets.
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Mechanism #2: EPA is preferentially released relative to DHA from
c:ittu1;lting triacylglycerols.
Objective:
2.1 To investigate the rate of hydrolysis of EPA and OHA from
triacylglycerols found in chylomicrons.
Mechanism *3: EPA is preferentially secreted relative to DHA in bile.
Objective:
3.1 To investigate the biliary secretion of EPA and OHA in phos-
pholipids from rats fed fish oil containing diets.
Chapter 2 of this report discusses the oxidation studies which examined
the hypothesis that enhanced. oxidation of EPA relative to OHA in the peripheral
tissues; i.e., skeletal muscle and cardiac muscle, results in less EPA available for
storage (Objectives 1.1, 1.2, 1.3). Chapter 3 covers the research that considered
the question of selective release of EPA from triacylglycerols (Objective 2.1).
These investigations employed heart lipoprotein lipase as the enzyme and
chylomicrons isolated. from lymph as the substrate. Lastly, Olapter 4 deals with
the secretion of EPA and OHA into bile using bile cannulated rats as the animal
model (Objective 3.1).
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L4.4 SECONDARY OBJEcrIVES Of THE STUDY
Previous work in our laboratory, as well as by others, compared the
differing effects of the n-3 and n--6 series of fatty acids on lipid metabolism.
Consequently, we decided it would be of interest and value to use the same
comparisons in the feeding expetiments reported in this thesis.
m addition, the experimental design of this study allowed. us to
investigate the effect of dietary fat composition, i.e., n-3 and n-6 fatty acids, on
fatty acid oxidation and on bile phosphoUpid composition. Even though there is
some evidence that a high fat diet has an effect on bile flow and the secretion of
biliary lipids (Knox et ai, 1991; BalasubramaniaJn et ai, 1985; Ramesha et ai,
1980; Turley and Dietschy, 1979), there are few data on the effect of diets on the
composition of biliary phospholipids. We were interested. in examining this
effect because it has been suggested that bile lipids contribute to the composition
of lipid in lymph.
Consequently, rats were fed either a diet containing 1O'Yo com oil or 8%
MaxEPA oil plus 2% com oil as the fat source to investigate the following
.j
objective"
Objective 1.1.1 To determine whether the rates of oxidation of EPA
and DHA by rat soleus muscle homogenates are
affected by diets rich in either n-6 fatty acids or n-3
fattyacid$.
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Objective 1.3.1
Objective 3.1.1
Objective 3.1.2
Objective 3.1.3
Objective 3.1.4
To determine whether the oxidation of EPA and DHA
by rat cardiac myocytes is afft!cted. by diets rich in
either n~ fatty acids or n-3 fatty acids.
To determine whether the composition of biliary
phospholipids could be altered by feeding rats diets
rich in either n-6 fatty acids or n-3 fatty acids.
To determine whether diets rich in n-6 fatty acids or
n-3 fatty acids affect the rate of bile Bow as well as the
biliary secretion of phospholipids. cholesterol,. and
bile acids.
To determine if feeding a meal rich in n-3 or n-6 fatty
acids could induce short-term changes in the fatty
acid composition of biliary phospholipids after rats
have been fed. diets containing either fish oil or com
oil
To determine whether diets rich in n-6 fatty acids or
n-3 fatty acids affect the rate of bile flow as well as the
biliary secretion of phospholipids, cholesterol. and
bile acids after an infusion of fish oil or com oil
36
L
CHAFfER 2.0
FATTY ACID OXIDATION IN SKELETAL AND CARDlAC MUSCLE
2.1 INTRODUcnON
While studying the mechanism(s) for the triacylgIycerol·!owering effect of
dietary fish oil , Wong and her colleagues (1984) found that not only did fish oil
feeding result in a decrease in the synthesis and secretion of VIDL by isolated
perfused rat livers, but that this decrease in synthesis and secretion was also
accompanied by an increase in ketogenesis, suggesting an inaease in hepatic
fatty add oxidation. Aarsland et al (1990) investigated whether the stimulation
of fatty acyl CoA oxidase and camitine palmitoyltransferase (CPT) activities, the
key enzymes in peroxisomal and mitochondrial oxidation of fatty acids,
respectively, might contribute to the triacylglycerol-lowering effect of fish oils in
rats. Their data support the concept that long chain n-3 fatty acids from fish oils
act by partitioning free fatty acids away from triacylglycerol synthesis toward
fatty acid oxidation (especially peroxisomal oxidation) in the liver. Furthennore.
Gavino and Gavino (1991) determined that CPT was more reactive with the fatty
acyl CoA of EPA than the fatty acyl CoA of DHA in liver mitochondria. These
results are consistent with increased. oxidation of EPA relative to ORA in liver.
Herzberg and Rogerson (1989) argued. that if enhanced oxidation is to
playa role in the hypotriacylglycerol~c effect of fish oils, then there should be
37
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a change in the. activity of lipoprotein lipase (U'L) in peripheral tissues to allow
for the increased delivery of fatty acids for oxidation. They deterIrtined the
activity of LPL in muscle (ie., hindlimb and heart) and adipose tissue of rats fed
diets containing com oil, tallow and marine oil as their fat source for a period of
2 weeks. These authors found that adipose tissue LPL activity was unaltered. by
dietary fat but muscle U'L activity was increased in animals fed fish oil (Figure
2.1) as they hypothesized.. This observation has been confirtned. by Balttell et al
(1991) who found that the activity of LPL was higher in the soleus muscle of rats
fed menhaden oil compared. with com oil, although there was no effect on
hepatic lipase.
Subsequently, Herzberg et al (1990) examined. the clearance of EPA and
18:1{n-9) by perfused hindquarters of rats fed either a corn oil or fish oil based
diet (Figure 22). They found that the clearance of both fatty adds was higher in
rats consuming the fish oil containing diet. In addition, with either diet, the
clearance of EPA was greater than 18:1{n·9). Thus, they concluded that there
may be preferential removal of EPA compared. with 18:1(n-9) regardless of the
dietary fat but that the removal of either fatty acid was enhanced. in animals fed
fish oil In human studies, it has been. shown that EPA disappears faster than
DRA from plasma or erythrocytes after fish oil supplementation (Hodge et al,.
1993; Brown et al, 1991). From the clearance data, we presumed that perhaps
more EPA is available to peripheral tjssues; i.e., skeletal muscle and heart, to take
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part in various metabolic processes such as oxidation. thus making it less
available for storage in adipose tissue..
These observations plus the fact that EPA is underrepresented in adipose tissue
triacylglycerols (Figure 1.8) compared to OHA led us to hypothesize that EPA is
oxidized at a faster rate in muscle than OHA. Thus, to investigate this proposaL
fatty acid oxidation studies were conducted using soleus muscle homogenates,
intact soleus muscle and cardiac myocytes. The purpose of the experiments
discussed in this chapter (section 2.3 to section 2.6) was to examine preferential
fatty acid oxidation, particularly oxidation of the EPA and ORA. in skeletal and
cardiac muscle.
The intent of the next section (2.2) is to describe the pathway of a-
oxidation of long chain fatty acids in muscle (Figure 2.3) and to review the
current literature on its regulation. It should be noted that there is a scarcity of
infonnation available on the regulation of fatty arid oxidation in skeletal muscle
since most studies have been done with the isolated perfused rat heart. nus
model is used often because it is a convenient. highly controlled and viable organ
system (Ontko, 1986).
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Figuzt! 2.1 Muscle Lipoprotein Lipase Activity <Adapted &om Herzberg ~d
Rogerson, 1989)... denotes ~ SignifiCoUlt difflUU\ce due to diet.
40
f
~5
!
..
...
--0- MaxEPA f.ct m.-EPA in PIl"f\IMte
Com 011 Mel rm.-EPA In pertuute
-<)-- MaxEPA fed 1'IIta.-OIelIte in perlu..te
Com 011 r.d .....01... In perlu.••te
604515
o+-----.,.-----~---___,----~
a
Figure 2.2 Hindq1Ulter Fatty Acid 09nnce (Adapted. &om Heaberg: et.d.
199O).
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Figure 2.3 kxidation of Long Otain Fatty Acids in Heart (Adapted from
Lopaschuk et aI. 1994).,
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2.2 B-OXIDATION OF FATIY AQDS IN MUSCLE
Fatty acid oxidation is a major energy source for some tissues (Le. cardiac
and skeletal muscle) in the body. The degree of fatty add utilization depends
upon the metabolic stab!: of the body and becomes significant when an individual
is fasting, exercising, or on a high fat diet. Fatty acid oxidation is quantitatively
important in muscle due to the body's large muscle mass (Bremer, 1983). Fatty
acids are degnded. by the oxidation of the B-carbon. and may be oxidi2:ed. in the
mitochondrial or peroxisomal matrix.. Peroxisomes appear to have a role in
chain shortening of very long chain fatty adds (Singh et al19B7).
The regulation of fatty acid oxidation in muscle appears to be a
complicated interplay of many factors such as the availability of energy-yielding
substrates, the need. for ATP, the acetyl CoA:CoA ratio, the level of malonyl CoA
and so on. In muscle, the overall rate of fatty add oxidation is controlled by the
supply of free fatty adds to the tissue and the need for energy. By comparison,
the key control in liver is a low plasma glucose concentration. When glucose
levels are low, there is a decrease in insulin secretion resulting in a decrease in
intracellular malonyl CoA and a rise in fatty acid oxidation (Halperin and
RoUeston, 1990).
2.2.1 THE PATHWAY OF MITOCHONDRIAL 8-OXIDATION OF FArrY
ACIDS
The initial step in fatty acid metabolism is the activation of fatty acids to
their corresponding fatty acyl CoAs. This activation takes place in the cytosol
prior to their entry into the mitochondrial mat::ri.x.. The activation reaction,
catalyzed by acyl CoA synthetase. is the summation of two steps:
1)
o
R-< +A'IP
o
Fauy Acid
2)
,?
R-C-AMP+CoA-SH
o
"
R-C-A.o.\tlP+ PPi
Acyl Adenylate
P
R-C-S-CoA + AMP
Fatty Acyl CoA
I
•j
Overall reaction:
o 0
R-C + AlP+CoA-SH+lbO---R-~-COA+AMP +2Pi+2fi
'Cf
The reaction is driven forward since inorganic pyrophosphate is hydro-
lyzed by a pyrophosphatase. The hydrolysis of two high energy compounds
makes this overall reaction essentially irreversible.
Long chain fatty acids require camitine for transport into the mito-
chondrial matrix (Figure 1.6) whereas medium chain (C8-CI0) acyl CoAs are
carnitine independent (McGarry et at 1977). McGarry et al (1977) used. the fact
that the transport of medium chain acyl CoAs was camitine independent when
malonyl CoA was found to potently suppress the oxidation of 1B:1(n-9) in rat
..
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liver homogenates while having no effect on the oxidation of octanoic acid or
octanoylca.mitine. Four components are presumed to be involved in the trans.-
port system (Halperin and Rolleston. 1990); 1) the malonyl CoA regulatory
protein of camitine pabnitoyltransferase (CP11 on the outer mitochondrial
membrane (Murthy and Pande, 1987) 2) the CPT on the inner aspect of the outer
mitochondrial membrane (CPTo or CPTl) which converts external acyl CoA to
acylcam.itine (Murthy and Pande, 1987), 3) a translocase which exchanges mito-
chondrial camitine for cytoplasmic fatty acyl~tine (Noel et ai, 1985), and 4)
the CPT on the inner mitochondrial membrane (CPTI or CPTV which regen-
erates fatty acyl CoA inside the mitochondria (Figure 1.6).
Saturated acyl CoAs (for example. 16:0) are then oxidized. by a recurring
sequence of four reactioN (Figure 2.4): 1) an oxidation reaction linked to FAD, 2)
a hydration step, 3) a second oxidation reaction linked to NAD+, and 4) the
thiolysis of CoA. The electron-transferring flavoprotein (ETF) shown in Figure
2.4 is an intermediate in the transfer of electrons from acyl CoA dehydrogenase
to the respiratory chain. The Q..oxidation of 16:0 requires 7 sequential cycles and
yields 8 acetyl CoA molecules, 7 FADHz. and 7 NADH per molecule of the fatty
acid. The oxidation of even chain unsaturated fatty acids foUows the same
sequence but requires two additional reactions involving an isomerase and
reductase. If odd chain fatty acids are oxidized, a propionyl CoA is generated in
the final thiolysis step.
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Figure 2.4 Fatty Acid. B-oxidation in the Mitochondri.iLl Matrix (Adapted
&om Ontko, 19M).
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2..2.2 PEROXISOMAL B-OXIDATION OF FATTY AODS
Peroxisomal S-oxidation occws by reactions which are similar to those of
mitochondrial fatty acid oxidation. As with mitochondrial B-oxidation,
peroxisomal B-oxidation proceeds via four consecutive reactions that take place
in the peroxisomal matrix (Reddy and Mannaerts, 1994; Schulz, 1990).
However, there are definite differences between the fatty acid oxidation in these
two organelles. The differences between the two pathways include the following
points:
Very long chain acyl CoA synthetase. the enzyme responsible for
the activation of very long chain fatty acids (chain length of 20
carbons or more), is present in peroxisomes and endoplasmic
reticulum but not in mitochondria (Singh and Poulos, 1988). This
may explain why long chain fatty acids are oxidized predominantly
in peroxisomes.
The first reaction in peroxisomal B-oxidation (desaturation of acyl
CoA) is catalyzed by an FAD-containing fatty acyl CoA oxidase
which is presumed. to be the rate-limiting enzyme whereas an acyl
CoA dehydrogenase is the first enzyme in the mitochondrial
pathway.
Peroxisomal B-oxidation is not directly coupled to an electron
transfer chain that cpnserves energy by means of oxidative
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phosphorylation. Electrons generated in the first oxidation step ace
transferred directly to molecular oxygen yielding Hz02 that is
disposed of by catalase. However, energy produced in the second
oxidation step (NAD~ reduction) is conserved in the form of high
energy level electrons of NADH
The second (hydration) and third. (NAD+-dependent dehydro-
genation) steps in peroxisomes ace catalyzed by a multifunctional
protein which also displays &3, 42..enoyl CoA isomerase activity
required for oxidation of unsaturated fatty adds (Reddy and
Mannaerts, 1994). On the other hand, it is proposed that all the
enzymes in the mitochondrial pathway are organized into a
multienzyme complex (Stanley and Tubbs, 1975; Srere, 1980).
Peroxisomal B-<lxidation does not go to completion but catalyzes a
limited number of B-oxidation cycles and thus, acts as a chain
shortening system. The enzymes have virtually no activity towards
short chain fatty acyl CoA esters.
Acetyl CoA generated by mitochondrial B-oxidation enters the
Krebs cycle for further oxidation or condenses to keto acids in the
liver. Peroxisomes lack the Ktebs cycle and ketogenic enzymes,
thus the fate of the acetyl units produced by the peroxisomal «-
oxidation is unknown. Either they are further oxidized in mito-
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cbondria or used for biosynthetic purposes (Red.dy and Mannaerts.
199').
The mechanism of fatty acid entry into peroxisomes still remains
unclear. The common belief that the uptake of fatty acyl substrates
into the peroxisomal mat:rix. was carnitine independent has been
challenged by recent evidence.. An enzyme (CPTp) which shares a
number of prope..rties with mitochondrial CPTo has been. identified.
in peroxisomes (Vamecq, 1987; Derrick and Ramsay. 1989;
Guzman and Geelen. 1993).
2.2.3 REGULATION
The overall factors which determine the rate of fatty acid oxidation in
muscle are substrate availability and the rate of energy ut:ilization. The supply of
fatty acids to muscle cells depends on the composition of the diet. the
concentration of VLDL in the citculation. the concentration of plasma fatty acids
complexed to a1bwnin. and the cellular uptake of free fatty acids from the
circulation.
Dietary long chain fatty acids enter the circulation as triacylglycerols in
chyloauaons and fatty acids become available to the muscle cell a.ftet the
hydrolysis of the triacylgiycerols by LPt.. If the diet is low in fat. then there is a
rapid rate of r:U navo synthesis of fatty acids in the liver from carbohydrate
precursors (Ontko, 1986). Fatty a.cids are then transported to the muscle in
..
triacyiglycerol-i'ich lipoproteins. VIDL It is believed that increased insulin
levels due to carbohydrate intake may promote LPL activity in adipose tissue
which is responsible for the hydrolysis of triacylglycerols at the plasma
membrane (Robinson,. 1963).
Fatty acids can also be mobilized from adipose tissue to the muscle in
calorie-restricted. diabetic, postabsorptive and fasting conditions. lhis is an
important regulatory process with. respect to rates of fatty acid oxidation in
many anim.a.l tissues. It has been postulated that the supply of fatty acids in
these conditions is mainly controlled by the activity of horrnone-sensitive lipase
(HSL) which is responsible for the hydrolysis of triacylglycerol within the
adipocyte (Stralfors et at 1987; Halperin and Rolleston, 1990). This enzyme is
subject to regulation by covalent modification. specifically phosphorylation/
dephosphorylation. When insulin levels are low. as in the case of fasting or
diabetes, HSL is phosphorylated resulting in a rise in activity and therefore, an
increase in triacylgiycerol hydrolysis.
Normally, the tissue level of fatty acids in the heart is very low. However,
oxygen deprivation to cardiac ceI.ls as in the case of ischemia, will diminish or
completely abolish mitochondrial B-oxidation, the Krebs cycle and respiratory
chain activity and hence, accumulation of fatty adds and their metabolic
derivatives occurs (Van Der Vusse et al, 1992). According to Van Der Vusse et al
(1992), in the initial phase of ischeJ:riia. when hardly any irreversible cell damage
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occurs, the rate of the so-called triacylglycerol-fatty acid cycle (Le.., simultaneous
hydrolysis and re:synthesis of triacylglycerol) is enhanced, leading to wasteful
energy consumption.
The route of fatty acid transport from the vascular space to the cytoplasm
of the cardiomyocytes comprises a sequence of events and, unlike other organs
such as liver, is much more complicated due to the presence of closed fenestrae
between the endothelial cells (Van Der Vusse et aL 1992). The cellular uptake of
fatty adds may involve fac:ilitated transport via a fatty acid binding protein
(FABP) but this hypothesis is still debatable since other studies claim that the
uptake occurs by spontaneous diffusion (Schulz, 1994). Van Der Vusse et al
(1992) states that •After transloca.tion through the luminal membrane of the
endothelial cell. diffusion of fatty acids occurs through the intet:stitial space
between the endothelial and parenchymal cells of the heart and is most likely
mediated. by albumin" (Figure 25). The sarcolemma is crossed either passively
or fac:ilitated by specific membrane proteins identified as plasma membrane
FABPs. three tissue specific FABPs have been isolated in the cytosol and it has
been suggested that these proteins are responsible for transporting fatty acids
within the cytoplasm to the mitochondrial membrane (Od:ner et al. 1972;
Brerner,1983; Schulz. 1994).
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Figure 2.S Transport of Fatty Acids in Heart Tissue (Adapted from Van Der
Vwse, 1992). Abbreviations are: FAzfatty acid; FABP=fatty acid
binding protein; LPL-lipoP1'Otein lipase.
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The need for ATP required for muscle work also in£I.uences the rate of
fatty add oxidation. Tn muscle tissues, which lack ketogenesis, Bremer (1983)
indicated that /H}xidation must be tightly coupled to the Krebs cycle through the
common mitochondrial pool of CoA,. especially under conditions in which. for
example, the heart uses fatty add almost exclusively for its energy needs.
Furthermore, he suggested that feedback mechanistns must exist by which a
variable use of acetyl CoA in mitochondria can adjust the rate of fatty acid
uptake, activation, and acylcamitine formation in the extramitochondrial
compartment (Bremer, 1983).
2.2..J.l ENZ'YMATIC REGULATION
The conversion of fatty adds to acetyl CoA consists of three major stages:
1) activation of fatty acids to form acyl CoA, 2) formation and translocation of
acylcarnitine and. regeneration of acyl CoA in the matrix. and 3) the a-oxidation
""I"""ce.
The activation reaction is catalyzed by the enzyme, acyl CoA synthetase.
It is not clear to what extent the synthetase reaction is rate-limiting. if at all, in the
oxidation of long chain fatty acids. It has been suggested that the rate-limiting
step for very long chain fatty acids is the chain shortening system which is
attributed to the peroxisomes (Singh et ai, 1987). The activation reaction appears
to be effectively controUed by the cytoplasmic acyl CoA;CoA ratio as well as the
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total concentration of CoA and is inhibited by its reaction products. inorganic
phosphate and AMP (Van Der Vusse et aI. 1992).
Acyl CoA synthetases appear to differ in their s:peci£icities with regards to
the~ length of fatty acids (Laze et aL 1990). For imtance. myocardial tissue
contains short chain. medium chain,. and long chain acyl CoA synthetases. The
long chain acyl CoA synthetase is predominantly localized on the outer side of
the mitochondrial outer membrane in the heart but probably also to some extent
at the sarcoplasmic reticulum (Van Oer Vusse et al. 1992). Furthermore. long
chain acyl CoA synthetases such as palmitoyl CoA synthetase have been shown
to be present in mitochondria, peroxisomes and aticrosomes (Miyazawa et at
1985) and immunological evidence suggests that the pabnitoyl CoA synthetases
located in these three organelles are identical (Miyazawa et al, 1985). Laze et at
(1990) observed that Iignoceroyl CoA synthetase. a very long chain acyl CoA
synthetase, and palmitoyl CoA synthetase are two distinct enzymes and that
mitochondria lack the former enzyme. This data further supports acyl CoA
synthetases' substrate specificity and subcellular regulation in fatty acid
metabolism.
Suzu.ki et aI (1990) provided evidence for the stimulation of long chain
acyl CoA synthetase in rat liver by diet at the pretranseriptional leveL They
observed that long chain acyl CoA synthetase mRNA is expressed in liver, heart.
and epididymal adipose tissue and to a much lesser extent. in brain,. small
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intestine, and lung. The level of long chain acyl CoA synthetase mRNA
increased seven to eight fold in rat liver by feeding a diet high in carbohydrate or
fae
CPTo and CPTi catalyze the interconversion of fatty acyl CoAs to fatty
acyLcamitines (Figure 1.6) and playa role in mitochondrial transport of fatty acyl
CoAs. The focnation of acylcamitines commits the fatty add to the oxidative
pathway. This step is considered. by some investigator as being rate-l.im.iting.
McGarry et al (1978, 19m proposed. that CPTo was the malonyl CoA-sensitive
enzyme and the key regulatory site for fatty acid oxidation in rat liver
mitochondria whereas CPTi appeared to be the malonyl CoA-insensitive
enzyme. It is assumed that malonyl CoA interacts competitively with palmitoyL
CoA causing a ronfonnational change in the catalytic component and thw, the
loss of activity of CPTo. In 1983, these researchers studied the response of CPTo
to camitine in mitochondria isolated &om various tissues in experimental
animals and man (McGarry et aJ.. 1983). In non-lipogenic tissues (i.e. cardiac and
skeletal muscle), they found a marked sensitivity of CPio to malonyl CoA
inhibition. However, in contrast to liver, the activity of CPTo in heart, and its
sensitivity toward malonyl CoA, does not appear to change in response to
fasting (Mynatt et al, 1992; Cook and Lappi, 1992). Cook and Lappi (1992)
suggested that changes in fatty acid oxidation in the heart are probably due to
changes in malonyl CoA concen~tions or to other inluoitors as opposed to
55
;
l
altered sensitivity to the inhibition in response to dietary states such as fasting.
Thus, possible control of myocardial fatty acid oxidation via the regulation of
CPTo by malonyl CoA remains an unresolved issue.
Veerkamp and Van Moerkerk (1985) compared. the effed:s of cam.itine
omission and of various inhibitors (i.e. malonyl CoA, tetradecyLglycid.ic acid. and
mersalyl) on fatty acid oxidation by homogen.ates of rat liver, rat ske!et:al muscle
and human skeletal muscle as well as rat muscle mitochondria. They also
reevaluated the effects of nutritional state, palmitate/albumin ratio and pH on
malonyl CoA sensitivity of palmitate oxidation. Inhlbitors of mitochondrial fatty
acid transport and the omission of camitine decreased. oxidation more strongly
with muscle than with liver homogenates. The effect on malonyl CoA sensitivity
was dependent on nutritional state, pH.. and palmitate/albumin ratio in liver
homogenates but only the latter parameter with muscle homogenates.
Swprisingly, malonyl CoA was found to be present in significant amounts
in rat heart and skeletal muscle (McGarty et al, 1978). Malonyl CoA is
synthesized from acetyl CoA by the enzyme, acetyl CoA carboxylase (ACq, and
it appears that in the heart the primary role of ACe is in regulating fatty acid
oxidation (Lopaschuk et ai, 1994). Biandri et a1 (1990) identified an unique
biotin-containing cytosolic protein of molecular mass 280 kDa expressed. in rat
cardiac and skeletal muscle that was coexpressed with the 265 kDa protein in rat
liver, mammary gland, and brown adipose tissue. They concluded. that the 280
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kDa protein is an isoform of ACC, distinct from the previously cloned 265 kDa
species. Its presence in cardiac and skeletal muscle, where fatty acid synthesis
rates are low, suggest that it might play altemative roles in these tissues such as
in the regulation of fatty acid oxidation or microsomal fatty acid elongation.
Saddik et al (1993) investigated the role of ACC in regulating fatty acid oxidation
in isolated, fatty acid perfused working rat hearts. The overall fatty acid
oxidation rates were determined by the addition of 1.2 mM PHIpalmitate to the
perfusate of hearts in which the endogenous triacylglycerol pool was prelabelled
with (l4{:Jpalmitate. Rates of both exogenous and endogenous fatty acid
oxidation were measured by simultaneous measurement of 3HZO and 14<:02
production, respectively. They found that ACC is an important regulator of fatty
acid oxidation in the heart and that acetyl CoA supply is a key determinant of
heart ACC activity. Furthermore, Awan and Saggerson (1993) examined
malonyl CoA metabolism in viable myocytes obtained from rat hearts and
concluded that malonyl CoA can be synthesized. within cardiac myocytes and
that the level of this metabolite can be acutely regulated. As acetyl CoA levels
increase, ACe is activated resulting in an increase in malonyl CoA and thus
malonyl CoA inhibition of fatty acid oxidation.
A great deal of work has focused on the characterization of the CPT
enzyme system. Difficulties in the characterization of these enzymes have been
due to the fact that the readily purified, catalytically active form of CPT isolated
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from detergent extracts of mitochondria represents only CPTi and not CPTo.
CPTo seems to lose its activity when released from its membrane environment.
It is not clear whether CPTo and CPTi result from the same mitochondrial CPT
protein and this has limited the attempts at molecular characterization of CPT
<egUlation.
To answer the question of whether CPTo and CPTi represent the same or
distinct proteins, two models have been postulated (Figure 2.6) (McGarry et ai,
1990). Model 1 suggests that they are the same protein but CPro has a
regulatory unit. Using detergents to solubilize the proteins is assumed to disrupt
the link between the regulatory and catalytic units in CPTo and consequently,
releases the enzyme from inhibitory control The second model suggests that
there are two distinct proteins. Murthy and Pande (1990) presented evidence
that supported the concept of model 2. They were able to obtain a solubilized
malonyl CoA-sensitive CPTo from the outer membranes of rat liver
mitochondria by using octyl glucoside in the presence of glycerol and were also
able to separate CPTo from CPTi using HPLC on a hydroxyapatite column.
Their results indicated that CPTo and CPTi are distinct proteins and that a
subunit of 90 kDa for liver and 86 kDa for muscle constituted a component of
their respective CPTo systems while the 66 kDa subW\it of CPTi did not. Their
most convincing evidence for this conclusion involved a polyclonaI antibody
5.
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Figure 1.6 P0S5ible Schemes to!' Malonyl eoA Inhibition of CPTo (Adapted
from McGury et aI. 1990). Mociell is representated on top and
Model 2 on the bottom of the dUgram. Abbrevi.;ations ue: CPTo
(UDle as CPTIl-eamitine palmitoyll:ranseraS4l! 0 (D; CPTi (ume
as CP11D=amitine paltnitoyl transferase i (II); Mal·
CoA=malonyl eoA; Palm..coAapalmitoyl eoAj
CARN=c:amitine.
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which was raised against CPTL This antibody precipitated the CPTi activity but
showed no reactivity with the CPTo fractions. Other investigators (Declercq et
al, 1987; Woeltje et ai, 1990) have also observed a protein in rat liver and muscle
mitochondria of 94 kDa and 86 kDa, respectively. Furthermore, a protein of
smaller mass (about 70 kDa) has been observed. in rat liver and muscle (Woeltje
et ai, 1987; Woe.ltje et ai, 1990). Recently, CPTo and CPTi have been cloned
providing further evidence that they are two different proteins (Esser et ai,
1993a;·Esser et ai, 1993b).
The B-oxidation pathway in mitochondria is primarily governed by the
rate of regeneration of the nucleotide substrates for acyl CoA dehydrogenase
(FAD) and B-hydroxyacyl CoA dehydrogenase (NAD+) (Figure 2.4) (Ontko,
1986; Wang et ai, 1991). However, the detailed mechanism of this regulation is
not known. It has been suggested that the H-oxidation enzymes in mitochondria
are organized in a multienzyme complex but this complex has not been isolated
(Stanley and Tubbs, 1975; Srere, 1980). One feature which contributes to the
complexity in this area of study is the existence of multiple enzyme forms
exhibiting different chain length specificities (Thorpe, 1989).
Three distinct acyl CoA dehydrogenases with different fatty acid chain length
specificities have been isolated from hepatic mitochondria (Ikeda et aI, 1985).
These enzymes have four presumably identical subunits, and each subunit
contains one noncovaIently bound FAD which functions as an electron acceptor
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in the dehydrogenation reaction. Two enoyl CoA hyciratases have been
identified in pig heart mitochondria (Fong and Schulz, 1981) with short and long
chain specificity. 8-hydroxyac:yl CoA dehydrogenase has broad chain length
specificity but a long chain specific enzyme has been isolated by El·Falchri and
Middleton (1982). The essential function of the long chain en.oyl CoA hydratase
and. 8-hydroxyacyl dehydrogenase remains to be established.
The equilibrium is far to the product side in the thiolysis reaction which
pulls the I3--oxidation cycle to completion. Two thiolases have been identified;
the 3-ketoacyl CoA thiolase is believed to be involved in B-oxidation and has
broad chain specificity while acetoacetyl CoA thiolase functions in ketone body
metabolism (Middleton, 1975). U the essential sulfhydryl group of the thioIase is
oxidized or blocked, the enzyme becomes inactive. Thiolases are sensitive to
oxygen. alkylating agents and heavy metal ions (Schulz, 1990).
According to Schulz (1994), -it is proposed that the flux of fatty acids
through B-oxidation in heart is controUed by the mitochondrial ratio of acetyl
CoA:CoASH. This ratio is det:emtined by the activity of the Krebs cycle and.
reflects the energy state of mitochondria and ultimately of the whole tissue. The
si.te of this control is the thiolase-<atalyzed last step of B-oxidation-. Studies
have demonstrated that both the activity of 3-ketoac:y1 CoA thiolase and the rate
of fatty acid oxidation, at sufficiently high levels of fatty acids, are inversely
related to the mitochondrial ratio 01 acetyl CoA:CoASH (Latipaa, 1989; Wang et
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aL 1991; Olowe and Schulz, 1980). Wang et a1 (1991) studied the mechanism by
which the rate of fatty add oxidation is tuned. to the energy demand of the heart
by studying the effects of changing intramitochondrial ratios of [acetyl
CoA/CoASH] and (NADH/NAD+) on the rate of B-oxidation. They concluded
that the rate of B-oxidation can be regu.Ia.ted by the intramitochondrial acetyl
CoA/CoASH ratio which reflects the energy demands of the heart. The thiolytic
cleavage catalyzed by 3-ketoacyl CoA thiolase may be the site at which 8-
oxidation is controlled by this ratio. Schulz (1993) notes that this regulatory
mechanism is not effective in liver, in which the regeneration of CoASH from.
acetyl CoA is facilitated not only by the Krebs cycle but also by ketone body
synthesis.
2.3 PURPOSE OF EXPERIMENTS
The primary objectives (1.I, 1.2, and 1.3) of the experiments described in
this chapter examine the first proposed mechanism; i.e., EPA is preferenti.a!ly
oxidized telative to ORA in muscle.. The secondary objectives (1.1.1 and 1.31)
addressed the effect of dietary fat composition.. i.e., n-3 and n4) fatty acids on hty
acid oxidation.
Objective 1.1 To examine the oxidation of EPA and OHA by soleus
muscle homogenates from rats fed. fish oil containing
diets.
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Objective1.1.l
Objective 1.2
Objectivel.3
Objective!.3.l
To determine whether the rates of oxidation of EPA
and OHA by rat soleus muscle homogenates are
affected by diets rich in either n-6 fatty acids or n-3
fattyac:ids.
To examine the oxidation of EPA and DHA by the
intact soleus muscle of rats fed. fish oil containing
diets.
To examine the oxidation of EPA and ORA by cardiac
myocytes of rats fed. fish oil containing diets.
To determine whether the oxidation of EPA and ORA
by rat cardiac myocytes is aifected by diets rich in
either n-6 fatty acids or n-3 fatty acids.
i
-I
2.4 MATERIALS AND METHODS
2.4.1 CHEMICALS
Unless otherwise stated, all chemicals were purchased from Sigma
O\emical Company (St. Louis, Mo). Organic: solvents, acids, and toluene were
obtained from Fisher Scientific (Dartmouth. NS.) while Ready SafetM came from
Beclanan (Fullerton. Ca.), diethyl ether from DDH (Toronto, Ont.), NCS (tissue
solubilizer) from Amersham (Oakville. Ont.), and omnifluor from New England
Nuclear (Boston, Mass). Radiolabelled materials were purchased from Dupont.
New England Nuclear (Mississauga. Ont.). For the myocyte preparations;
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collagenase (Worthington type mwas purchased from Worthington Biochemical
(Freehold. N.J.) and the Joklik-MEM media (Gibco 41D-2300EB) from Gibco Ltd.
(Burlington. Ont.).
The components for the animals' diets excluding the fat sources were
ordered from 1m (Costa Mesa. Ca.). Mazolat'M com oil was purchased from a
local grocery store and MaxEPA oil was obtained as a gift from RJ'. Scherer.
Wtndsor. Ont.
2-4.2 ANIMALS
These experiments were carried out in accordance with the guidelines of
the Canadian Council of Animal Care. Male Sprague-Dawley rats from Charles
River Company (LaPrairie. Quebec) weighing initially 200-250 g were used for
skeletal muscle homoge:nates and cardiac myocyte preparations while those
initially weighing 160-190 g were used for the intact muscle experiments.
Animals were housed individually in plastic cages in a room maintained. at U h
light-dark cycles and a constant temperature (-20OC). The animals were
acclimatized. for about 1 week under these conditions before the start of the
experiment. The animals were then fed one of two basic diets for two weeks; a
diet containing 100/.. com oil or S'f.. MaxEPA oil plus 2% com oil as the fat source.
The diets were essentially modified AIN-76A diets containing 10% fat
with the following composition (g/kg): glucose-600; casein-ZOO; fat-100;
cellulose-SO; AThl' mineral mix-3S; AlN vitamin mix-to; methionine-3; choline
..
l
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chloride-2; TBHQ-O.02. Diets were prepared and stored as to minimize
oxidation (Fritsche and Johnston. 1988). The com oil containing diets were stored
under nitrogen at 40(: and the MaxEPA oil containing diets were stored. under
nitrogen at -2:IJOC. The fatty acid composition of the oils and diets was
determined by GLC and the results shown in Table 2.1. Any oxidation of the
diets was checked by analyzing the fatty add composition of the diets at various
times during the feeding period.
2..4.3 SKELETAL MUSCLE HOMOGENATE PREPARATION AND
INCUBATION
After 2 weeks on the diet, rats were fasted for 24-28 hours. Soleus muscle
homogenates were prepared using a method adapted from Zuurveld et al (1985)
and. total fatty acid oxidation was examined. The homogenization buffer
consisted of 250 mM sucrose, 2 mM EDTA and 10 mM Tris (pH 7.4). The
incubation medium (pH 7.4) contained, at a final concentration, the following; 25
mM sucrose, 30 mM Ka. 10 mM KH2P04, 5 mM Mg02, 1 mM EDTA, 0.025 mM
cytochrome c, 7S mM Tris, 5 mM ATP, 1 mM NAD, 0.1 mM CoA, 03 mM L-
camitine, and 05 mM L-malic acid. After the pH was adjusted, 0.1 mM fatty acid
free albumin and 0.5 mM [1-14<:]fatty acid were added.
The two soleus muscles weighing -0.30 g together were removed from a
cervically dislocated rat and homogenized in a potter Elvehjem tissue grinder for
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Table%.1 Fatty Acid Composition of the Diets and Oils (% of Total
Weight). V~uesaft mean weight percent of each fatty acid ~ S.D.
for t:hrtt samples of each diet.·
Fatty Acid MuEPA ComOll MuEPA CornOll
Diet Diet: ou
14-<) 8.05.0.20
16:0 18.13 ± 1.05 10.63 ~0.63 16.02 ~0.20 11.66 :;!;.O.ll
16:1 (n-7) 8.51 ±0.13 0.06 ±0.08 11.39%0.% 0.52:!:0.17
18:0 2.95 %0.20 1.77:t: 0.07 2.65:1: 0.13 1.68:1: 0.09
18:1 (n-9) 13.45:1: 1.00 28.28:t: 0.35 5.25:1: 0.28 26.55 ± 0.07
18:1 (n-7) 6.45 ~ 0.35
18:2(n~) 13.28 %0.79 55.51 :0.43 1.38:1: 0.03 58.73:1: 0.13
18:3 (n-3) 0.69 ~ 0.02 0.85 ~ 0.02 0.52 ± 0.07 0.90 :0.03
18:4-(n+3) 2.34.:1:0..24- 3.01 ~ 0.49 0.25 :!:0.05
2001 (n-9) 0 0.13 ±0.07
2O:4(n~) 0.64.0.03 0.69 :1:0.05
:m-.5(n-3) 11.48 ±:0.94 18.07:t: 0.39
22:1 (n-ll) 1.49 :t:0.14
22S (n-3) 1.34%0.03 1.57:l: 0.11
22.-6 (n-3) 7.31 %0.40 10.74 %0.08
.. l
3 min in 105. mL of the homogenization buffer. Fatty add oxidation was
measured by adding 200 ~l of the hom.ogena.te in 800 ~L of the incubation
medium containing either 0.5 mM [1_14c]-:EPA or [1-14c]-DHA. For the sake of
comparison the oxidation of other fatty acids was also determined. and these
fatty acids included 16;0, 18:1(n-9), 18:2(n-6) and 2O:4(n-6).
Incubations were carried out in 2S mL Erlenmeyer flasks in a shaking
water bath at 370<:. Reactions were started. by the addition of the homogenate,
and the flask was sealed with a stopper holding a centre well containing a piece
of folded filter paper. Incubations were carried out for 30 or 60 min.. The
incubation was terminated by the injectioo of 0.2 mL of 3 M perchloric acid into
the medium.. 14<:02 was collected by adding 0.3 ml of NCS (tissue solubilizer)
to the centre well. The flasks were shaken for an additional two hours following
which the centre wells were removed and added to a scintillation vial containing
10 mL of omnifluor-toluene. Radioactivity was determined. in a Beckman IS
7500 liquid scintillation counter using external standard quench correction. The
rate of 14<:02 production was linear for tb.eone hour incubation.
2.4.4 INTAcr SKElETAL MUSCLE PREPARATION AND INCUBATION
After a 24 hour fast. rats were anaesthetized with sodium pentobarbitol
(65 mg/loo g body weight). To maintain. muscles at their in situ resting length.
the soleus muscles were exposed. by blunt dissection and mounted. on surgical
stainless-steel wire supports (Ethicon, size 5) before the tendons were cut. .The
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tendons were then cut and the muscles preincubated. in 4.5 mL Krebs Ringer
Bicarbonate buffer for 30 min at 37OC. The medium contained the foUowing: 10
mM glucose; 0.10 unit/mL insulin, 0.1 roM fatty acid free albumin, and 0.5 mM
[l-14<:}fatty acid. The medium was equilibrated with 02/C02 (95%:5%) before
use and flasks were continuously gassed. throughout the preincubation period.
Muscles were then transferred to fresh medium of the same composition,
saturated with 02/C02, (95%:5%). A centre well with a piece of folded filter
paper was placed. in the flask and the flask stoppered. After a 30 min incubation
at 370C. the reaction was stopped with the injection of 0.2 mL of 30 % perch10ric
acid into the medium. NCS (0.3 mL) was added to the centre well in order to
collect 14{:02,. The flasks were shaken for an additional hour following which the
centre wells were removed. and added to a scintillation vial containing 10 mL of
omnifluor-toluene. Radioactivity was determined in a Beckman LS 7500 liquid
scintillation counter using extem.al standard quench correction. The rate of
14{:02 production was linear for the 30 min incubation.
Since a number of reports (Bonen et al. 1994; Palmer et al, 1981; MaItin
and Harris, 1985; Segal and Faulkner. 1985) suggest that the functional integrity
and viability of incubated muscles decrease with time, the viability of the intact
soleus muscle preparation during the incubation period was assessed by
measuring muscle ATP enzymaticallY according to the method by Lamprecht
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and Trautschotd (198!). The following experiments were performed using the
ATP concentration of freeze-da.mped soleus muscles (in trWo) (2351 ~ol/gdry
weight ± 2.92, n:::15) as an index. [n each set of experiments, from the same rat,
one muscle was treated one way while the contralateral muscle was treated a
second way. Using the paired Student's t-test, comparisons were made to see if
there were significant differences. First, intact muscles on the stainless steel
support (clipped) were continuously gassed with 02/C02 (9S'Yo;5'Yo) for 60 min
(2O.64 ~ollg dry weight ± 5.82, n:::4) compared to noncontinuously gassed
(14.70 ~ollg dry weight ± 4.61). Second, clipped muscles were continuously
gassed. for 30 min (IB.29 J.1IIl.ollg dry weight ± 4.43, nsll) versus those
noncontinuously gassed (20.84 j.Ul\ol/g dry weight ± 4..61). And lastly, clipped
muscles were noncontinuously gassed for 30 min (IS.IO lJ.Il\ollg dry weight ±
3.84. n=6) compared to those freeze.clamped (2S.60 J.1IIl..ollg dry weight ± 6.98).
In the last two approaches there were no significant differences. Thus, the
method used to detemtine fatty acid oxidation in the intact soleus muscle as
explained in the previous paragraph was a result of these observations.
2.4.5 PREPARATION OF CARDIAC MYOCYiES AND INCUBATION
Cardiac rnyocytes were isolated from rat hearts using an adaptation of the
procedures descrtbed by Kryski et a1 (1985) and Rodrigues et al (1992). After an
overnight fast, rats were injected intraperitoneally with 2 U/g body weight of
heparin (Solopak Lab, Elkgrove Village, m.) one hour prior to sacri.6.ce. The
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animals were anaesthetized with a ketalean-40 mg/kg (MTC Pharmaceuticals,
Cambridge, Ont) and xylazine-10 mg/kg (MTC Pharmaceuticals, Cambridge,
Ont.) mixture and the heart was then quickly removed. The heart was placed for
10 sec in a 50 mL beaker filled with Ca2+-free Joklik Medium supplemented with
1.2 mM MgS04 and 1.0 mM dl-eamitine (Solution Al. This solution had
previously been equilibrated with Oz/C02 (95%:5%) for 30 min, the pH adjusted
to 7.4 and warmed to 370C. The heart was then transferred to a large weigh boat
containing warm Solution A and as much fat and membrane tissue as possible
were removed. Using small forceps, the aorta was positioned on a cannula with
a second person securely tying it in place. The above procedure was performed
in less than two minutes.
The heart was perfused retrograde for 5 min in a non·recirculating system
with Solution A. Following, for approximately 15 min, it was perfused with
Solution B at a flow rate of 6--8 mL/min. Solution B contained Solution A, 251J.M
Ca2+, 0.1% fatty acid free albumin and 100 U/mL Collagenase. The ventricles
were isolated from the perfusion apparatus, sliced. with scissors and then
incubated with 15 mL of Solution C in a 370C waterbath shaking at 120·150
cycles/min for 10 min. Solution C contained Solution A, 2S IJ.M Ca2+ and 1.0 %
fatty add free albumin.
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Damaged and dead cells were removed by aspiration and the remaining
cells were incubated. with 15 mL of Solution B for 7 min at 370C under O2IC02
(95%50/0) gas at 140 cycles/min. Dispersed cells were decanted into a 50 mL
plastic centrifuge tube. The residual tissue was washed twice with 10 mL of
Solution C containing 250 J,1M Ca2+ to dislodge more myocytes, which were also
added to the centrifuge tube. These pooled cells were centrifuged at 4S g for 90
sec. The pellet was washed with 20 mL of Solution C containing incremental
Ca2+ concentrations of 250 pM. 500 pM. and 1 O\M and then.. resuspended with
20 mL of 1 mM ea2+ Solution C. Myocytes were filtered through a 200 pM
silkscreen mesh into a 50 mL plastic centrifuge tube. The cells were allowed to
settle for 15 minutes and then the medium was removed. via aspiration.
Subsequently, the cells were resuspended in 1:20 dilution (w/v) of Krebs-
Henseleit buffer containing 1.0 mM Ca02"and 1.25% fatty add free albumin.
Cell number and viability were determined microscopically by counting
samples from the final cell suspension using a Neubauer hemocytometer. Only
elongated. (rod shaped) cells which excluded trypan blue were considered viable.
The following cak:u.lation determined the number of live cells per mL as well as
per he"",
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Cell count X Dilytipn factor.: Cells/mL
4 x 10-4- (Ou.mber volume)
Cells/mL x Volume of ce1l suspension "" live cells obtained
fromonehe:art
To ensure that the cells were respiring. the rate of oxygen consumption was
measured. with a Oark electrode for cells isolated from rats on either diet. The
substrate used for these experiments was 05 mM 18:1(n-9).
To determine fatty acid oxidation, incubations were carried. out in 25 mL
plastic Erlenmeyer flasks in a shaking bath at 37OC. Cardiac myocytes were
incubated in Krebs-Henseleit buffer containing 1.0 mM ea02" 1.250/0 fatty acid
free albumin, 0.1 mM [1_14cJ oleic acid (18:1, n-9) plus 0.2 mM or 0.4 mM
unlabelled fatty acid. The unlabelled fatty acid was either 18:1(n-9), 2.0:S(n-3) or
22:6(n-3). Peroxisomal oxidation was determined. by adding 2.0 mM KCN to the
medium prior to the addition of the myocytes (nz4). Two hundred. (2.00)
microlitres of cells were incubated in 800 )lL of medium,. saturated with 02/C02
(95")'0:.5%), for 60 min in a temperature controlled. (3700 shaking bath. At the end
of the incubation, 0.2 mL of 30% perc:hloric acid were injected into the medium to
stop the reaction. The 14c0:z was collected and counted by liquid scintillation
spectrometry as desaibed. for the intact muscle preparations. The acid soluble
contents left in the flasks were placed. in a 15 mL eppendorf conical tube and
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centrifuged for 5 min. The supernatant was neutralized with 3 M K3P04 and 200
pI. were added to a scintillation vial containing 10 mL of an aqueous scintillation
solvent and subsequently counted. The rate of 14<:02 production was linear for
the 60 min incubation period and with the volume of cells used in the reaction.
2.4.6 STATISTICAL ANALYSIS
Demographic data such as grams of food that the animals ate, weight of
muscle tissue, and weight gain of animals was compared using the Student's t-
test. Paired comparisons were made between the contralateral intact soleus
muscles of the same rat. Statistical analysis employed the paired Student's t-test.
Fatty acid oxidation by muscle homogenates and cardiac myocytes was analyzed
by a two-way ANOVA (factors were diet and fatty acid). Differences between
means were determined using Duncan's new multiple range test. Data presented
are means ± S.D. Differences were considered. significant if p < 0.05.
2.5 RESULTS
2.5.1 OXIDATION OF FA'ITY AaDS IN SKELETAL MUSCLE
HOMOGENATES
Food consumption was similar in each experimental group irrespective of
dietary regime, indicating that appetite was not affected and diets were well
tolerated. After two weeks on the diets the animals in both groups had similar
weight gain; 67.6 g ~ 13.0 (n::l0) for the MaxEPA oil fed group and 68.3 g ~ 12.4
(n::lO) for the com oil fed group.' Rat soleus muscle (Figure 2.7) was used for
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these preparations because it is a red, aerobic muscle. easily exposed and has a
weU-deflned tendon so that the muscle can easily be removed without damage.
The weight of the two soleus muscles from an individual animal used in the
preparation were similar in both groups; 0.30 g:!: 0.03 (n:zlO) and 028 g ± OM
(n=lO) for the fish oil and com oil fed groups, respectively. Oxidation of fatty
acids by soleus muscle homogenates was not affected by diet (Figure 2.8). In rats
fed either diet, EPA was utilized at a significantly higher rate than DHA. For
MaxEPA fed animals, EPA was oxidized. at a rate of 0.379 J.1lII.ollg tissue/h :!:
0.299 and ORA was oxidized at a rate of 0.168 J.1IIl.ol/g tissue/h.:t 0.108. For com
oil fed animals, the rates for EPA and OHA were 0.316 J.1IIl.ol/g tissue/h.:t 0.222
and 0.119 J.1lII.ol/g tissue/h ± 0.129, respectively.
rn addition, 18:1(n-9) and 18:2(n-6) were oxidized at a greater rate than the
other fatty acids examined. (Figure 2.8). The two 20 carbon fatty acids. 2f):4(n-6)
and EPA, were oxidized at similar rates. From these results. it is evident that
fatty acids are preferentially oxidized. by soleus homogena.tes.
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Figure 2.7 DNpo' Muscles of the Rat Hindlimb (Adapted &om Hebel &nd
Stromberg.. 1976).
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Figure 2.8 Fatty Acid Oxidation By Soleus Muscle Homage-nates. Results
are means :t: S.D. for 10 muscle preparations except for 16:0 where
n=S. Means not sharing a common supersaipt are significandy
different.
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2..5.2 OXIDATION OF FATI'Y AODS IN INTACT SKELETAL MUSCLE
2.5.2.1 VIABILITY OF INTACT MUSCLE
In hindquarter perfusions, Herzberg et al (1990) demonstrated. that EPA
was removed &om the perfusate at a greater rate than 18:1(n-9) (Figure 2.2).
However, in the soleus muscle homogenates, 18:1(n-9) was shown to be oxidized
at a faster rate than OHA and EPA (Figure 2.8). In addition, EPA appears to be
oxidized at twice the rate of ORA under these conditions. Due to these
observations and the fact that any regulatory effects of the plasma membrane are
absent in the muscle homogenates used for the oxidation study, fatty acid
oxidation in the intact muscle next was examined.
Rat soleus muscle was used for the intact muscle preparations in order to
compare the oxidation results discussed in Section 25.1. In addition. it has been
recognized that because of the well-defined tendon, the soleus muscle can be
attached to clips or supports for incubation in vitro relatively easily. Maintaining
the muscle at resting length can positively affect metabolism. by decreasing the
risk of hypoxia.
According to Bonen et al (1994), the basic principle of this in tlitro
procedure is that individual muscles can be placed in small ve:ssels and that the
oxygenation and content of the incubation medium can be controlled..
Additionally, contralateral muscles from the same animals can be used for
comparisons. Furthermore, an adv~tageof the incubated muscle preparation is
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that differences in muscle capillarization are circumvented because oxygen and
substrate enter the muscle exclusively via diffusion from the incubation medium.
However, one potential disadvantage is that if incubating conditions are not
controlled properly, diffusion of these substances may be inadequate and muscle
viability will then be compromised (Bonen et ai, 1994).
Recent studies have provided evidence that hypoxia may occur in
conventionally incubated rat muscles; i.e., rat muscles which are not supported
and thus, are not at their resting length. For example, lactate levels and
lactate:pyruvate ratios in incubated rabbit muscles were twice those observed in
freshly dissected tissues (palmer et al, 1981). Similarly, isolated soleus and
extensor digitorum longus (EDL) muscles from young rats showed a central loss
of glycogen and a-glycan phosphorylase activity (Maltin and Harris, 1985; Segal
i and Faulkner, 1985). These changes were progressive with the time of
incubation, and occurred more rapidly at higher temperatures. Tissue in the
centre of incubated rat muscles had a lowered rate of incorporation of labelled
amino acids, suggesting that oxygen diffusion to the tissue core was insufficient
(Maltin and Harris, 1985). Baracos et al (1989) found that maintenance of
maximal 02 saturation of the medium by continuous aeration with Oz/C02
(950/0:50/0) stimulated protein synthesis by 20%, providing further evidence that
the supply of oxygen is limiting in conventionally incubated muscles.
78
Newsholme et al (1986) challe:nged the suggestion that their muscle
preparations were not viable. In their experiments, muscles (soleus and EDLl
were isolated and preincubated for 30 min. Preincubation medium was
equilibrated with 02/C02 (95%:5%) immediately before use and the flasks were
gassed with 02/C02 throughout this period. Muscles were then transferred to
fresh medium (02 saturated) and the gassing continued for the initial 15 min of
the 60 min incubation period. They found that the ooncentration ratios, i.e.,
ATP/AOP and ATP/AMP, were sUnilar in muscles freeze-c1amped in situ
compared to those incubated for 60-90 min in uitJ"O. Furthermore, the rates of
glycogenolysis were low, indicating an absence of hypoxiC stress. The rates of
! glucose tnnsport, glycolysis, and glycogen synthesis in these muscle
preparations were linear with time over a 60 min incubation, indicating there
was no significant development of hypoxia during the time course of the
incubation. Finally, electron micrographs of stripped soleus muscle, which had
been incubated for 60 min, indicated a normal mitochondrial morphology. It is
important to note that much of the work conducted by Newsholate·s group
employed stripped muscle treatments. However, when criticizing intact muscle
preparations in terms of optimal viability, MaItin and Harris (1986) were
referring essentially to whole muscle preparations and not stripped muscles.
Studies have shown that during incubation of whole muscles there was a
decrease in ATP and phosphocre~tine concentrations (Goldberg et al, 1975;
·"i
Bonen et aL 1994). If a muscle is not kept at its resting length then oxygen may
not be able to diffuse to the core of the muscle. Consequently, there may be
insufficient oxygen to sustain aerobic metabolism. Thus, muscles must be kept
extended or at resting length by placing them on some kind of support bridge.
Nevertheless, even when the muscle is on a support there are problems of not
enough oxygen getting to the centre of the tissue for aerobic metabolism during
incubations greater than 60 minutes. nus is due to what has been coined the
"core effect". Muscles stained histochemically for such substances as glycogen or
phosphorylase activity after 60 minutes of incubation have shown the
development of a "core" (the absence of stainable glycogen in the core) (Goldberg
et aL 1975). This "core" implies that oxygen has ~~deficient and that glycogen
I has been metabol.ized aNerobica1ly to supply energy for processes including
protein synthesis. Such .i".defidency would also excl.ude fatty acid oxidation as
an energy source.
"Core" formation and diffusion of oxygen are influenced by tissue
thickness and the metabolic rate of the donor animal Bonen et a1 (1994)
suggested that oxygenation of the incubating medium occurs via continuous
bubbling of 02/C02 (95'Yo;5'Yo) through the medium or by saturating the oxygen
content of the buffer. They found that the latter method can more than
adequately maintain the oxygen during experiments for .s....90 min duration.
Consequently, Bonen et a1 (1994)' states that the problem with the in vitro
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preparation is not the adequacy of the oxygen in the medium surrounding the
muscles. but rather whether the oxygen can penetrate to all the muscle fibres.
Goldberg et al (1975) suggested continuous aeration and ensuring that the
cross-sectional diameter of the tissue is s 105 mm, found in an animal weighing
60 g.. to guarantee viability. In other words, the use of younger animals with
smaller. thinner muscles or reducing the diffusion distance by taking small
muscle strips from a larger muscle would result in a viable preparation.
However. in the experiments reported in this thesis, continuous gassing
was not possible because of the closed. system used to capture the labelled C02.
The animals were on diets for 2 weeks and thus, weighed 250-300 g when the
muscle was excised In order to develop a model of intact muscle to use to obtain
results that were meaningful for the situation in moo, i.t was essential that the
physiological viability and integrity of the muscle be retained. Thus, the viability
of the isolated muscle during the intended incubation period was assessed using
ATP levels as an index for viability as described and reported. in Section 2.4.4.
2.5.2.2. FArrY AOD OXIDATION RESULTS IN lNTACf SKELETAL
MUSCLE
The weight gain for the animals on both diets was similar with the
MaxEPA oil fed. animals gaining 92.44 ~ 7.89 g (n:4) while the com oil fed
animals gained 84.16 ~ 8.95 g (n:4). The initial weights of the rats ranged. from
160-190 g.
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To determine if the rate of fatty acid oxidation was lineat, m.uscles from
the same rat were incubated for 15 or 30 min using 0.5 mM of unlabelled 18:1(n-
9) as the substrate. Figure 2.9 shows the time cowse resulting from five
experiments. It is evident that the time course is not linear. Indeed there is a
substantial lag. The problem may involve transport mechanisms and thus, I
added labelled substrate to the preincubation medium in order to allow
translocation of the substrate to take place and equilibration of tissue pools with
. i the labeL This treatment caused the rate of oxidation not only to become more
linear with time but also to i.nc:rease tenfold (Figure 2.10). Consequently, labelled
fatty acid was added to the preincubation medium for this procedure as
discussed in Section 2.4.4.
There was no effect of diet when comparing the rates of oxidation of
18:1(0-9) and EPA (Figure 2.11). However. it is apparent that 18:1(0-9) was
oxidized at 1.4-2.3 times greater a rate than EPA, regardless of diet in the intact
soleus muscle preparation. It is interesting to note that the rates of oxidation in
this model are madcedly less than observed for the muscle homogenates by at
least nine times for EPA and about 25 times for 18:1{n·9) (Figures 2.11 and 2.8).
The reason for the differences in the rates of oxidation could be a consequence of
the complex transport system involving the transfer of the substrate from the
·1
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Figure 2.9
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Time Course for Oleic Acid Oxidation in Isolated Soleus Muscle
Pre-Incubated Without and Incubated. With Labdled Oleic Acid
(1-{YCI18:l. n-9).
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Figure 2.10 Time Course fot' Oleic Acid Oxid.ation in Isolated Soleus Muscle
Preincu.bated Uld Incubated With Labelled. Oleic Acid. (1-
[14C118:1, n-9).
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Oteic Acid vs EPA Olddatton in Intact Soleus Mu.cle
•o 18:1(n-9)
figure 1.11 Oxidation of Oleic Acid and EPA in lntact Soleus Muscle.
Raults are means ± S.D. for 4 intact muscle preparations.
·Significant difference in rate of oxidation between the 2 fatty
acids, regardless of diet (p<O.OSl.
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incubation medium into the mitochondrial matrix (Refer to Figure 2.5), a
diffusion problem. or due to the fact that in the homogenate experiments all the
cofactors necessary for oxidiltion and the Krebs cycle are added to the incubation
medium. Thus. the mitochondria are exposed to optimal conditions for
oxidation. Furthermore. the intact muscle model maintains the muscle at its
resting length and. it is possible that the muscle does not use fuel efficiently when
resting. nus could be a aitical factor when examining the differentiation of
oxidation among varying substrates.
Since there was no effect of diet in the experiments using soleus muscle
homogenates or intact muscles. the oxidation rates of EPA versus ORA were first
compared using chow fed animals (n:8). As illustrated in Figure 2.12, there was
no significant difference in the rate of oxidation of either fatty acid with EPA
being oxidized at a rate of 0.017 %: 0.005 }1n\ol/g tissue/3D min while OHA
oxidized at a rate of 0.019 %: O.OU }1II\Ol/g tissue/3D min.
We also examined the rates of oxidation of EPA and OHA in the intact
soleus muscle of rats red fish oil containing diets since we were interested in the
effects of fish oil feeding on fatty acid oxidation. The animals gained. 82.72 g ±
15.23 (n::::7) after 2 weeks on the diet. There was no significant difference
between the rates of oxidation for the 2 fatty acids with the rates of oxidation for
EPA and OHA being 0.022 ± 0.008 }1n\ollg tissue/3D min and 0.018 ± 0.007
}1II\Ol/g tissue/JO min. respectively (Figure 2..13).
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Figure 2.U Oxidation of EPA and OHA in Chow Fed. Rats. Results ue means
: S.D. for 8 intact muscle preparations. No significant difference
between the 2. fatty adds.
l
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Figure 2.13 Oxidation of EPA and ORA in Intact Soleus Muscle of Fish Oil
Fed RAbi. Results Me means :: S.D. for 7 intJ.ct muscle
preparatiow. No significant difference betwHn the 2 fatty a.cids.
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2.5.3 OXIDATION OF FATTY ACIDS IN CARDIAC MYOCYI'ES
Over the two week feeding period. the two groups of animals had similar
weight gains with the MaxEPA fed rats gaining 73.9 ± 24.6 g (n=10) and the com
oil fed rats gaining 703.: 23.9 g (n...l0). The initial weights ranged from 236-305 g
for the com oil fed animals and 237-315 g for the fish oil fed group while the final
weights ranged from 3fJ1-367 g and 320-382 g. respectively.
The viability of the cell preparatior;' for the com oil fed group was 76.6%
± 6.6% (n=lO) and 73.0% ± 8.7"'/0 (n=10) for the fish oil fed rats. The yield ex-
pressed as 107 cells/heart was 1.03 ± 1.23 (Range=O.14-3.74 x 107 cells/hem) and
1.88 ± 2.10 (Range=O.30-6.10 x 107 cells/heart) for the MaxEPA and com oil
groups. respectively. It is i.r:nportant to note that the yield only takes into account
the live cells (refer to formula in Section 2.45). The oxygen consumption results
were 7.9 :t; 5.9 ronal 02. consumedhnin/loS cells (n=5) and 7.4 :t; 3.8 nmol 02.
consumed/ minlloS cells (n:a6) for the fish oil and com oil fed animals.
respectively.
The experiments with cardiac myocytes were carried out as competition
experiments. In each incubation the label was in oleate regardless of which fatty
acid was added. Therefore. for the oxidation resultS. a lower apparent rate indi-
cates that the added fatty acid was oxidized at a greater rate than oleate or it
inhibited oleate oxidation. 'The rates of oxidation for 0.1 mM HI4<:)18:1(n-9)
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were extrapolated from the data and the results for the oxidation of 0.2 mM and
0.4 mM 18:1(n-9) were adjusted accordingly and plotted.
rn the experiments conducted with skeletal muscle, oxidation rates were
based on the measurement of 14(:02 production. Since 14(:02 forms only a £rae.
tion of the oxidation products from 14(:·l.abelled fatty acids, the more accurate
procedure is to measure both the 14(:02 and 14(:-labelled add-soluble products
produced. Consequently, in the following text. [14qfatty acid oxidation will
refer to its conversion into the sum of 14<:02 and 14(:-labelled acid-soluble pro-
ducts. The latter represented in the com oil fed group; about 33-53% of the total
14(: products for flasks with only 18:1(n-9), 35-43% for flasks containing
unlabelled OHA and 38-U'fa for flasks containing unlabelled EPA and for the
fish oil fed group; 500/0 for 18:1(n-9), 36-39'Yo for OHA and 3&420/0 for EPA
(Figures 2.14, 2.15, 2.16 and 2.17).
We hypothesized that we would observe a lower rate of oleate oxidation
with flasks incubated with EPA compared to OHA, suggesting that less 18:1(n-9)
is being oxidized when EPA is added to the medium. compared to ORA. How-
ever, Figures 2.14, 2.15, 2.16 and..2.17 illustrate that there was no difference in the
oxidation of 18:1(n-9) when either EPA or OHA was added to the incubation
medium. regardless of the concentration of the added fatty acid or the diet. rt is
apparent that 18:1(n-9) is the preferred substrate of the heart celIs when 02 mM
of the fatty acids were added to the medium for the animals fed fish oil contain-
ingdiets.
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Figure 2.14 14C Production in CudiiilC Myocytes of fish Oil Fed. b.ts Using
0.2 mM Fatty Acid. These experiments ue c;ompetition
experiments because in each incubation the label was in oleate
regardlu. of which fatty acid. was added. Cardiac Myocytes were
incubated. in Kreb..Henseleit buffer containing LO mM CaC12..
1.2S% fatty acid free albumin. 0.1 mM [1-14C] oleic acid (18:1,. n.g)
plus 0.2 m.M unlabelled 18:1(n,.lJ), EPA or ORA. Results an:
means =S.D. for 10 myocyte preparations. MeULS not sh.uing a
common superscript .ue significantly diffuent.
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figure 2.15 14C Production in ~.J.cMyocytes of Corn Oil Fed Ra.ts Using
0.2mM F.J.tty Acid. These experiments are competition
experiments because in e.J.ch incubation the label wu in oleate
regardless of which fatty acid wu added. ~cMyocytes were
incub.J.ted. in Krebs-Henseleit buffer containing 1.0 mM CaC4..
1.25% fatty acid free albumin.. 0.1 mM [1.14C} oleic .J.cid (18:1, n-9)
plus 0.2. mM unlabelled 18:1(n~).EPA or OHA. Results are
means ± S.D. for 10 myocyte pnepua.tions. No significant
difference wu observed. among the rata of oxid.J.tion when
either fatty acid wu ..dded to the medium.
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Figure 1.16 14c Production in Cardiac: Myocytes of Fish Oil Fed Rats Using
0.4 mM Fatty Acid. These experiments ue competition
experi..J:nents because in each incubation the label wu in oleate
regardless of which fatty aci:tc1 was lIdd.ed. Cudiu: Myocytes
were tncu.bated. in Kn!})s.Hmseleit buffer containing LO mM
CaClz. US% htty acid. free dbw:nin. 0.1 mM [1-14C1 oleic acid
(18:1,. n.g) plus 0.4 mM unlabelled 18:1(n·9). EPA or ORA.
Results ue meutt; :t: S.D. for 10 myocyte preprations. No
significant difference was obsenred among the rates of oxidation
when either of the fatty acids wu added to the medium.
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FiS"lft 2.17 14e Procluction in Cardiac Myocytes of Com Oil Fed IU.ts Using
0.4 mM Fatty Acid. These experiments are cOlnpetition
experiments because in each incubation the label was in oleate
regardless of which fatty acid was added. Cardiac Myocytes were
incubated. in Kn:bs-Henseleit buffer containing 1.0 m.M CaClz.
L2.S'Yo fatty acid frM albumin. 0.1 mM [1-14CJ oleic acid (18:L n-9)
plus 0.4 mM unlabelled 18:1(n-9), EPA or ORA. Results are
trl.e~ :t; S.D. EOt' 10 myocyte prepuations. No signifiant
difference was obsuved. iimong the rates of oxicb.tion when
either of the fatty acids wu added to the medium..
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2..6 DISCUSSION
nus study appeus to be the only investigation to date examining the
differences in the oxidation of EPA and DRA in skeletal and cardiac muscle.
However, differential oxidation of these two fatty acids has been studied in liver
(Gavino and Gavino, 1991; Herzberg et a1, 1996). Furthermore, others have
determined preferential utilization of long chain fatty adds in muscle tissue but
were more concemed with comparing saturated versus unsaturated fatty acids
or the d.ifferences between the metabolism of the 18 and 20 carbon fatty adds and
consequently, omitted. the use of DHA in their experiments (Okano and Shimojo,
1982; Hagve and Sprecher, 1989).
Okano and. Shimojo (1982) determined the utilization of long chain fatty
acids in white and red muscle slices prepared from quadriceps femoris muscle of
rats, using labelled 16:0 and 18:2(n-6) as substrates. This study showed that the
utilization of fatty acid did depend on muscle fibre type and that each fatty acid
was oxidized to CO2 and esterified to lipid esters to a different extent by the
skeletal muscles examined. Higher rates of fatty acid oxidation were observed in
the red muscle which is consistent with the fact that red muscle has a higher
respiratory capacity and has higher activities of the B-oxidation enzymes. These
authors also found that the incorporation rates of fatty acid into triacylglycerols
and phospholipids were greater in red muscle than those in white muscle. The
rates of oxidation and esterification of 18:2(n-6) in both types of muscle were tess
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Hagve and. Sprecher (1989) investigated the integrated metabolism
than 16:0. Total uptake of 18:2{n~)by the two muscles studied was estimated to
be as low as 35-51'Yo of that of 16:0. Fractional uptakes of 18.:2(n~) into CO2,
triacylglyceroIs, and phospholipids also differed from those with 16:0.
I Swprisingly, Okano and Shimojo (1982) used muscle slices weighing 250 mg.
Due to the size of the muscle and. the fact that they did not maintain their
muscles at their resting length, there may have been problems with the viability
of the muscle satnples and thus the interpretation of their resu.lts.
Huxtable and Walril (1971) reported that beef heart mitochondria oxidized
[U.14cj16;O faster than [U-14cI18:2(n-.6). Okano and Shimojo (1982) commented
, that the data from this investigation as well as their study suggest that the
isomerase and/or epimerase reaction at the double bonds of unsaturated fatty
! acids caused a delay in a-.oxidation compared with saturated fatty acids.
!
including oxidation, esterification, and. the conversion of polyunsaturated fatty
acids of both the n-6 and 0-3 series (i.e., 18:3(n-3), 18:2(n-6), 18:3(n-6), 20;3(n-6),
2O;4{n~), 2O:5(n-3» in isolated rat cardiac myocytes and in the perfused heart.
They found that myocytes were able to take up and metabolize both the n-6 and
0-3 fatty acids. However, the uptake of 18:3(n~ and EPA was significantly
lower than that for the other fatty acids studied. These authors remarked that in
other studies done with hepatocytes incubated. with 18:3(n-3) and EPA, the
lipoproteillS secreted contained EPA (Hagve and Ouistophersen- 1983). Thus.
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they were surprised that EPA was not efficiently taken up by the heart even
though it is available to this tissue Of all the fatty acids examined. the rate of
oxidation of 18:3(n-6), as measured by 14<:02 production from the labelled. fatty
acid, was the greatest. From their data, it is evident that the other fatty acids
were oxidized. at similar rates, implying that the majority of n~3 and n-6 fatty
acids found in tissues do not undergo preferential oxidation in the heart. In
addition. Hagve and Sprecher (1989) were wtable to detect any products of
unsaturation or chain elongation when appropriate n-6 and n-3 fatty adds were
incubated with myocytes or when the heart was perfused with (1-14<:]18:2(n-6).
Since it appears that the heart is unable to elongate 18 carbon fatty acids to their
corresponding 20 or 22 cubon fatty acid, they suggested. that heart phospholipid
composition must, in part, be regulated by specific mechanisms in removing
fatty acids from the circulation.
We compared the oxidation of EPA and DHA in rat soleus muscle
homogenates. intact soleus muscle and rat ca.rdia.c myoc:ytes (Table 22).
Furthermore, the oxidation of 18:1(n-9) was studied for each model whereas the
oxidation of 16:0 and the n-6 fatty acids was only investigated in the homogenate
experiments. Our results obtained from the homogenate experiments support
the first proposed. mechanism; Le., that EPA is preferentially oxidized relative to
Table 2.2 SWIUIlUy of Pritnary and Secondary Objectives and Results for
Mec:hanismMl
Mechanism.l.; EPA is preferentially oxidized relative to DRA in muscle.
-I
Ob·ective
1.1 To examine the oxidation of EPA
and ORA by solew muscle
homoge:nates from rats fed fish oil
containinlZ diets.
1.1.1 To determine whether the rates
of oxidation of EPA and ORA by rat
solew muscle homoge:nates are
affected by diets rich in either n~ fatty
acids or n-3 fattY adds.
1.2 To examine the oxidation of EPA
and OHA by the intact soleus muscle
of rab fed. fish oil containinlt diets.
1.3 To examine the oxidation of EPA
andOHAbyaroacmy~of~ts
fed. fish oil containing diets.
1.3.1 To determine whether the
oxidation of EPA and OHA by rat
cardiac myocytes is affected. by diets
rich in either n~ fatty acids or n-3 fatty
acids.
Result
EPA was oxidized at a significantly
greater level than ORA by solew
muscle homogenate.
No significant difference due to diet.
No significant difference between the
rate of oxidation of EPA and OHA
bv the intact soleus muscle.
No significant difference in the rate
of oxidation of 18;1(n·9) by cardiac
my~when EPA or OHA were
added to the incubation medium.
No significant difference due to diet.
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DHA in muscle. In fact. EPA was oxidized at twice the rate of OHA by the
skeletal muscle homogenates. Howeve%, this phenomenon was not seen in the
intact muscle or in the cardiac myoc:ytes. In addition. 18:1(n-9) was oxidized. at a
greater rate than the n-3 fatty acids in all three experiments and thus provides
evidence that there is differential oxidation of fatty acids.
The rat soleus muscle homogenate experiments provided evidence that
the rate of oxidation for EPA was faster when compared to the rate for OHA
regardless of diet. However, Herzberg et al (1996) commented that since they
previously observed that there was greater lipoprotein lipase activity in heart
and skeletal muscle of fish oil compared to com oU fed rats, it is possible that
there is a net effect of diet on the oxidation of these fatty acids because of more
rapid lipolysis of triacylglycerol·rich lipoproteins in fish oil fed animals.
The finding that EPA was oxidized at a faste% rate than DRA by muscle
homogenates is consistent with the data. obtained. by Herzberg et al (1996) when
they studied. the fatty acid oxidation of EPA and OHA in rat hepatoeytes. The
experiment with hepatoc:ytes was a competition experiment similar to the one
used for the heart cell investigations. Of the added. fatty acids only one, EPA,
was oxidized at a significantly greater rate than oleate. This evidence that EPA
was oxidized at a greater rate than the other fatty acids was confirmed by the
ketoacid production. Both acetoacetate and 3-hydroxy butyrate syntheses were
greater with EPA than for any other added fatty acid. Furthermore, Gavino and
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Gavino (1989) found that CPTo in liver mitochondria had a higher activity with
EPA-CoA than DHA-CoA, implying that EPA is preferred for oxidation
compared to OHA in the liver. These researchers also obtained similar results
when the mitochondria were incubated with the free nonesterified. fatty acids.
However, when we choose the more physiological approach by
examining fatty acid oxidation in the intact soleus muscle or cardiac myocytes,
we did not find differences between DHA and EPA (Table 2.2). These results
indicate that the long chain n-3 fatty acids are oxidized to a similar extent in
these two systems and thus, are not differentially oxidized.. The experimental
design of these oxidation studies used in rJitro models. It would be more
physiological to examine in TJioo rates of oxidation using the approach suggested
by Jones (1994). In the experiments outlined in this chapter, the animals
consumed diets that contained. different amounts of specific fatty acids resulting
in a variation in the enrichment of the endogenous fatty acid pools. Thus,
according to Jones (1994) "endogenous pools of specific fatty acids which are
targeted for oxidation will likely be depleted Or expanded. in response to the
exogenous fatty acid blend delivered. by feeding the diet" or the exogenous fatty
acid added. to the medium as in the case of our experiments. The amount of
labelled fatty acid would likely be diluted by the amount of tissue fatty acids (i.e.,
endogenous fatty acids). For this reason, interPretation of the results remains
difficult. In order to rectify this problem, it would be reasonable to control the
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amount and blend of dietary fatty acids the rats consume as well as the
endogenous pools.
Although EPA was cleared faster than 18:1(n-9) in the perfused
hindquarter (Rettberg et al. 1990), we observed a greater oxidation rate for this
monounsaturated fatty acid in the three muscle experiments. rn addition, we
found that 18:2(n-6) was oxidized at a siatilar rate to 18:1(n-9). Other
investigators (Leyton et aL 1987; Mead et aL 1956; Cenedella and Allen. 1969;
Jones et aL 1985; WUlebrands, 1%4) have reported preferential oxidation of
18:1(n-9) over other long chain fatty acids in mice, rats, and humans. In fact,
Willebrands (1964) showed a greater uptake rate for 18:1(n-9) versus 18:2(n-6)
and 18:0 in perfused heart studies. Leyton et al (1987) commented that the
relatively high oxidation rate for 18;I(n-9) is probably due to the fact that it is
preferentially incorporated into triacylglycerols and thus, is a ready source of
energy. HO'Wever, the work of Leyton and others may be uninterpret:able since
they did not correct for the varying amounts of fatty acids found in the tissue
pools. Jones (1994) recently observed. no preferential oxidation with regards to
whole body oxidation of the three unsaturated 18 carbon fatty acids, Le., 18:1(n-
9), 18:2(n-6t and 18:3(n-3), in a study in which he controlled the amount of
dietary fatty adds consumed by the rats and the endogenous pools of these fatty
acids. However, Couet et al (1989) studied the mitochondrial oxidation of
18:3(n-3), 18:2(n-6) and 18:1(n-9) in rat liver. Their results showed that the rate of
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oxidation of 18:3(n-3} in liver mitochondria was the highest. itnplying that this
fatty arid is preferentially oxidized.
It has been shown previously that 20 carbon fatty acids have a slow rate of
oxidation (Coots, 1965; Sinclair, 1974). rn the homogenate experiments. we
observed that EPA and 20;4(n~) were oxidized at similar rates and that these
rates were lower than the 18 carbon unsaturated. fatty acids, regardless of the
diet. Two reasons have been given for this lower oxidative rate; these fatty acids
are initially oxidized by the peroxisomal pathway which functions by chain
shortening to 18 carbon fatty acids which in turn enter mitochondria for
subsequent further oxidation (Lazarow and deDuve. 1976) and that they are
mainly incorporated into phospholipids (Coots, 1965; Sinclair, 1974).
Many studies have examined the influence of diet on peroxisomal IS-
oxidation. Interestingly, the relative contribution of peroxisomes to the total
oxidation capacity in the rat heart has been estimated to be 1D-3O"Yo for common
fatty acids but up to 45% for some fatty acids with a chain length exceeding 22
carbons (Van Der Vusse et al. 1992). However, Om et al (1994) estimated the
contribution of peroxisomes to palmitate B-oxidation in rat heart homogenates
by measuring the activity of acyl CoA oxidase, the enzyme presumed to catalyze
the rate limiting step of peroxisomal B-oxidation. Based. on an estimated.
palmitoyl eoA oxidase activity of 0.3 nmol/min/ mg protein, the contribution of
peroxisomes to palmitate oxidation-would maximally be 4%.
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Several investigators used. unhydrogenated. marine oils to study the
effects on n-3 fatty acids on peroxisomal activity (Aarsland et al, 1990; Vamecq
et at 1993; Decraemer et at 1994). Aarsland and coworkers (1990) investigated
whether stimulation of fatty acyl CoA oxidase and CPT activities occurs in the
heart and liver &om rats after the administration of purified EPA (ethyl ester).
The activities of CPT, fatty acyl CoA oxidase and peroxisomal fatty acid
oxidation were increased in the liver homogenate but not in the heart
homogenate when compared with rats receiving palmitic acid for 5 days.
Vamecq et al (1993) studied peroxisomal and mitochondrial B-oxidation
rates in liver and heart from animals given high fat diets for 8 weeks according to
various n-3 or n~ fatty acid ratios. Their data support the occurence of
peroxisomal proliferation upon n-3 fatty acid enriched (salmon oil) diets in both
tissues tested. In the liver, they found an increase in the activities of acyl CoA
oxidase and camitine acyl transferase but no Significant difference for the
mitochondrial enzyme, acyl CoA dehydrogenase, with increasing content of
salmon oil as compared to the activity of this enzyme in rats fed the control. low
fat diet. In the heart, there was a increase in activity of the three enzymes
examined in a.nimals fed the highest amount of n-3 fatty adds (ie., n-3/n~ fatty
acid ratio of to). Vamecq and coUeagues (1993) explain that since n-3
polyunsaturated. fatty acids are effectively absorbed from. the intestine and
transported via the blood to other tissues, then the induction of cardiac enzymes,
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especially in rats with the n-J/n-6 ratio of 10, may be directly related. to the
higher supply of DHA and EPA in the blood of these animals. OHA and EPA
increase the activities of the three enzymes examined and thus, appear to
stimulate mitochondrial and peroxisomal 8-oxidation.
DeCraemer et at (1994) examined peroxisomes in liver, heart and kidney
of mice fed a commercial fish oil preparation for 3 weeks. They observed
hepatomegaly and increased. activities of two peroxisomal enzymes, catalase and
fatty acyl CoA oxidase, in the liver. In addition, the number of peroxisomes and
cyanide-insensitive fatty acyl CoA oxidation were increased. In the heart. there
was an increase in catalase activity and. the peroxisomal number. These authors
suggested. that these results were probably due to the increase ORA and EPA in
the diet.
The mechanisms by which dietary fish oil elicits an induction of
peroxisomes in liver and heart is not clear. Vamecq et al (1993) feel that the
mechanism involves the peroxisome proliferator activated. receptor (pPAR) and
the n-3 polyunsaturated fatty acids. The PPAR was recently identified by
£ssemann and Green (1990). nus receptor is a member of the steroid hormone
superfamily of the putative ligand·activated. transcription factors. PPAR has
been well characterized and, in fact, a high level of expression of mouse PPAR
mRNA has been found in liver. kidney and heart (Reddy and Mannaern, 1994).
However. the na~ ligand which binds to PPAR remains unknown.
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Peroxisome proliferators activate PPAR (Reddy and Mannaerts, 1994). Fatty
acids such as 2O:4{n-6), 12:0, and 18:2(n-6) have been shown to activate this
receptor (Reddy and Mannaerts, 1994). Vamecq et al (1993) speculate that the
natural ligand is likely to be a physiological metabolite whose cellular
concentration increases upon exposure to peroxisome prol.iferators. These
authors suggest that the natural ligand of PPAR belongs to the family of the n-3
fatty acids or is generated from the n-3 fatty acids. The ligand may be the CoA
esters of EPA and OHA as suggested by Bremer and Norum (1982) in their
mechanism for the increase in peroxisomal proliferation seen when animals are
fed fish oils. Bremer and Norum (1982) proposed that the accumulation of CoA
esters of very long chain unsaturated fatty acids which are poorly oxidized by
mitochondria trigger this process. In fact, Osmundsen et al (1985) foW\d that
OHA was a potent inhibitor of mitochondrial1S-oxidation and this finding may
be relevant to the mechanism speculated by Bremer and Norum (1982).
The incorporation into phospholipids may explain the fate of EPA in
muscle tissues and the reason for preferential oxidation of 18:1(n-9). While
studying the independent effects of individual n-6 and n-3 polyunsaturated fatty
acids on LDL metabolism, Spady (1993) observed that 18:3(n-3) is absorbed well
and is found in the triacylglycerols of liver and adipose tissue but appears to be
preferentially oxidized rather than incorporated into membrane phospholipids.
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However, EPA and OHA increased the total n-3 fatty acid content of liver
phospholipids by three to six fold.
In S\.UIl.malY, then. our findings indicate that even though the rate of
oxidation of EPA over ORA was doubled in the experiments which employed
soleus muscle homogenates. there was no differential oxidation between OHA
and EPA in muscle when these fatty acids were incubated with either the intact
soleus muscle or cardiac myocytes (Table 2.2). Since the latter two experiments
may be more representative of the physiological state, it appears that these
results may not support our first postulated mechanism that EPA is
preferentially oxidized compared to OHA by muscle. Due to the fact that there
are discrepancies in the results obtained from the three oxidation studies. more
investigative work should be done to determine the question of preferential
oxidation of EPA relative to OHA. However, it is evident from the data that
preferential oxidation of fatty acids does occur. In all three experimental
approaches, 18:1(n-9) was a preferred substrate for oxidation.
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CHAYrER3.0
HYDROLYSIS OF CHYLOMICRON TRIAYLGLYCEROL BY MUSCLE
LIPOPROTEIN LIPASE
3.1 INTRODUCTION
It is known that lipoprotein Upase (LPL) activity is affected by the amoW\t
of dietary fat as well as the type of dietary fat. High fat diets appear to increase
LPL activity in rnusde (Smolin et aL 1986; Pederson et a.l. 1980). Similarly,
dietary fish oil enhances muscle LPL activity (Herzberg et al, 1989; Baltzell et al,
1991; Anil et al, 1992). From these studies conducted with marine oils,
researchers have suggested that there is a shift from fatty acids being deposited
to being used for cellular metaboUc: processes such as oxidation. Furthermore,
LPL exhibits substrate specificity. For instance, longer chain fatty acids seem to
be hydrolyzed at slower rates than short chain fatty add esters (Wang et al, 1993;
Wang, 1994; Melin et al, 1991).
We suggested that EPA is preferen~y hydrolyzed compared. to DRA
from circulating triacylglycerols by muscle LPL with the hypothesis that if more
EPA is released to the peripheral tissues for metabolism then less would be
available for storage in adipose tissue. Consequently, our second hypothesis to
explain the underrepresentation of EPA in tissue triacylglycerols compared to
DHA is that EPA is preferentially released. from circulating triacylglycerol
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compared to OHA. 'Therefore, chylomicrons were incubated with cardiac LPL to
detennin.e if there was selective release of EPA. To gain further understanding
and insight into this question, a review of LPL in myocytes, including its
synthesis, transport, regulation and substrate specificity, is presented in the next
3.2 LIPOPROTEIN UPASE IN MYOCYI'ES
LPL is the major enzyme responsible for hydrolysis of triacylglycerois in
chylomic:rons and VIDL and provides free fatty acids and sn-2 mono--
acylglycerois as its principal products for tissue utilization. nus enzyme shows a
low degree of chemical substrate specificity since it can hydrolyze long and short
chain lriacylglycerois, diacylglycerois, monoacylglycerols as well as long and
short chain phosphatidylcholines (Oliveaona and Bengtsson-Cliveaona, 1987).
LPL catalyzes not only the cleavage of ester bonds but also their formation.
Consequently, LPL also acts as a transacylase (Bengtsson and Oliveaona, 1980).
Monoacylglycerols and diacylglycerois are efficient acyl acceptors and fatty
acids can be used as substrates as shown by the incorporation of labelled oleate
into diacylglycerols and triacylglycerols in studies conducted by Bengtsson and
Olivecrona (1980).
For maximal activity, LPl requires the presence of a cofactor, apoprotein
CIL a protein component present at the surface layer of the triacylglycerol-rich
lipoproteins (Nilsson·Ehle, 1987; Bensadoun, 1991). Apoprotein CIt a 9000 Da
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peptide present in HOL. VLDL, and chylomicrons, is most frequendy provided
in vitro by the addition of whole serum. This serum is pretreated with heat at
620C for 10 min to abolish endogenous lipase activity and can be kept at -200c
for at least a year without the loss of activating ability (Nilsson-ate, 1987).
The high sensitivity of LPL to product inhibition makes it necessary to
sequester the fatty acids during incubation experiments to prevent their
accumulation at the surface of the emulsion particles. Thus, albumin is an
essential component to obtain nuudmal enzyme activity. In the absence of a fatty
acid carrier such as albumin, fatty acids and monoacylglycerols accumulate at
the site of triacylglycerol hydrolysis and inhibit the hydrolytic reaction (Nilsson-
Ehle, 1987; Olivecrona et at 1987). However, Wang et a1 (1993) discovered that
not only is albumin a fatty acid acceptor but also acts as an inhibitor by its direct
interaction with short and medium chain triacylglycerols. Thus, in the presence
of apoprotein CII and albumin, there is a preferential activation effect of LPL for
the hydrolysis of long chain triacylglycerols. It is interesting to note that the role
of apoprotein en in activating the enzyme and the role of albumin in accepting
the long chain fatty acids are important for optimum LPL catalysis in the
hydrolysis of long chain triacylglycerols.
LPL is synthesized in most tissues including adipose tissue, heart, lung.
mammary gland, skeletal muscle, kidney, ovary. testes, spleen, and small
intestine (Braun and Severson.. 1992; Bensadoun, 1991). Adipose tissue, heart
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and lactating mammary gland have the highest transcriptional and catalytic
activity (Braun and Severson. 1992). LPL belongs to the gene family that
includes hepatic and pancreatic lipases. In fact. human LPL is 46% homologous
with rat hepatic lipase and 28% homologous with porcine pancreatic lipase
(Bensadoun.1991). However, it has no homology with lingual lipase or hormone
sensitive lipase.
Skeletal muscle LPL is Significantly higher in the fast twitch red and slow
twitch red fibres than in the fast twitch white fibres. Since muscles are made up
of a mixture of fibre types, LPL activity depends on whether the muscle has
predominantly red or white fibres. In the rat, skeletal muscle forms approx-
imately 45% of the body weight and about one third of the muscle mass is made
of red fibres (Borensztajn. 1987). Consequently, the total LPL activity in this
tissue is substantial (Borensztajn. 1987). In contrast, heart LPL accounts for only
a small fraction of the total enzyme activity present in extrahepatic tissues and
makes a quantitatively minor contribution to the catabolism of plasma
triacylglycerol-rich lipoproteim. However. more attention and interest has been
generated in studying card.iac LPL rather than skeletal muscle LPL because the
heart can be isolated intact and the vascular bed can be perfused with relative
In muscle. as well as other tissues, the site of action of LPL is the
endothelial swface to which the~e is bound. However, these cells are
no
incapable of sYnthesizing LPL. LPL is synthesized in both myocytes and
nonmuscle cells and is distributed throughout the tissue in several compart-
ments. Blanchette-Mackie et at (1989) used electron microscopy to study the
immunolocalization of lPL in the hearts of young mice. They found that in the
fed state, 78% of LPL was locali2ed in the myocytes, 3-6% in extracellular space
and 18% in capillary endothelium. Interestingly, however, LPL appears to
undergo developmental regulation (Braun and Severson, 1992). For instance, in
the neonatal heart,. the majority of LPL is found in the mesenchymal ce.I.ls
whereas the cardiac myocyte represents the predominant source in the adult
heart (Bagby and Coril, 1989).
The synthesis, transport and site of action of LPL in the heart is
schematically represented in Figure 3.1. As depicted in the diagram, LPL is
synthesized as an inactive glycosylated proenzyme in the lumen of the rough
sarcoplasmic reticulum. After the trimming of high mannose N~ligo­
saccharides, activation and modification of LPL takes place in the Golgi system
where progressive N-linked glycosylation, required for catalytic activity, occurs.
As the glycoprotein moves through the Golgi processing stacks by vesiculCU'
transport from the cis- to the trans-cistemae, the oligosaccharide is further
modified. by processing enzymes. Glycoproteins processed. by the Golgi are
sorted. in the trans-Golgi network for i) delivery to Iysosomes for degradation, il)
incorporation into secretory vesi~ (regulated mechanism), or iii) delivery to
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Figure 3.1 Synthesis, Transport and Site of Action of Lipoprotein Lipase
(Adapted from Vall DerVusse, 1992).
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the plasma membrane (constitutive or spontaneous mechanism). The consti-
tutive mechanism refer3 to a process in which proteins are secreted as they are
synthesized, without any intracellular accumulation. The regulated mechanism
refers to the process in which newly synthesized proteins are stored. in secretory
vesicles and then released when the cell receives a stimulus from an appropriate
secretagogue (Braun and Severson. 1992).
The majority of cardiac LPL is found in secretory vesicles of myocytes. In
the presence of secretagogues active LPL is transported and secreted. [f not,
degradation of I.PL takes place by lysosomes that fuse with the secretory
vesicles. After secretion. I.PL is transported across the enothelium by an
unknown mechanism and is fixed at the luminal extent of the glycocalyx, which
I is anchored at the basement membrane of endothelial cells. Little information is
known about the translocation of UL from the sites of synthesis, across the
interstitial spaces and to the luminal surface of capillary endothelia! cells.
Blanchette-Mackie et al (1989) proposed that LPL is transferred along bridges of
heparan sulphate proreoglycan molecules that connect the cell surfaces of cardiac
myocytes and capillary endotheli.a1 cells in the heart.
The rate of hydrolysis of triacylglycerols in the circ:u1ating lipoproteins is
regulated by the plasma concentration of triacylglycerols, the amount of LPL
attached to the endothelial luminal surface, and the presence of specific activator
proteins (Le.• apoprotein em in the coat of the lipoprotein particles (Van Det
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Vusse et al. 1992}. In addition, LPL activity is responsive to tissue-specific
regulation. The targeting of triacylglycerol-rich lipoproteins to specific tissues
for storage or oxidation depends on the energy needs of that particular tissue or
the nutritional status of the organism (Sugden et aI. 1993). For instance, in
fasting or starvation. muscle LPL activity seems to increase while the activity of
adipose tissue LPL decreases (Ni.I.sson-Eh1e et ai, 1976; Cryer et ai, 1976;
Borensztajn and Robinson, 1970). It has been suggested that this phenomenon
OCC\US to divert circulating triacylglycerols &om adipose tissue to muscle where
they are needed. and utilized.
Sugden et al (1993) assessed. whether changes in LPL activities in adipose
tissue and muscle are reciprocally and coordinately regulated to gain iNight into
the potential relative importance of adipose tissue and muscle as major sites of
plasma triacylglycerol clearance during continuow or int:emJpted feeding. LPL
activities in parametrial and interscapular adipose tissue, soleus and adductor
longus muscles and hearts of female rats were measured during progressive
starvation, chow ~feeding after 24 h of starvation and throughout dark and
light phases in rats permitted unrestricted access to chow. These authors showed
a progressive fall in adipose tissue LPL activities during the 24 h of starvation, a
dramatic increase in skeletal muscle LPL between 9 and 12 h of starvation, and a
25-fold raise in ca.rdiac LPL activities within 6 h of starvation reaching a
maximum after 12 h. Upon refeeding chow ad libitum, they found that the
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activity of adipose LPL increased rapidly within 2 h. Even though adipose LPL
activity was higher than muscle LPL activities, Sugden and coworkers (1993)
observed increases in both cardiac and skeletal oxidative muscle LPL activities
after refeeding and throughout the whole 6 h refeeding period. In addition,.
adipose tissue LPL activities exceeded those of cardiac and skeletal muscle
throughout both light and dark phases. The lowest adipose tissue LPL activities
were observed at 9 h into the dark phase. Cardiac LPL activity decEned
throughout the dark phase. with a minimum at 9 h into the dark phase. No such
variation was observed for skeletal muscle LPL. The authors found that a diurnal
nadir in plasma triacylglycerol concentrations coincided with the peak in cardiac
LPL activities. The results demonstrate that, during umestricted feeding and ~
! feeding after prolonged starvation, changes in skeletal muscle and adipose tissue
LPL activities are neither reciprocal nor co--ordinate. Furthermore. Sugden et al
(1993) commented that the regulation of cardiac LPL activity during the diurnal
cycle may be an important aspect of both cardiac fuel selection and. whole body
triacylglycerol metabolism.
There have been a number of studies investigating the effects of hoer.ones
and diet on LPL activity. The effects of hormones on LPL activity have been
reported. for a variety of tissues. After a meal, the Il'lain site of triacylglycerol
hydrolysis is adipose tissue where LPL is increased by insulin, the effect being
increased by glucocorticoids (Vance and Vance, 1991). In fact, the activity of
I
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muscle LPL is relatively low when compared with that in adipose tissue when
insulin is effectively regulating metabolism. According to Cryer (1981), muscle
lipase activity is not maintained by insulin but rather by glucocorticoids, with the
possible involvement of glucagon, catecholamines and thyroid hormones.
Cardiac myocytes isolated from diabetic rat hearts have decreased cellular LPL
activity and reduced release of LPL in response to heparin which could be the
cause of the fall in functional U't. activity in the whole heart. Administration of
insulin in TJirJo rapidly reversed the effects of diabetes on LPL in cardiac myo-
cytes. However, incubations of control and diabetic myocytes with insulin in.
uitro had no effect on either cellular or heparin releasable LPL activities. Thus,
additional factors active in moo may be required. for insulin to be effective in an in
uitro incubation or the decrease in LPL activity may not be due to insulin
deficiency directly, but instead be secondary to one or more of the multiple
metabolic factors that are altered. in acute models of diabetes (Braun and
Severson, 1992).
Norepinephrine and glucagon perfusion of isolated rat heart have been
shown to increase the functional activity of LPL attached to the luminal side of
the endothelium (the heparin-releasable fraction) with a concomitant and quanti·
tatively comparable decrease in the activity of the non-heparin releasable
enzyme (Stam and Hiilsmann.. 1980). According to Van der Vusse et al (1992),
1hese inverse changes in LPL actiVity favour a hoc:none induced stimulation of
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lipase transport from the intracellular compartment to the va.sc:u.1ar endothelial
site of enzyme action~.
Feeding a high carbohydrate or high fat diet affects LPL activity. The
consumption of carbohydrate causes muscle LPL activity to be maintained at low
levels. When anima1.s are deprived of food, muscle U'L activity is increased.
Carbohydrate feeding caused a rapid decline in activity when glucose was used
as the carbohydrate source (pederson and Schotz, 1980). Feeding a diet
containing saturated fat for 2 weeks stimulated. skeletal muscle LPL activity and
depressed the activity in adipose tissue compared to feeding a diet high. in
carbohydrate (Linder et al 1916; DeGasquet et al, 1977; Delhorme and Ranis.
1975). Brown and Layman (1988) used varying amounts of fat in the diet to
examine the relationships of changes in tissue LPL activity with plasma clearance
and tissue uptake of fatty acids. They fed female rats diets which contained
either 12% kJ from fat or n% kJ from fat for a period of eight weeks. Animals
fed the high fat diet had higher levels of fasting plasma triacylglycerols and
lower LPL activities in the heart, renal adipose tissue and post-heparin plasma.
LPL activites in skeletal muscle varied with higher values found in the soleus
and plantaris (red slow twitch muscles) and no differences observed in the gas-
tro<nemiWi. Furthermore, they found that only the lowered renal adipose tissue
LPL activity was associated with a lower uptake of fatty acids from 14c-labelled
chylomicron triacylglycerols and ~ncluded. that in general tissue and plasma
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LPL activities were not a direct index of the uptake of fatty acids by tissues or the
clearance of chylomicron triacylglycerols.
Similarly, others have demonstrated the potential for high fat feeding to
decrease adipose LPL activity (Delorme and Harris, 1975). rn addition. when
animals were fed fat enriched diets for 10 days, heart LPL activity either in-
creased (Delorme and Harris, 1975) or was not different (Alousi and Mallov,
1964) from the controls who were fed a carbohydrate-rich diet. Acute feeding of
fat (Le., Wesson 0il'tM) to starved or fed. rats has been reported to result in no
change in heart LPL activity (Alousi and MaIlov, 1964). However, Pederson et al
(1981) reported that one hour aIter the acute feeding of fat to starved rats, the
heart U'L &action that is readily releasable by heparin was significantly
increased. Smolin et al (1986) found that in rats fed. a single test meal containing
70% kca1 as vegetable oil, epididymal and retroperitoneal fat LPL activities were
less and cardiac U'L activity greater when oompared to that of rats fed a single
high carbohydrate meal (700/0 kcal as cornstarch). However, the activity of the
red gastrocnemius and soleus muscles were unaltered by single test meals.
The type of fat in the diet may affect LPL activity as well For instance,
Marette and coworkers (1990) compared the effects of dietary saturated and
polyunsaturated fats on adipose tissue LPt activity. Rats were fed for 4 weeks it
purified high fat diet (600/0 of energy as fat) either composed of lard or com oil.
They found that epididymal adipose tissue LPL activity was lower in rats fed
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com oil diets and suggested that this finding may relate to the higher concen-
tration of lipid peroxides measured in this tissue of these rats. Other investi-
gations (Herzberg and Rogerson, 1989; Baltzell et al, 1991; Ani! et al, 1992; Haug
and Hostma.r:k. 1981; Otto et all992; Groot et al1989; Huff et ai, 1993; Murphy
et al1993) have shown that diets containing fish oils affect the activity of tissue
ilL Upon feeding with fish oils, muscle LPL activity was either enhanced
(Herzberg and Rogerson, 1989; Baltzell et al, 1991; Ani! et ai, 1992) or did not
change (Otto et aL 1992).
In addition to the synthesis and regulation of this enzyme, many investi-
gators have been interested in examining the substrate specificity of LPL (Wang
et al, 1993; Wang, 1994; Bauer, 1988; Melin et al, 1991; Nilsson et al, 1987). From
their data, Wang et al (1993) showed that tributyrylglycerol represented the best
substrate for LPL. and the LPL preferential reactivity followed the order of:
C4>C6>C8>CI0>Cl2>C18:1, which is also the order of solubility. More recently,
Wang (1994) utilized chromogenic short chain esters of p-nitrophenol as sub-
strates for probing the active site of LPL. The results indicated that there is a
consistent trend in the decrease of the Michae1i.s-Menten constant with increasing
acyl chain length- It was concluded that the decrease in reactivity with increasing
chain length is probably not a consequence of a lower affinity of the substrate for
the enzyme. Furthermore, Wang (1994) states that the reason that butyrate ester
has the optimum acyl chain length to be a substrate of LPL can be attributed to
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its chain length being long enough for optimum interaction wtih the active site
His-Ser-Asp triad in forming the transition state complex. yet it is short enough
to provide freedom for optimum positioning of the ester bond for transition state
complex formation.
Bauer (1988) performed substrate speci£idty studies of partially purified
rabbit heart LPL Both saturated. and unsaturated. fatty acid chain hydrolysis
were investigated. using synacyl and mixed. acyl triacylglycerol emulsion sub--
strates. It was found that trans, monounsaturated and some saturated fatty adds
were more favourably hydrolyzed. than polyunsaturated. cis fatty acids. Bauer
I (1988) concluded that these findings may be of physiological significance and
may relate to the production of lipoprotein remnant particles relatively enriched
in polyunsaturated. fatty adds. espec:ially when consumed in the diet, and the
subsequent preferential delivery of these fatty adds to the liver.
i
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3.3 PURPOSE OF EXPERIMENT
The experiment outlined in this chapter examine the second. proposed.
mechanism; i.e., EPA is preferentially released relative to ORA from circulating
triacylgiycerols.. The objective i.!I as furrows:
Objective 2.1 To investigate the rate of hydrolysis of EPA and OHA
from triacylgiycerols found in chylomicrons.
·-1
3.4 MATERlAI.S AND METHODS
3.4.1 CHEMICALS
Unless otherwise stated., all chemicals were purchased &om Sigma
0\em.ica1 Company (St. Louis, Mo). Monoheptadecanoin, diheptadecanoin, and
triheptadecanoin were ordered from NuChek Prep (Elysian, M1'J'.). Organic
solvents and acids were obtained. from Fisher Scientific (Dartmouth, N.5.) while
diethyl ether was from DOH (Toronto, Ont.). MaxEPA oil was obtained as a gift
from R.P. Scherer, Windsor, Ont.
3.4.2 CANNULATION Of THE MAIN INTESTINAL LYMPH DUer AND
CHYLOMICRON COLLEcnON
Male. Spraque--Dawley rats weighing -350 g were obtained from the
Charles River Company (Laprairie, Quebec). They were housed in plastic cages
and maintained on a U hour light/U hour dade. cycle at an ambient temperature
of 22OC. These animals were fed standard laboratory chow. Prior to cannula-
U1
tion. animals were given an oral dose of MaxEPA oil to aid in the visualization of
the main intestinal lymph trunk.
Rats were fitted with exteriorized. cannulas in the duodenum and the main
intestinal lymphatic trunk by the method desaibed in Chemenko et a1 (1989).
The animals were anaesthetized intramuscularly with a ketalean-40 mg/kg
(MTC Pharmaceuticals, Cambridge, Ontario) and ,q,1a.zine-1O mg/kg (MTC
Pharmaceuticals. Cambridge, Ontario) mixture. A laparotomy with a midline
incision was performed on the rats. The duodenum and small intestine were
deflected. to expose the mesenteric artery and superior intestinal lymphatic
t::runk. The overlying connective tissue was dissected away from the lymphatic
trunk and a small incision was made. A cannula of polyethylene robing (pE SO,
Oay Adams) was inserted into the incision, and after a good £low had been
established, this was secured using a drop of cyanobutylacrylate (Krazy Glue™.
The Borden Co., Ltd., Willowdale, Ont.). The lymphatic cannula was exterior-
ized through a stab wound in the right flank.
The duodenum was cannulated with a 5 French infant nasogastnc feeding
tube, in a caudal direction. through a small incision about 1 en distal to the
pylorus. This cannula was also secured with a drop of glue. The duodenal
cannula was exteriorized through a stab wound in the left flank. The laparotomy
was closed by suturing the muscle layer, then the skin using 4-0 silk.
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FoUowing surgery, the rats were immobilized in BoUman restraint cages
and placed in a warm. dark room. Lymph flow was promoted by the continuous
infusion of saline through the duodenal cannula (2.5 mL/h). Coagulation of
lymph was prevented by the addition of heparin to the lymph collecting flasks.
Each rat was given intraduodenally a 1.0 mL bolus dose containing 05 mL of
MaxEPA oil plus 05 m.L of 20 mM sodium taurocholate three times during the 24
hour collection of lymph. The oil and sodium taurocholate were sonicated just
before dosing to ensure homogeneity.
3.4.3 ISOLAnON OF CHYLOMICRONS
This isolation of chylomicrons was modified from the procedure described
by Lindgreen et al (1m). Fresh lymph was centrifuged for 90 min at 60,000 g at
180<: in a Beckman ultracentrifuge using an 80 TI rotor. The chylomicrons were
then removed and layered into the bottom of a centrifuge tube containing 6 m.L
of 1.0063 giL (0.195 M NaO) density solution. The chylomicrons were centri-
fuged once again at 60,000 g for 90 min. Chylomicrons were then transfened. to a
screw<apped vial and stored in the refrigerator until assayed for total triacyl·
glycerol concentration. Triacylglycerol concentration of the chylomicrons was
detemtined enzymatically using a Trigiyceride-UV Kit from Sigma Diagnostics
(Procedure No. 3J4.-UV). This method involves four enzymatic steps. first
triacylglycerols are hydrolyzed to glycerol and free fatty acids by lipase. Second,
glycerol is phosphorylated by ATP in a reaction catalyzed by glycerol kinase.
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Third, ATP is· then regenerated in a reaction catalyzed by pyruvate kinase
between ADP and phosphoenol pyruvate. And lastly, the resulting PYTUvate
from the previous step is reduced to lactate while NADH is oxidized to NAD by
lactate dehydrogenase. The decrease in absorption of NADH is :neasured at 340
nm since this decrease in aborption is directly proprotional to the triacylglycerol
concentration in the sample. The assay was linear with time and the amount of
chylomicrons.
3.4.4 PREPARAnON OF CARDIAC LIPOPROTEIN LIPASE
The rats were anaesthetized intramuscularly with a ketaiean-40 mg/kg
(MTC Pharmaceuticals, Cambridge, Ontario) and xylazine-lO mg/kg ~C
Pharmaceuticals, Cambridge, Ontario) mixture and the heart was quickly
excised. Acetone powders were prepared from the heart by homogenizing the
tissue in 100 mL of acetone in a Waring Blender for 1 min. The homogenate was
filtered onto Whatman no. 5 filter paper and washed briefly with additional
aliquots of acetone and ethyl ether in order to further delipidate. The air-dried
acetone powders were stored at ·700C until extraction.
The acetone powders were solubilized in a buffer containing 1.0 M
ethylene glycol, 0.05 M Tris, and 0.125% deoxycholate, pH 8.4. Extracts were
prepared by homogenizing the powder in the buffer at a 1:10 dilution for 2 min
and then filtering through a polyethylene mesh. One (1) mL of the filtrate was
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used for the incubation experiments. The filtrate contained both the intra· and
extra'"Oillular pools of LPL
3.4.5 INCUBATION OF CHYLOMICRONS WITH LIPOPROTEIN LIPASE
The hydrolysis of triacylglycerol in chylomicrons isolated &om lymph by
cardiac LPL was conducted according to a procedure adapted &om EkstrOm et al
(1989). Olylom.icrons containing 70 mg of triacylglycerols were incubated at
370<: in 10 mL of a 40 mM HEPES buffer solution (pH 7.4) containing 5 mM
Ca02 and 0.6 g fatty add free bovine senun albumin. To this medium, 1 mL of
rat serum that was heated for 10 min at 620C (source of apoprotein em and 1 mL
of the enzyme filtrate were added to start the reaction. At times 0, 5, 15, 30, 60,
and 120 min, 1 mL aliquots of the incubation medium were taken and
immediately mixed with chlorofonn.-m.ethanol (2:1) containing hydroquinone
and C17 internal standards for monoacylglycerol, diacylglycerol. triacylglycerol.
and the free fatty acid.
Lipids were then extracted by the method of Folch et al (1957). The lipid
fractions were separated by thin layer chromatography on silica gel G using
hexane:diethyl ether-glacial acetic acid (80::ID'.2). The lipid spots were visualized
with iodine and identified. by comparison with. known standards. The
monoacylglycerol. diacylglycerol, triacylglyceroi, and fatty acid spots were
scraped off, eluted with chioroform·methanol and the dried eluate
transmethylated. as previously described (Keough and Kariel. 1987). The fatty
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acid methyl esters were separated by GLC using a Supelcowax 60 m capillary
column in a Hewlett Packard 336S Series II GC. Oven temperature was 19QOC
ramped SOC/min to 2l00c and remained there for an additional 12 min. The
injection port and flame ionization detector oven temperatures were 23Q0C. The
fatty acids were identified by comparison of retention times with known
standards from Sigma CJ\emical Co.. Peak areas were integrated using Hewlett
Paclcard 3365 Series II O'Lemstation Software.
3.4.6 STATISTICAL ANALYSIS
The significance of differences in the distribution of individual fatty acids
among different lipids was calculated using repeated measures of analysis (time
and fatty acid were the factors). p < 0.05 was the O1t-off used to determine
significance.
3.5 RESULTS
The main fatty acids foWld in the chylomicron triacylglycerols included
14:0,16:0, 16;1(n-7), 18:0. 18:1(n-9), 18:2(n-6), EPA and DHA (Table 3.1). 18:3(n-3),
18;4(n-3), 2O:4{n-6), and 22:5(n-3) were minor contributors to the fatty acid
content of the triacylglycerols foWld in the extracted chylomic:rons (fable 3.1).
When chylomiaons were incubated with LPL, triacylglycerol was
degraded and monoacylglycerols. diacylglycerols and free fatty acids were
generated. Figures 3.2, 3.3, and 3.~ represents the percentage of the fatty acids.
ORA and EPA, found in the monoacylglycerol, diacylglycerol and free fatty acid
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fractions that were released from the original chylomicron triacylglycerols over
the two hour time COUISe. Figure 3.5 depicts the proportion of these two fatty
acids remaining in the triacylglycerol component. The fatty acid composition of
the different lipids changed with incubation times. However, the relative release
and accumulation of EPA and ORA in the four lipids followed the same pattern
and did not differ significantly. The same observations were seen when 18:1(n-9)
and 18:2(n~) (Figures 3.6 and 3.1) were included in the analysis even though the
actual amounts of these two fatty acids were greater in the chylomicron
triacylglycerols than were the long chain n-3 fatty acids and consequently, more
substrate was available to the enzyme.
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Table 3.1 Fatty Acid Composition of Chylomicron Triacy1iPYC:uols (weight
%.. V.iI1ues aft mUJd '* S.D.)
Fatty Acid 0/0 of Total Fatty Acids
14-1) 6.3: 13
16:0 24.2:: 0.6
16:1 (n-7) 9.4:1: 1.7
18:0 62:0.7
18:1 (n-9) 16.9:l: 1.1
18:2 (n-6) 14.6 % 3.0
18:3 Cn-3) 15:1:0.1
1S,4(n-3) 1.9%0.3
20:4 (n-6) 1.6:0.2-
EPA (20:5, n-3) 8.9: 1.0
22:5 (n-3) 1.5.:1:0.1
DHA (22;6. n-3) 7.0 :1:0.7
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Figure 3.2
MONQACYLGLYCEROL
~ EPA
___ DBA
The Proportion of EPA and. DHA in the Original Chylomicron
TriacylglyceroLs Found in Mon(Mcylglycerols. Results ue means
=S.D. for 5 experiments. No significant diHerenc:e between the 2
fatty acids over time.
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DIACYLGLYCEROL
-0- EPA
___ ORA
--
.. j
Figure 3.3 The Proportion of EPA mel ORA in the Origin..al Chylomicron
Triacylglyc:erolt found. in DiAcylglyCt!rOls. Results are means ::I:
S.D. for 5 experiments. No sigrtifiant diffuenc:e between the 2
fatty acids ovn time.
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FAlTYACID
---0-- EPA
n... ...
Figure 3.4 The Proportion of EPA and. ORA in the Original Chylomicron
Triacylglycerols Released. as Free F~ttyAcids. Results ue means
± S.D. for 5 experiments. No significant difference between the 2
btty ~cids over time.
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TRlACYLGLYCEROL
--<0- EPA
Figure 3.5 The Proportion of EPA and ORA in the Original Chylomicron
Triacylglycerols Remaining in the Triacylglycerols. Results are
means % S.D. for 5 experiments. No significant difference
between the 2 fatty acids over time.
i
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OLEIC ACID. 18:1(n-9)
--0-- MONOACYLGLYCEROL
OlACYLGLYCEROL
T1UACYLGLYCEROL
--
Figuft 3.6 The Proportion of Fatty Acid From the Original Chylomiaon
Rem.aining in TriacylglyceroLs or Accumulating in
MonoacylglyceroLs, Dia.cylglycuoLs, or Free Fatty Acids. Results
are mons :t: S.D. for 5 experiments.
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LINOLEIC ACID. 18:1(1H)
~ T1UACYLGLYCEllOL
~ DlACYLGLYCD.O:L
_ L
"
Figure 3.1 The Proportion of Fatty Acid From the Original Chylomicron
Remaining in Triacylglyc::erob or Ac::cumulating in
Monoacylglyc::erob, DiaqlgIyceroLs, or Free Fatty Acids. Results
aft means % S.D. for 5 experiments.
3.6 DISCUSSION
We examined the lipolysis of chylomicron lipids with cardiac LPL to see
whether EPA and ORA 6hibited. different rates of hydrolysis. It is assumed that
if fatty acids are released from chylomicron triacylglycerols at different rates,
then the tissue distribution of the fatty acids could be influenced by this event.
This study demonstrated no difference in the hydrolysis pattern of the two n-3
fatty acids and thus the data does not support the second proposed mechanism
(Table 3.2). In fact, the pattern resembled that of two predominant fatty adds
found in chylomicron triacylglycerols. i.e., 18:1(n-9) and 18:2(n-6).
Most of the research concerning fish oils and LPL has dealt with the effect
i on LPL activities of peripheral tissues upon fish oil feeding. Groot et at (1989)
measured plasma lipoprotein 1eve1s and LPL activities in post-heparin serum
after a 24 h fast in pigs that had been fed a diet containing either 21% energy
from mackerel oil or lard fat. After 8 weeks. both the plasma triacylglycerol and
cholesterol levels were lower in the n-.ackerel oil fed group of animals.
Moreover, LPL activity in post·heparin serum taken 6 h after a meal,. was
decreased by 31% in the fish oil fed pigs. Similarly, Huff et al (1993) studied the
effects of fish oil and com oil on different parameters including the lipolytic
enzymes, LPL and. hepatic lipase. These researchers fed miniature pigs diets
containing supplements of com oil or MaxEPA oil for 3 to 6 weeks. The fish oil
diet signiikantly reduced post-heparin plasma LPL and hepatic lipase activities.
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ToJ.ble.3.2 Swrunuy of Primary Objective utd Result for Mechanism #2.
Mech.utism 112: EPA is prefeftntially released relative to ORA &om
circul..ting tri..cylglycerois.
..[
Ob·ective
2.1 To investigate the rate of hydrolysis
of EPA and DHA from triacylglycerols
found in chylomicrons.
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Result
No significant differe:nce observed
with regards to
the proportion of EPA or DHA
released from.
triacylglycerols in chylomiaons.
i
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which the authors suggested may be an adaptive response to the low
concentration of substrates for these enzymes. In contrast, Harris et a1 (1988)
found no effect of a fish oil diet on the LPL and hepatic lipase activity of post-
heparin plasma measured in f1itro while examining the effects of n-3 fatty adds
on chylomicron formation and metabolism in healthy volunteers.
As already cited in Section 2..1, Herzberg and Roger30n (1989) examined
the activity of LPL in adipose tissue, heart and skeletal muscle of rats fed. diets
containing fish oil, corn oil or tallow. Adipose tissue LPL activity was unaffected
by dietaxy fat; however, heart and skeletal muscle LPL activity was higher in
animals fed fish oil. Herzberg and Rogerson (1989) remarked that these results
are not inconsistent with the findings observed by Harris et al (1988). Post-
heparin plasma LPL activity represents both muscle and adipose tissue activity.
The difference in heart and muscle LPL activities could be masked. by the
contribution of adipose tissue activity to the total measured. Accordingly,
Baltzell and colleagues (1991) found similar results to Herzberg and Rogerson
(1989) when they investigated the role of LPL and hepatic lipase on the
triacylglycerol-Iowenng effect of fish oil. These researchers fed rats l2..5 % by
weight of lard, com oil or menhaden oil as the primary fat source in otherwise
identical diets for 2 weeks. Soleus muscle LPL was greatest for the fish oil fed
group whereas adipose tissue LPL did not differ between groups. There was no
difference in hepatic lipase between the oil fed. groups. However, the lard group
1.37
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had elevated hepatic lipase. from their cla~Baltzell et at (1991) concluded that
increased soleus LPL, decreased fat weight and and therefore total adipose LPL.
along with a decreased pJ.a.sma triacylglycerol suggest a shift from fat deposition
to oxidation with menhaden oil feeding. Furthermore. the lack of response of
hepatic lipase to fish oil feeding suggested that this enzyme did not contribute to
the fish oil-stimulated lowering of plasma triacylglyceroL However, in a
subsequent study, the same investigators showed. contrasting results with respect
to the ertects of dietary fish oil to LPL activity (Otto et al,. 1992). These authors
found that feeding rats low fat (SO g/kg diet) or medium fat (95 g/kg) menhaden
oil supplemented diets, as opposed to the high. fat diets, had no effect on skeletal
j muscle or epididymal adipose tissue LPL activity. Thus, Otto et at (1992)
commented that the catabolism of trtacylglycerol-rich lipoproteins contributes
little, if any. to the fish oil reductions of triacylg1ycerol or free fatty acids in
plasma. Furthermore. they suggested that the results from this study indicate
that the apparent direct inhibition of triacylglycerol secretion by fish oil imposes
a rate limitation only when feeding high fat diets. At lower fat concentrations,
hepatic triacylglycerol synthesis appears to limit secretion..
Interestingly, Ani! and coworkers (1992) found the activity of LPL in both
adipose tissue and aorta was Significantly higher in rats fed 100/.. (w/w) sardine
oil than in rats fed groundnut oil. They suggested. that this result may be the
cause for increased clearance of triacylglycerol-rich lipoproteins from circulation.
·1
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When 22'Yo of the diet contained fish oil for 4 weeks, adipose tissue LPL activity
was less than that found in rats given an equal amount of coconut oil (Haug and.
HostmarIc. 1987).
Little research has been done to determine the processes by which EPA
and. DHA are transported to different tissues and the factors that control their
uptake and incorporation into tissue lipids. However. there have been a few
investigations that compared the hydrolysis of polyenoic fatty adds with
particu1ar attention to the two eicosanoid precursors, 2O:4(n-6) and EPA. Nilsson
et al (1987b) found that during the lipolysis of rat chylomicrons with LPL. rH]-
2O:4(n-6) esters in triacylglycerol were hydrolyzed at a slower rate than [14<:}-
18:2(n-6) esters. When they added antiserwn against hepatic lipase to the
postheparin plasma which contairts both LPL and hepatic lipase. t:hese: authors
found that the hydrolysis of 20:4{n-6) was less efficient, suggesting that these two
enzymes may interact in the hydrolysis of these esters. However. we found the
rate of hydrolysis of EPA and ORA (consisting of 20 and 22 carbons,
respectively) from chylomicron triacylglycerols was similar to the rate of
hydrolysis of 18:2(n-6).
Previously, these same authors (Nilsson et al. 1987a) demonstrated a
preferential incorporation of dietary 2O:4(n-6) into chyle lipoprotein
phospholipids, a relative resistance of 20:4 esters of chyle triacylglycerol to
hydrolysis by LPL. a preferential feIease of 2O:4(n-6) for phospholipid acylation.
l
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and a low rate.of oxidation of this fatty acid. They suggested that these factors
may contribute to the d.iffeIences seen in the incorporation into tissue lipids
between the absorbed 20:4(n-6} and the predominant dietary 16 and 18 carbon
fatty acids.
In 1991, Nilsson's group examined the lipolysis of rat chylomicron
polyenoic fatty acid esters with bovine milk LPL and human hepatic lipase in
tritro (Melin et al. 1991). Otylomiaons obtained after feeding fish oil or soy bean
oil emulsions were used as substrates. LPL hydrolyzed EPA and 2O:4(n-6) at a
slower rate than 14 and 18 carbon acid esters. More EPA and 20:4(n-6)
accumulated in the remaining triacylglycerols and diacylglycerols. When added
together with !.PL, hepatic lipase increased the rate of lipolysis of the 20 carbon
polyunsaturates of both diacylgIycerols and triacylglycerols. They suggested
that the tri- and di-acylglycerol species containing these fatty acids may
accumulate at the surface of the remnant particles and act as substrates fur
hepatic lipase during a concerted. action of this enzyme and LPL.
In the present study, 2O:4(n-6) accounted fur an extremely small
proportion of the chylomicron triacylglycerol content and therefore, the
hydrolysis of this fatty acid could not be compared to the major components
such as EPA and DHA. The two long chain n-3 fatty acids demonstrated the
same hydrolysis pattern as the major 18 carbon fatty adds and there was no
significant difference in their rate of release from triacylglycerols. nus finding
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suggests that 20 and 22 carbon polyunsaturates behave similarly to 18 carbon
fatty acids in contrast to the results obtained in the investigations of NHsson and
his colleagues. The investigations by Nilsson and his coUeagues showed
different hydrolysis patterns for 18 and 20 carbon n~ polyunsaturates. The
discrepancies between the present study and those conducted by Nilsson's group
include the fact that they compared 2Q;4(n-6) with 18:2(n~) and we looked. at the
long chain n-3 fatty acids. In addition. they looked at the rate of hydrolysis and
we examined. the per cent of fatty acid removed from circulating triacylglyceroL
And finally, they used purified mille LPL and not LPL from heart.
To conclude, we found no significant difference between the percentage of
EPA and DRA removed from triacylglycerols found in lymph chylomicrons,
suggesting there is no preferential release of these fatty acids relative to each
other. Thus, preferential release of EPA from chylomicroN by I.PL does not
appear to explain the lower storage of EPA in adipose tissue. However. to
further explore the question of preferential release of EPA relative to DRA from
circulating triacylglycerols similar studies could be done examining the
metabolism of VLDL in relation to the effect of lipoprotein lipase.
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CHAPTER • .o
SECRETION OF fATlY ACIDS IN BitE
4.1 INTRODUcnON
Bile. a green/yellow viscous fluid, functions in both a secretory and
excretory capacity in our bodies. It has a role in fat digestion and absorption
and. through the synthesis of bile acids from cholesterol coupled with their
subsequent fecal loss, represents the major route of cholesterol excretion in the
body (Coleman and Rahman, 1992; Vance and Vance, 1991).
Bile is secreted by the liver into small ducts called. bile canaliculi. The
canaliculi drain into the biliary tree of the portal tract which consists of the canals
of Hering, bile ductules and bUe duets. In the rat, the bile ducts flow together in
the portal area to form the hepatic duct. a tube that is 12-45 rom in length with a
diameter of 1 rom (Hebel and Stromberg, 1976). The duct crosses the beginning
of the duodenum dorsally and runs among the lobules of the pancreatic body
toward its opening which ties 7-35 aun distal to the pyloNS. rn many species bile
can be redirected into the gall bladder where it is concentrated (by the removal of
water and salts) and stored. However, the rat has no gall bladder and
consequently, studies done with this animal examine only hepatic bile (Coleman
and Rahman, 1992).
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The three main biliary lipids are bile adds, cholesterol. and phospholipids.
In fact, in humans, bile contains per 100 mL about 1 g of bile acids conjugated to
taurine or glycine. 100 mg of free cholesterol. and 300 mg of phospholipids
(Vance and Vance, 1991). Bile acids are formed in the liver via the ra~l..intiting
initial hydroxylation of free cholesterol at the 7 a position by cholesterol 7
a:·hydroxylase (Hayes et aL 1992). The primary precursor pool for bile acid
synthesis is thought to be lipoprotein cholesterol but the exact mechanism of
cholesterol delivery is unclear.
Biliary phospholipids are predominantly phosphatidylcholine (PC) which
comprise between 80-90% of the total phospholipids in rat bile (Coleman and
Rahman, 1992; Hayes et al, 1992). The remainder is composed of sphingomyelin
and phosphatidylethanolamine. The fatty add pattern of biliary PC is largely 1-
palmiteyl, 2 linoleyl (16:O-18:2(n-6» and 1-pabnitoyl,. 2-oleoyl (16:(H8:1(n·9)).
Hepatic synthesis of PC is the major source of this phospholipid. Studies in man
(Coleman and Rahman, 1992) suggest that phospholipid secretion in bile is
mainly regulated by the in~atic pool of this lipid and is only partially
influenced by its hepatocellular uptake (Balint et aI. 1967). fn fact. the immediate
source of biliary PC appears to be from a preformed hepatic pool, mainly from
the membranes of the endoplasmic reticulum and bile canaliculi of hepatocytes.
Biliary cholesterol is almost exclusively nonesterified and is the least
concentrated lipid in bile. representing <1.0 mol% in most mammalian biles
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(Hayes et ai, 1992). Biliary cholesterol appeazs to be derived from both th 1'tDW
(l6-2.00/o) and preformed sources, Le., cholesterol in membranes of liver cells,
from the uptake and processing of lipoproteins, and that released from its
esterified form in hepatocytes. (Coleman and Rahman, 1m).
There appears to be a relationship between the secretion of bile acids and
the other two biliary lipids both in terms of total amount of bile acids as well as
the effectiveness of individual bile acids. H bile add seaetion is low, as in the
case of fasting, then biliary lipid secretion is low and vice versa. Bile acids which
are more hydrophobic such as deoxycholic add are more e.ffective in provoking
lipid secretion than those acids which are hydrophilic (Coleman and Rahman.
1992).
The secretion of bile acids is now well understood (S.maU. 1m). Bile adds
undergo efficient enterohepatic circulation, and the rate of bile acid secretion is
almost entirely dependent on the recycling frequency of preformed bile acids.
The secretion of cholesterol in bile seems to depend on the coordinated and
simultaneous secretion of PC and bile acids. According to Hayes et aI (1992), PC
is secreted in the form of lamellae at together with free cholesterol as vesicles, via
the smooth endoplasmic reticulum and Colgi apparatus of hepatoc:yte:s. Bile
adds are secreted separately into the bile canaliculi, whereupon they disperse the
lamellae and vesicles to form the mi~ necessary for solubilizing and
absorbing fat in the small intestine '(Hayes et al, 1992).
144
.[
Most of the processes of bile formation are due to the activities of
hepatoeytes (Coleman and Rahman,. 1992). As the bile travels through the
canaliculi in the liver, mod.ification of its composition may occur in the ductules
and ducts depending on various factors such as diet. drugs, and so on.
Interestingly, Sheppard and Herzberg (1992) found that the long chain n-3 fatty
acids are enriched in hepatic triac:yIglycerols of fish oil fed [ats, suggesting an
increased availability of these fatty acids in the liver. 'This increased supply is a
possible source for bile phospholipid synthesis. Correspondingly, to account for
the underrepresentation of EPA compared. to DHA in adipose tissue, we propose
that supplementation of fish oil in the diet results in more EPA being available
for hepatic phospholipid synthesis and consequently, more EPA being secreted
by the liver. In this part of the investigation. we determined. the fatty acid profile
as well as the proportion of fatty acids of phospholipids secreted. in the bile of
rats being fed a diet containing MaxEPA oil as its primary fat soutte.
4.2 EFFEcr OF DIETARY FAT ON BlLE PHOSPHOLIPID
COMPOSmON
The experimental design of this study also allowed us to investigate the
effect of dietary fat composition. ie., n-3 and n-6 fatty adds, on bile phospholipid
composition. We were interested in examining this effect because it has been
suggested by previous work done in our laboratory that bile lipids contribute to
the composition of lipid in lymph. ,
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Herzberg et al (1992) found an effect of prior diet on the lipid composition
of lymph.. Rats fed a diet containing 10% fish oil for a period of two weeks had a
higher proportion of EPA in lymph lipids than those fed com. oil containing
diets. Com. oil fed animals had a higher percentage of 18:2(n-6). Thus it was
concluded that endogenous lipid made a Significant contribution to the
composition of lipid in lymph. Indeed, Bergstedt et al (1990) showed that
endogenous lipids accounted for a significant proportion (25-50%) of lymph
lipid. Baxter (1966) estimated that 50% of this endogenous contribution came
from bile lipid.
While conducting experiments in rats to determine the role of luminal PC
in the lymphatic transport of fat, Tso et al (1977, 1981) concluded that the fatty
acid composition of lymph did reflect the composition of bile phospholipid.
Subsequently, Herzberg and coworkers (1992) suggested that d.ifferenc::es seen in
the p~infusionlymph composition of 18:2(n-6), 20:1(n-9), EPA, and DHA reflect
differences seen in the fatty acid composition of bile phospholipids.
Thus, it is conceivable that feeding diets with different fats may induce
changes to the fatty acid profile of biliary phospholipids that could account for
the differences seen in lymph composition.. Robins et a1 (1986, 1991) have shown
that it is possible under certain circumstances to change the composition of bile
phospholipids. In a first set of experiments, Robins and Patton (1986)
continuously fed rats fatty acids that were more or equally hydrophilic than the
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fatty acids thar are ordinarily prevalent in bile PC Bile became highly enriched
in new molecula.r species of PC that contained the particular fatty acid that was
fed. In a second set of studies, Robins and coworkers (1991) attempted to acutely
change the composition of biliary PC by perfusing isolated. livers with a variety
of single aIbwnin-bound fatty adds. Their data showed short·term changes with
respect to biliary PC composition with a greater utilization of shorter chain than
longer chain fatty adds.
Even though there is some evidence that a high fat diet has an effect on
bile flow and the secretion of biliary lipids (Knox et a.1, 1991; Balasubramaniam
et a.1, 1985; Ramesha et at 1980; Turley and Dietschy, 1979), there are few data
on the effect of diets, especially those rich in n-3 and n-6 fatty acids, on bile
phospholipid composition. We undertook studies to determine the following; 1)
whether the composition of biliary phospholipids could be altered by feeding
rats diets rich in either n-6 fatty acids or n-3 fatty adds, 2) whether a single
intraduodenal infusion of fat rich in n-3 or n-6 fatty acids could induce changes
in the fatty acid composition of biliary phospholipids after the rats had been fed
diets containing MaxEPA or com oil. and 3) if these different dietary fats affect
the rate of bile flow and the secretion of phospholipids, cholesteroL and bile
acids.
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4.3 PURPOSE OF EXPERIMENTS
The primary objective (3.1) of the experiments outlined in this chapter
examine the third. proposed mechanism; i.e., EPA is preferentially secreted.
relative to DHA in bile The secondary objectives (3.1.1, 3.1.2, 3.13, and 3.1.4)
addressed the effect of dietary fat composition, i.e., n-3 and n-6 fatty acids on bile
flow and composition.
Objective 3.1
Objective 3.1.1
Objective 3.1.2
Objective 3.13
To investigate the biliary secretion of EPA and DHA
in phospholipids from rats fed fish oil containing
diets.
To determine whether the composition of biliary
phospholipids could be altered by feeding rats diets
rich in either n-6 fatty acids or n-3 fatty adds.
To determine whether diets rich in n-6 fatty adds or
n-3 fatty acids affe<:t the rate of bile flow as well as the
biliary secretion of phospholipids, cholesterol, and
bile acids.
To determine if feeding a meal rich in n-3 or n-6 fatty
acids could induce shorHerm changes in the fatty
acid composition of biliary phospholipids after rats
have been fed diets containing either fish oil or com
oil
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Objective 3.1.4 To determine whether diets rich in n-6 fatty adds or
n-3 fatty acids affect the rate of bile flow as well as the
biliary secretion of phospholipids, cholesterol. and
bile acids after an infusion of fish oil or com oil.
4.4 MATERIALS AND METHODS
4.4.1 CHEMICALS
Unless ot:hetwise stated, all chemicals were purchased from Sigma
. 1 Chemical Company (51. Louis, Mo). Organic solvents and acids were obtained
from Fisher Scientific (Dartmouth. NS.) while diethyl ether was from SDH
(Toronto, Ont.).
The components for the animals' diets excluding the fat sources were
ordered from IQ\l (Costa Mesa,. Ca.). Mazola™ com oil was purchased from a
Local grocery store and MaxEPA oil was obtained as a gift from R.P. Scherer,
Windsor,Ont.
4.4.2 ANIMALS
Male. Sprague-Dawley rats (250-300 g) were obtained from Otarles River
Company (LaPrairie, Quebec). They were maintained for two weeks on diets
containing either 100/0 com oil or 8"10 MaxEPA oil plus 2% com oil The diets had
the following composition (g/kg): gluc0se-600; casein-200; fat-lOO; cellulose-50;
Am mineral mix-3S; AIN" vitamin mix-tO; methionine-3; choline ch.Ioride-2;
TBHQ-O.02. Diets were prepared and stored so as to minimize oxidation (Fritsche
·1
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and Johnston. 1988). The com oil containing diets were stored under nitrogen at
40C and the MaxEPA oil containing diets were stored under nitrogen at -2JJOC.
The fatty acid composition of the oils and diets was determined by GLC and the
results shown in Table 2.1. Any oxidation of the diets was checked by analyzing
the fatty acid composition of the diets at various times during the feeding period.
It is important to note that MaxEPA oil does contain about 0.6% (w/v)
cholesterol (Balasubramaniam et aI, 1985), resulting in the MaxEPA oil diet
contairting about 0.09% (w/w) cholesteroL Since this was a small proportion of
the total diet. supplemental cholesterol was not added to the com oil diet.
4.4.3 CANNULAnON OF THE Bn.E DUCT
At the end of the two week feeding period, rats were fitted with
exteriorized cannulas in the duodenum and common bile duct. Rats were
anesthetized with ketalean-40 mg/kg (MfC Pharmaceuticals, Cambridge,
Ontario) and xylazine-l0 mg/kg (MfC Pharmaceuticals, Cambridge. Ontario)
mixture and their abdomen was opened with a midline incision. The common
bile duct was exposed. and cannulated using a PE 10 (Oay Adams) cannula. The
cannula was secured in place by two 4-0 sill: ties above the cannulation site and
the common duct tied off below. The bile cannula was exteriorized through a
stab wound in the right flank. The duodenum was exposed and cannulated using
a 5 French Pediatric Feeding Tube (UNO Plastics Ltd., Denmark) cut to
approximately 20 em in length. The cannula was inserted 1 em distal to the
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pylorus. The ·cannula was secured using 2 drops of cyanoacrylate adhesive
(I<razy GIue™, The Borden Co., Ltd.. Willowda!e, Ontario) and. patency was
checked by observing for leakage after infusing 0.5 rnL of nor:mal saline. The
duodenal cannula was exteriorized through a stab wound in the left flank. The
laparotomy was closed by suturing the muscle layer, then the skin,. using 4-0 silk.
Immediately following surgery, the animals were immobilized in Bollman
restraint cages. 5% glucose in normal saline was infused through the duodenal
cannula at 3.0 rnL/h foc the duration of the experiment.
4.4.4 BILE COLLEcnON TO EXAMINE THE EFFECT OF DIET ON BILE
OUTPUT AND COMPOSmON
Immediately after the surgery, bile was collected at 60 minute intervals for
six hours. At the end of the collection period. the collection test tube was
weighed and. the bile output was obtained by subtracting the weight of the
previously weighed. empty test tube. Portions of the bile were prepared. for lipid
analysis (0.2 mL foc phosphorus and cholesterol assays and. 0.3 mL foc total fatty
acid analysis of biliary phospholipids) and the remainder stored at -woe for bile
acid detennina.tion. Missing values in the phospholipid and. total bile acids data
in both parts of the experiment were due to contamination oc insufficient sample,
respectively. This part of the experiment determined the effects of diet on biliary
flow and composition and consequently, there were two groups studied.. i.e., the
MaxEPA oil and the com oil fed ~oups.
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4.4.5 BILE COLLECTION TO EXAMINE THE EFFECT Of DIET AND fAT
INFUSED ON BILEOUfPUT AND COMPOSmON
Following an overnight recovery, some of the rats were given
intraduodenallya 1.0 mL bolus dose containing 0.5 mL of MaxEPA oil or com all
plus 0.5 mL of 20 mM sodium taurocholate. The oil and sodium taurocholate
were sonicated jwt before infusion to ensure homogeneity. Consequently, there
were four groups studied to examine not only the effect of diet on biliary flow
and composition but to also determine the effects of an infusion of dietary fat;
Group I, designated MdMi, was fed. a diet (d) with MaxEPA oil (M) and
received an infusion (i) of MaxEPA oiL Group 2. or MclCi was fed. a diet with
MaxEPA oil and received an infusion of com oil (0, Group 3 or CdCi was fed. a
diet with com oil and received an infusion of com oil, and Group 4 or CdMi was
fed. a diet with. com oil and received an infusion of MaxEPA oil.
Bile was again collected at 60 minute intervals for six hows. At the end of
the collection period, the same procedure for portioning out the bile was
foUowed as described in section 4.4.4.
4.4.6 ANALYSIS Of BILIARY LIPIDS
Lipids were extracted from bile by the method of Fokh et al (1957).
Phospholipids were separated by thin layer chromatography on silica gel G
using hexane:diethyl ether-glacial acetic acid (80-..20".2). 1he phospholipid spot
was visualized with iodine and identified by comparison with known standards
from Sigma Qemical Co.• The phospholipid spot was scraped off, eluted with
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chloroform-methanol and the dried eluate transmethylated. as previously
desaibed (Keough and Kariel, 1987). The fatty add methyl esters were
separated. by GLC using a Supelcowax 60 m capillary column in a Hewlett
Packard 3365 Series II GC. Oven temperature was 1900<: ramped SOC/min to
2100 C and remained there for an additional 12 min. The injection port and flame
ionization detector oven temperatures were 2300<:. The fatty acids were
identified by comparison of retention times with known standards from Sigma
Chemical Co. Peak areas were integrated. using Hewlett Packard 3365 Series II
Otemstation Software.
Lipid phosphorus content was measured. by the method of Bartlett (1959)
using 25 J.l.L of the lipid extract. Cholesterol was measured in 50 J.l.L samples of
the bile lipid extracts by the method of Zlatkis and Zak (1%9). The procedures
for determining phosphorus and cholesterol are based. on colorimetry. The
analysis of phosphorus in the sample is based. on the reduction of phospho-
molybdate produced by heating the phosphorus reaction mixture in sulfuric
acid. The absorption of the resultant blue colour is measured at 830 nm and is
proportional to the concentration of phosphorus up to 1.5 J,lM in the reaction
mixture. The determination of cholesterol is based. on the reaction of cholesterol
with o-phthalaldehyde in an acetic acid-sulfuric acid medium resulting in a stable
pink colour with an absorbance read at 550 nm.
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Bile add concentration was deten:nined using 3 a-hydroxysteroid
dehydrogenase in the presence of NAD. The production of NADH was
quantified spectrophotometrically at 340 nm (Stempfel and Sidbury,l964).
4.4.7 sTAnsnCALANALYSIS
The data were analyzed by a two factor (time and diet) ANOVA when
only the effect of diet was examined whereas a three factor (time, diet and fat
infused) ANOYA was employed when both the effects of diet and oil infused
were studied. The pooled. totals of bile output and biliary lipids were analyzed
by a tw"o factor (diet and meal infused) ANOYA. The fatty add composition
data were arcsin transformed before the analysis of variance to correct for the
non-normal distribution of percentage data (Zar. 1984). Effects were considered
signi.6cant if p<O.05, n..s. indicates an effect was not significant. General trends
over time were examined. in these experiments and not comparisons at
individual time periods. Thus. multiple comparisons of the means were not
estimated.
4.5 RESULTS
4.5.1 EFFECT OF FISH OIL OlET ON EPA AND ORA SECRETION IN BILE
Rats fed fish oil containing diets did not show a significance difference in
the proportion of EPA and OHA (F1,72zO.60, nos.), as a percentage of total fatty
adds. in biliary phospholipids (Table 4.2). In the 6 hourly collections, EPA
accounted for 2-3% of the total ratty adds and OHA accounted. for 1-3%. From
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this data, it does not appear that EPA is preferentially secreted relative to ORA
in bile and, thus, refuting the third mechansim.
4.5.2 EFFECf OF DIETARY FISH OIL AND CORN OIL ON BILE OUTPUT
AND COMPosmON
~ Bile output during the six hours collection is shown in Figure
4.1. There was a decrease in flow with time (FS,174=6.42, p<O.OOOI) for both
groups with an apparent plateau in secretion beginning at hour 3. The MaxEPA
oil fed animals had a greater output at each time (Fl,174=45.04, p<O.OOOl).
Table 4.1 depicts the pooled. 6 hour values for bile output as well as the
biliary lipids. When time is removed as a factor, there is still a Significant
difference of bile secretion between the 2 dietary groups (Fl,27=8.29, p=O.OO7l).
T"ble 4.1 Total Amount of Bile Flow o1I\d Biliolry Lipids in 6 Hours, me.:an:
S.D. (n).
MaxEPAoil 4.33·:0.55 133.16:3275 1.68·:0.49
15) (7) 15)
Group
Cornall
Bile Flow mL Bile Acids Ololesterol
1=01 1=01
3.37: 110 111.60: 40.94 LIS: 0.52
1(14) (6) 13)
Phospholipid
lumol
6.98·: 1.71
1(8)
3.98: 1.39
(6)
!
'I
• denotes a sitmific.ant difference between 81"l UD5, D<O.05.
Biliary Lipid. Figure 4.2 illustrates the effect of fat prefeeding on biliary
bile acid secretion. The concentration of bile acids in bile was the same in rats
consuming the two diets (Fl,73:3.98, n.s.). Simila.rly, there was no significant
difference when time was removed as a factor (Table 4.1) (Fl,n=O.94, n.s.). As
expected. because of the interroption of the enterohepatic circulation. continued
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bile add drainage resulted in a decrease in output with time for both groups
(FS7-!'"7.73, p<o.oool).
1he effect of fat prefeeding on the concentration of biliary cholesterol
(Fl,174=1.02, n.s.) and phospholipid (Fl,72:::{1.97, n.s.) is shown in Figures 4.3 and
4.4, respectively. No sig:ni.ficant difference due to diet was found.. Nevertheless,
the rats fed MaxEPA oil had a greater total secretion of of both lipids (Table 4.1)
because of the greater volume of bile (cholesterol, Fl,26=7.04, p:O.Ol34;
phospholipids, Fl,12=10.62, p=O.OO69). Furthermore, the concentration did not
j significantly change with time for either group of animals (cholesterol,.
FS,174=O.49, n.s.; phospholipids, FS,72=O.70, ru.).
fattY Add ComvowitiQn and Dilt:r:ibutjgn in Biliary PhQlphglipi45 The
fatty acid composition of biliary phospholipids is presented in Table 42. The
results indicate an effect of prior diet. The MaxEPA oil fed rats had significantly
higher proportions of 18:1(n-9) (Fl,84=9.93, p=-O.0023), EPA (Fl,84==59.04,
p<O.OOOl), and OHA (Fl,84-15.13, p::(lOOO2) than the com oil fed group. On the
other hand, animals fed com oil had substantially more 2O;4(n~) (Fl,84""22..11,
p=O.OOO4) than those fed fish oiL Surprisingly, the concentration of 18:2(n-6)
(Fl,84-a().15, n.s.) did not differ between the two diets although 18:2(n~) intake
was much greater in the com oil fed. rats.
The pattern and distribution of the fatty adds in biliary phospholipids of
MaxEPA fed rats are illwtrated in Table 4.2. The predominant fatty acids are
16:0,18:0, 18:1(n-9), and 18:2(n~),which make up approximately 71% of the total
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Figure 4.1 BUe output in rab fed diets containing MaxEPA or Com Oil.
Results are means % S.D. for 16 animals. -There wu ~ significant
difference due to diet and time (p<O.OOOl), with the MaxEPA
group having a greater output.
157
Table 4.2 F"tty Acid Composition of Bile Phospholipids (% of Tow.. mean:l:
S.D.). "denotes significant diHl!tI!IlCl! due to diet (p<O.OS). No
significant difference due to lime for all fatty acids.
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Figure U Bile acid concentrations in bile of rats fed. diets containing
MaxEPA or Com OiL Results ue means:2: S.D. for 8 or 9 ntimm.
'"There wu a significant difference with time (p<O.OOOl), with the
concentrations decreasing over time. No significant difference
due to diet.
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Figure 4.3 Cholesterol concentrations in bile of rats feel diets containing
MaxEPA or Corn OU. Results are ttleatlS:t: S.D. for 15 or 16
animals. No signi.fi~tdifferences due to diet and time.
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Figure 4.4 Phospholipid COl\Ce1\trations in bile of rats fed. diets containing
MaxEPA or Com Oil. Results are means ~ S.D. for 6 or 8
animals. No significant difference due to diet and time.
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fatty acid composition. The remaining fatty acids are essentially 18:3(n-3), 20:4(n-
6), EPA, 22;5(n-3), and OHA. EPA and DHA account for 2..5% and 2% of the total,
respectively. The n-3 fatty acids made up about S% (range 3.2--6.5%) of the total
fatty acids in the 6 hour collection period. whereas the n-6 fatty acids accounted
for 16.5% (range 14.3-17.4%). For all the fatty acids the proportions remained.
relatively constant throughout the entire experimental period (16:0, FS.B4=O.37,
n.s.; 18:0, FS,84;0.81, n.s.; 18:1(n-9), FS,84=O.39, n.s.; 18:2(n--6), FS,84""1.09, n.s.;
18:3(n-3), FS.B4==O.61, n.s.; 20:4(n--6), FS,84=1.57, n.s.; EPA, FS.B4==O.33, n.s.; 22;5(n-
3), FS.B4=1.74, n.s.; OHA, FS,84=1.32, n.s.).
The pattern and distribution of the fatty acids in biliary phospholipids of
com oil fed. animals are shown in Table 4.2.. Similar to the MaxEPA fed rats, the
predominant fatty acids were 16:0, 18:0, 18:1(n-9), and 18:2(n-6). However, in this
case, 18:1(n-9) accounts for ~bout 7% of total fatty acids as compared to 11%
observed in the bile of those fed MaxEPA Moreover, 2O:4(n--6) makes up a
considerable proportion, approximately 9% of the total compared to 3.S% for the
fish oil fed animals. The predominant fatty acids contribute nearly 75% of the
total fatty acid composition. The balance of fatty acids is mostly 18:3(n-3), DHA
and to a much lesser extent, EPA. EPA accounted for 0.3-0.4% of the total and
was only detected. at hours 1,3, and S whereas DHA contributed 1.3% of the total
in the first hour and declined steadily to about 0.3% by the last hour of the study.
In this case, the n-3 fatty acids made up about 1% (range 0.3-2.9%) of the total
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fatty acids while the n-6 fatty acids accounted for 21% (range 16.9-26.9%). "There
was no significant change with time for any of the fatty acids analyzed.
4.5~ EFFECTS OF A SINGLE INTRADUODENAL INFUSION OF FISH OIL
OR CORN OIL ON BILE OurPUT AND COMPOSmON AFrER
ADAPTATION TO DlETS CONTAINING FISH OIL OR CORN OlL
~ The bile output during the six one-hour collection periods is
shown in Figure 4..5. There were independent effects of diet (F1,218""71.6.
p<O.OOO1) and oil infused (Fl,218=4.84, p<O.05) on bile flow. Animals fed.
MaxEPA containing diets and infused with. MaxEPA oil had the great2St output
at all collection points whereas those fed com oil and given an infusion of com
oil had the lowest. In rats previously fed com oil. the infusion of fish oil
increased bile flow. Conversely, in rats fed fish oil. a meal of com oil lowered bile
sec:retion. Bile flow did not change in any individual group during the col1ection
period (FS,218==O.94, n.s.).
Table 4.3 presents the total volume of bile over the entire collection
period. When time was removed as a factor, only the diet had a significant effect
on bile secretion with MaxEPA fed rats having a larger output (F1,31=2121,
p<O.OOOl). The fat ir\f'wed. did not alter tota.! bile secreted (Fl,3123.63, nos.).
BjlWy Lipids Figures 4.6, 4.7, and 4.8 illustrate the effects of diet and
infused fat on the concentrations of biliary cholesterol, phospholipids, and bile
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Table 4.3 Total Bile Flow and Bi.li.uy Upids Secreted in 6 Hours, mean ~
S.D. (n).
Group Bile Flow Bile Acids Cholesterol Phospholipid
mL IUDtol+ Iulnol++ _01
MdMi 3.91· :0.39 25.38: 2.03 0.88 %0.35 3.17: 0.93
(9) (5) (10) (4)
MdCi 3.59· %0.47 42.37 : 15.01 0.59%0.31 1.75 ± 0.95
(7) (4) (9) (3)
CdCi 2.66%0.70 32.93::t 7.64 0.71:!: 0.37 3.64%0.93
(8) (5) (8) (3)
CdMi 3.07 :0.55 43.45 ± 11.04 0.53: 0.33 2.08 ± 1.62
(10) (5) (10) (4)
"denotes .. significant diffeftnee (p<O.OS) due to diet. Thus, the MuEPA oil-fed groups hael
.. higher bile flow than the Corn oil-fed gnNps.
+a significant interac:ti.OQ between the oil infused. and diet;: i.e., ~ount of bile acid.ll
ino:n!uecI significantly when the oil infused. diHend &om the fat souree in the diet.
++a significant interaction betwun the oil infused and diet;: i.e.. eholesterolleve1s <leaeued
significantly when the oil infused. diffen!d from the fat source in the met.
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Figure 4.5 Bile output in rats fed diets containing MaxEPA or Com Oil and
given an infusion of either oil. Results are means ± S.D. for 8 to
10 animals in each group. ·Significant effect of diet and oil
infused (p<O.OS), with MdMi having the greatest output. No
significant difference due to time.
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Figure 4.6 Cholesterol concentrations in bile of rats fed diets containing
MaxEPA or Com Oil and given an infusion of either oil. Results
are means ± S.D. for 8 or 10 animals in each group. "Significant
interaction between prior diet and fat infused when fat infused
differed from fat in diet (p<O.OOOl). Time had a significant effect
for all groups (p<O.OOOl).
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Figure 4.7 Phospholipid concentrations in bile of rats fed diets containing
MaxEPA or Com Oil and given an infusion of either oil. Results
are means ± S.D. for 3 or 4 animals in each group. "Significant
interaction between prior diet and fat infused when fat infused
differed from fat in diet (p=O.0002). Time had a significant effect
for all groups (p=O.OOOS).
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Figure 4.8 Bile acid concentrations in bile of rats fed diets containing
MaxEPA or Com Oil and given an infusion of either oil. Results
are means ± S.D. for 5 to 9 animals in each group. "Significant
effect of diet (p=O.0118) and time (p<O.OOOl).
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acids, respectively. There was a significant interaction between the effects of diet
and infused fat on the concentrations of cholesterol (Fl,217=34.2, p<O.OOOl) and
phospholipids (Fl,68-IS.13, p2{).OOO2). When the animals were given an
infusion of oil that differed &om the fat source in their diet, the level of both
biliary lipids decreased. For the bUe acid concentration. there was an effect of
diet (Fl.l64=6.49, p=O.01l8)but not infused fat (Fl,l64...a,69, n.s.).
In response to either oil infusion, which contained 20 mM taurocholate.
the bile acid. concentration was highest in the first hour for all four groups. Over
time. there was a decline in bile acid levels. The concentration of all three lipids
decreased significantly with time for all four groups, an effect that was
independent of both the diet and the fat infused (cholesterol, FS,217=9·87.
p<O.OOOl; bile acids, FS.164=51.29. p<o.OOOI; phospholipids. FS,68=4.84. p=
01lOO8).
Table 4..3 indicates the total amounts of these three lipids over the six hour
collection period. When time was eliminated as a factor, the following were
observed.; 1) a significant interaction between the oil infused. and diet with
respect to cholesterol (FI~.87,p=O.0337) and bile acids (Fl,lS=6.71. p<o.021);
i.e., cholesterolleveIs decreased. and the amount of bile acids increased when the
oil infused. differed from the fat source in the diet and. 2) an independent effect
of diet (Fl,lO=2.84. n.s.) and infused. meal (Fl.lO=O.OO9. n.s.) on total
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phospholipids; i.e., no differences were demonstrated. when the fat infused
differed from the dietary fat source.
Fatty Acid Composition and Distribution in BUiary Phospholipids The
fatty acid composition of biliary phospholipids is presented in Table 4.4. The
highest proportions for all n·3 and n--6 fatty acids were observed in the first
hourly collection of bile. The percent of the total for both series of fatty acids
declined rapidly. The results indicate a significant interaction between the effects
of prior diet and fat infused for 18:I(n-9) (Fl,181::6.36, p==O.OI25), EPA
(FI,181::20.68, p<O.OOOl), and DHA (Fl,181::20.90, p<O.OOOI). MdMi had the
highest proportions of EPA and DRA. The proportions of EPA and ORA
decreased after com oil was infused into rats previously consuming a diet
containing fish oil (MdCi). No increase of either of the long chain n-3 fatty acids
was observed after fish oil was infused in animals that were previously fed com
oil for 2 weeks (CdMi).
The fat infused had a Significant effect on 20:4(n-6) (FI,18l=1.05, p<O.OS),
but previous diet did not (FI,181::1.64, n.s.). When comparing MdMi and MdCi,
there appealS to be a relatively greater decrease with time of 20;4(n-6) in the
MdMi rats even though the actual proportion of this fatty acid is larger in MdMi
animals at each time point. Furthermore, there is a greater decline of 20:4(n-6) in
CdCi as compared to CdMi. nus o~servation was similar when examining the
proportion of 18:2(n-6) in CdCi and CdML UnoIeic acid (18;2, n-6) also had a
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similar reduction with time in the MdCi animals when compared to MdMi. The
proportion of 16:0 remained relatively constant over time for all four groups,
making up about 35-40% of the total. Over the six hour study interval, the
proportions of 18:1(n-9) (FS,181",20.90, p:::::O.OOOS), 18:2{n-6) (FS,181=8.00,
p<O.OOOl), 20:4(n-6) (FS,181=9.59, p<O.OOOI), and EPA (FS,181",2.52. p==O.031l)
decreased for all 4 groups whereas the amount of 18:0 (FS,181=4.24, p<o.OOOl)
increased. It appears that 18:1(n-9) and 18:2(n-6) were replaced by 18:0.
The predominant fatty acids in biliary phospholipids of MdMi rats are
16:0, 18:0, and 18:2(n-6), making up approximately 74% of the total fatty acid
composition (Table 4.4). EPA and ORA account for 4% of the total in the first
hour of collection and 1% in the sixth hour. The n-6 fatty acids accounted for 26%
in hour 1 and declined. to 16% by hour 6.
The major and minor fatty acids in biliary phospholipids of MdCi rats are
similar to those seen in MdMi animals (Table 4.4). However, after the com oil
infusion there was a greater decline in the two major n-3 as well as the major n-6
fatty acids by the sixth hour. rn the first hour, n-3 and n-6 fatty acids made up 2%
and 19% of the total, respectively.
16:0, 18:0, and 18:2(n-6) are the major fatty acids and 18:1(n-9) and 20:4(n-
6) are minor components in the biliary phospholipids of the CdCi and CdMi
a..nimals (Table 4.4). The long champ-3 fatty acids are either not present in the
case of EPA or account for less than 1% of the total for ORA. The infusion of
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MaxEPA oil did not increase the proportions of these two fatty adds.
Furthermore, a relatively larger decline with time was seen in the total
percentage of n-6 fatty acids after the infusion of corn oil compared to marine oil.
Table 4.4 Fatty Acid. Composition of Bile Pbospholipicb (weight %, mean ±
S.D.) ... denotes siprifiant intenction between prior diet OI.ft.d fa.t
inhlsed (p<O.05). fdcnota significant effect of only bt infused
(p<O.o5). ~enota signi6ant dfect due to tUne (p<O-OS).0_. T_' t.a::1(D-9j.... -.-..
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4.6 DISCUSSION
4.6.1 BILIARY SECRETION OF EPA AND ORA
This study was conducted to compare the secretion of OHA and EPA in
the bile of rats fed a diet containing fish oil. We hypothesized that EPA would be
preferentially secreted. compared to OHA, and thus, partially explain why
relatively more OHA is stored in triac:ylglycerols of tissues than EPA. Even
though biliary phospholipids are enriched in the long chain n-3 fatty acids found
in dietary fish oils, no significant difference in the relative proportions of EPA (2-
3% of the total fatty acids) and OHA (1-3% of the total) was observed. Berr et al
(1993) found similar results in Syrian hamsters fed chow supplemented with
MaxEPA oil for 3 weeks. However, Balasubramaniam et al (1985) found that the
bile phospholipids contained approximately 4% EPA and 10% ORA in rats fed
MaxEPA oil for 2 weeks with relatively the same proportions of the long chain n-
3 fatty acids in their experimental diet as we had.
The differential storage of OHA compared to EPA is thus, not due to the
selective secretion of liPA into bile by the liver.
4.6.2 BILE OtrrPIIT AND COMPOSmON
~ Previous studies have shown that feeding a high fat diet had
an effect on bile flow (Turley and Dietschy, 1979; Cuuan et al, 1990; Knox et ai,
1991). Knox et al (1991) fed rats either chow or chow mixed with 20% (w:w)
giyceryltrioleate for 7-10 days.lhei found bile flow was higher in the chow fed
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animals than in the fat preted group duringgl~ infusion. Similarly,
Turley and Dietschy (1919) collected. bile for 2 hoUIS from female rats weighing
between 190-230 g and found that bile flow was between 0.76 -{I.99 mL/h for
those animals on laboratory chow while those on a cholesterol feed (20/0
cholesterol and 100/0 com oil) for 12 days had a lower flow ranging between 0.72
and 0.87 mL/h. Conversely, Chautan et al (1990) reported. a flow of 0.65 mL/h
for their low fat group and 0.80-1.10 mL/h for animals re<:eiving diets containing
10% fat.
The feeding of polyunsaturated compared to saturated lipids has also
been shown to have an effect on the rate of bile flow. Ramesha et al (1980) fed
rats diets containing 100/0 safflower oil, coconut oil or hydrogenated vegetable
oils for 30 days, after which hepatic cholesterol and bile add synthesis and their
excretion through the bile and feces were studied.. They found the rate of bile
flow was appreciably higher in the rats receiving the diet containing safflower oil
(0.54 mL/h ± 0.02) than in those receiving coconut oil (0.45 ± 0.02) or those
receiving a commercial preparation of hydrogenated vegetable oil (0.44 ± 0.02).
In this investigation. we observed. an effect of diet on bile output. with the
MaxEPA fed group having a greater flow. 'This result is not in agreement with
O1.autan et al (1990). When studying animals on diets supplemented. with 10%
salmon oil. 10% com oil or 6% com oil and 4% salmon oil for a period of 4 weeks.
these authors found that bile output did not differ between the fish oil and com
V6
oil fed animals. They observed that salmon oil ingestion (by itself or in
combination with com oil) led to a substantial increase in flow rate of bile over
the low fat diet (containing 2.3% com oil and 2.2% lard). In contrast, com oil
ingestion only slightly affected. this rate. However, Chautan and coworkers
(1990) only collected bile for 90 minutes, unlike our study in which we obtained
hourly collections for a 6 hour period.
In !:he second part of this study, we found that prior diet and meal infused
independently affected. the rate of bile secretion. Rats fed a diet enriched in n-3
fatty acids had a greater flow rate than those consuming an n-6 enriched diet.
Furthermore, when MaxEPA oil was infused. intraduodenaily to animals that
were previously fed com oil, there was an increase in their bile flow. The reverse
holds true in animals fed fish oil and then given a meal of com oil. The reason
for the difference in bile output is not known.
~ Endogenous bile acids provide the primary stimulus for bile
flow and facilitate the secretion of lipids into bile (Turley and Dietschy, 1982). If a
treatment or condition causes bile acid secretion to be low, then presumably
biliary lipid secretion is low and vice versa. In our investigation the recirculation
of bile acids is surgically interrupted and one would expect a decline in the bile
acid output along with a decrease in biliary lipid concentrations. Even though we
did observe a decrease in bile acid levels with time, there was not an
accompanying fall in biliary cholesterol or phospholipids concentration in bile in
the first part. of the experiment when only the effect of prior diet was
investigated.
We found an increase in the total quantity of bile acids secreted in rats fed
MaxEPA oil compared to com oil fed animals. This increase occuned
concomitantly with. an increase in biliary phospholipid and cholesterol secretion.
However, the concentration of bile lipids did not differ.
When the effects of an infused dietary fat rich in n-3 or n--6 fatty acids
were eXamined in rats previously fed diets containing either com oil or maxEPA
oil, there was a decline in bile acid levels with time along with an accompanying
fall in cholesterol and phospholipid concentrations. We demonstrated an
independent effect of diet and oil infused on the amount of bile acids secreted.
per hour. However, when we examined the total amount of bile acids secreted in
the six hour collection, we found a significant interaction between diet and
infused fat. When a different oil than found in the diet is infused, there is an
increase in bile acid secretion.
rnterestingly, Balasubramaniam et al (1985) found there was no difference
in the bile acid pool size or synthetic rate of bile acids between animals fed a
saturated. fat and diets rich in n-6 or n-3 fatty acids, a finding similar to our data
involving the effect of diet only. Choi et al (1989) have shown that the activity of
cholesterol 7 «-hydroxylase is not altered. by fish oll feeding, suggesting that the
synthesis of bile acids is not changed in rats fed fish oil.
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Biliary Cbolutsrpl Previously, diets enriched with n-6 fatty acids have
been shown to stimulate cholesterol secretion into bile (Balasubramaniam et a.L
1985 ; Ramesha et al, 1980). Balasubramaniam et al (1985) found a twofold
increase in biliary secretion of cholesterol when n-6 fatty acids replaced saturated
fats. Similarly, Ramesha et al (1980) observed that the concentration of
cholesterol in bile was markedly higher in safflower oil fed rats than in coconut
oil fed or hydrogenated. vegetable oil fed rats. In contrast. Chautan and
coworkers (1990) reported that com oil ingestion only moderately affected biliary
cholesterol level in rats when compared to the level in aniInals on a low fat diet.
As well, Turley and Dietschy (1979) found little change in rats fed. a diet
supplemented with 2"10 cholesterol and 10"10 com oil with regards to the secretion
of biliary cholesterol during a two hour collection period when compared to the
group fed chow. In fact, these investigators demonstrated. that cholesterol output
and the molar percentage of cholesterol in bile was essentially the same in female
rats subjected to diurnal light cycling.. fasting for 4B hours. intravenous
administration of chylomiaons. and diets containing either cholestytamine,
cholesterol and com oil or bile acid. They concluded that the rate of hepatic
cholesterol synthesis, level of hepatic choleste.ryl esteIs, and the amount of
cholesterol absorbed &om the diet played no role in determining the rate of
biliary cholesterol secretion. Consequently, increasing the availability of
cholesterol in the hepatocyte did not influence the amount of cholesterol secreted.
into bUe. However, Coleman and Rahman (1992) stated that there is recent
evid~ suggesting that all of the preformed. free cholesterol in the liver is in a
single pool and is potentially available for secretion into bile. 'The large pool of
free cholesterol is found in hepatocyte membranes and its size is- partly regulated
(and hence the secretion of biliary cholesterol is regulated.) by the extent of
cholesterol esterification (Coleman and Rahman. 1992). Thus, if the free
cholesterol pool expands then there is an increase in biliary choEesterol secretion.
In accordance with this idea, Robins et al (1993) recently examjned biliary lipid
secretion in conjunction with hepatic cholesterol synthesis in ra-ts during normal
growth. These authors observed that when cholesterol synthesis was at its high
point (during mid-dark cycle) there was a strong linear relationship between
hepatic cholesterol synthesis and biliary cholesterol secretion. Their data suggest
that increased biliary cholesterol secretion at mid.-dark occurred in response to
increased hepatic cholesterol synthesis. Robins and coworkers (1993) attributed
the differences in their results &om Turley and Dietsc.hy (1979) 00 methodol.ogical
differences. Turley and Dietschy (1979) used the administratiC)n of a bile acid-
binding resin to increase hepatic cholesterol synthesis but these bile acid-binding
resins also increase bile acid synthesis and do not result in either an increase in
newly synthesized cholesterol or total cholesterol in bile. Morec:wer, the infusion
of lipoprotein-eholesrerol was used to suppress hepatic cholesterol synthesis and
although synthesis was suppressed, an increase in hepatic cho lesterol promotes
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cholesteryl ester formation and may not result in an increase in hepatic pool of
unesterified. cholesterol that is used for biliary secretion.
Since diets rich in n-3 fatty acids have been found to lower plasma lipids
even more than diets containing n-6 fatty acids in rats (Herzberg and Rogerson.
1988; Balasubramaniam et aI. 1985; Olautan et at. 1990), it was postulated that
these diets may result in an increase in biliary cholesterol output.
BalasubramaniaIn et al (1985) reasoned that an increase in biliary cholesterol
transferred to bile during ingestion of a diet rich in n·3 fatty acids might increase
the lithogenic properties of bile, inaeasing the chance of gallstone formation in
man. However they further stated that the "absertO! of an excess incidence of
gallstones in populations habitually consuming quantities of n-3 fatty acids
suggests increased solubility of cholesterol in bile, perhaps due to a change in the
fatty acid composition of biliary phospholipids or an increase in the
phospholipid concentration in the bile". Paul et al (1980) remarked that the fatty
acid composition of biliary phospholipids is modified by dietary fat and thus, the
solubility of cholesterol in bile may be better when phospholipids contain very
unsaturated. fatty acids, thus avoiding the production of lithogenic bile. In
agreement, Herr et al (1992), while studying whether dietary supplementation of
EPA and DHA decreases cholesterol saturation and prevents the formation of
cholesterol crystals in bile of patients with gallstones. concluded that cholesterol
saturation can be influenced. by the fatty acid composition of
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phosphatidylcholines secreted in bile. They found that an intake of 3.75 g of the
long chain n-3 fatty acids per day increased the amounts of EPA and OHA in
biliary phospholipids while reducing or displacing 18:2(n-£) and 20:4(n-6). From
their data, it was evident that the molar ratio of cholesterol to phospholipid
declined and, as a result, the cholesterol saturation index was reduced by ZS%.
Likewise, Tierney et al (1993) studied the effects of fish oil on human gallbladder
bile. Their data suggested that fish oil reduced gallbladder bile cholesterol. did
not alter the molar per cent total phospholipids, and delayed cholesterol crystal
appearance time in humans with cholesterol gallstones. They suggested that fish
oil may be of benefit in preventing and/or dissolving cholesterol gallstones. In
addition, studies conducted. with experimental animals have demonstrated that
fish oil exerts a protective effect against gallstones (Dam, 1971; Booker et al,
1990; Scobey et ai, 1991).
We found no difference in biliary cholesterol concentration between the
com oil fed and MaxEPA oil fed groups. However, due to the greater bile flow in
fish oil fed rats, these animals had a greater total cholesterol excretion in bile.
Similarly, Otautan et al (1990) observed no difference in biliary cholesterol
output when they compared. their data from com oil fed and salmon oil fed rats.
However, they reported an enhancement of biliary cholesterol secretion due to
the salmon oil diet when comparing this group to the animals receiving the low
fat diet. These authors estimated the amount of cholesterol secreted in reference
182
to bile flow per hour. Ii their data are adjus~ per millilltre of bile secreted. per
hour, then the cholesterol output becomes 0..34,. 0.33, 0.33, and. 0.31 j.lIIlol/mL in
the low fat diet, com oil diet, com and salmon oil combination diet and the
salmon oil diet. respectively. Therefore, it appealS that there was no difference in
total cholesterol secreted per hour.
On the other hand, Balasubramaniam et al (1985) found twice as much
cholesterol in a 10 hour pooled bile sample from fish oil fed rats compared to
! safflower oil fed animals, but these investigators did not report the volume of
bile collected. Thus we cannot determine the actual concentration of cholesterol
in the secreted bile. In addition, these researchers suggested that decreases in the
LDL and HDL cholesterol seen in their rats related to the increase in the
cholesterol secretion. As well, Smit and coworkers (1994) demonstrated. that
feeding fish oil causes changes in· intrahepatic cholesterol transport and the
hypersecretion of cholesteroL in association with an increase in bile acids and
phospholipids, into bile in mo. These authors surmised that this increase in the
disposition of cholesterol into bile was potentiated by a bile acid dependent
secretion, presumably by facilitating the recruitment of bile destined cholesterol.
However, in our study the rise in cholesterol output seems to pertain to the
increase in bile output which may be a result of the differing fatty acid profile
seen in the phospholipids of rat bile.
··1
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Ben et a). (1993) examined the excretory pathways for cholesterol in Syrian
hamsters. They fed these animals diets that were enriched. with n-3 or n-6 fatty
acids for a period of 3 weeks. Surprisingly, and in contrast to the other
investigations, they found that the n-6 polyunsaturated fatty acids were
responsible not only for an increase in the synthesis of the bile acid, cholic acid,
but also for the biliary seoetion of cholesterol while the n-3 fatty acids did not
enhance either parameter. Furthermore, they, too, commented that the
differences in biliary secretion of cholesterol were associated with the diet·
induced alterations of the fatty acid pattern of phospholipids secreted in bile but
the differences in secretion are contradictory to what we observed, i.e., that the
amount of cholesterol was increased in fish oU fed animals.
Chautan et al (1990) found that in rats fed fish oU, the hepatic acyl-CoA
cholesterol acylt:ramferase (ACAT) activity and biliary cholesterol secretion were
enhanced. Thw, they concluded that there was an increase in the production of
cholesteryl ester and hence, an increase in cholesterol storage. They further
stated that this apparent overload of cholesterol in hepatocytes would trigger
both the mechanism of cholesterol esterification and secretion in bile in order to
maintain intracellular cholesterol homeostasis. However, Rustan et al (1988)
reported that EPA could inhibit ACAT activity. These authors studied the effects
of EPA, DHA, 18:1(n-9), 16:0 and 18:0 on the synthesis and secretion of
cholesterol and cholesterol esters by; culhu:ed rat hepatocytes and microsomes.
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They found that EPA and DRA decreased the synthesis and secretion of
cholesterol ester by inhibiting ACAT activity while the other fatty acids
examined. had the opposite effect. In addition. EPA decreased IiMG CoA
reductase activity in hepatic microsomes (Mizuguchi et aI. 1993). These authors
assumed that the reduced activity was due to an increase in microsomal free
cholesterol and the change in fatty acid composition of membrane
phospholipids. In contrast, Field et aI (1987) found that the regulation of HMG
CoA reductase and ACAT in the liver and phospholipids was most likely related
to the degree of fat saturation in the membrane and not necessarily to the specific
class of polyunsaturates in the membrane.
Interestingly, in the part of the study examining the effect of prior diet and
meaL we observed that the level of cholesterol did not differ between the MdMi
and CdCi groups. However, there was a significant interaction between the diet
and the infused meal Thus, when the infused oil differed from the fat found in
the diet, the cholesterol concentration declined. These results suggest that the
infusion of the different fat emptied the biliary pool of this lipid rapidly as
illustrated in Figure 4.6. As yet. the consequence of this event has not been
elucidated. In addition, when we removed the influence of time and pooled the
total amounts of the biliary lipids throughout the study period. the significant
interaction of diet and infused oil for cholesterol remained.
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Although there have been a number of studies examining continuous fat
feeding on biliary lipids, only one other study looked at the effects of supplying a
single dose of fatty acid on cholesterol secretion. nus was done using perfused
liver and using single albumin-bound 16;1 and 18:1 (Robins et ill. 1991). Robins
and coworkers (1991) observed an inaease in biliary cholesterol secretion
relative to PC when the population of Pes that was newly formed included more
hydrophilic molecular species of PC than are present in native bile. This
observation was only seen with the perfusion of 16:1-
Biliw Photpholjllid Mansbach and Arnold (1986) previously reported.
that pre£eeding fat to rats increased the concentration of triacylglycerol in lymph
by 500/" over chow fed controls. Considering that fat feeding increases circulating
secretin levels which would inaease biliary flow, they hypothesized that fat pre-
feeding in some way altered bUe composition or flow so that more PC is
delivered to the intestine of the fat pre-fed animals as compared. to chow fed
controls. These authors found that up to two hours after bile duct cannulations in
rats, PC was greater in the fat pre-fed group (Knox et ai, 1992). However, they
also observed a more sustained increase in PC secretion into bile in the chow fed
group.
Due to greater bUe flow, we observed greater phospholipid output in the
MaxEPA fed animals. However, there was no effect of diet or time on the actual
concentration of phospholipid in the bile of either group. Chautan et al (1990)
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obtained similar results. Balasubramaniam and coworkers (1985) also observed
a greater output in fish oil fed animals than in the safflower oil group in their 10
hour pooled samples (26.1 )J.tt\olll0 h ±3.5 and 23.1 ± 3.1, respectively).
Similarly to the results observed for cholesterol, there was no significant
difference in the phospholipid concentration between the MdMi and CdO
groups but there was a significant interaction between the diet and oil infused.
We postulate that this is a result of the flux through the hepatic pool of
phospholipids available for bile secretion rapidly ina-easing when the fat infused
was different than that found in the diet. The biochemical basis for this increase
is unknown. In contrast to biliary cholesterol, when the factor of time was
eliminated, the interaction of diet and infused fat disappeared for phospholipids.
Fitty Acid Composition and Distribution in QUiitY" Pbospboljpids
There are two main sources of biliary phospholipids; de rlOOO synthesis which
may contribute only 3% of biliary PC secretion (Robins and Brunengraber, 1982)
and a preformed hepatic pooL Coleman and Rahman (1992) stated that "the
preformed pool probably involves contributions from many of the membranes of
the hepatocyte, especially those of the endoplasmic reticulum and bile
canaliculus. 1ltis PC pool clearly encompasses pre-existing PC but may possibly
draw on 'remodelled' PC produced from the larger pool by acyltransferase
action".
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Many authors (Robins et al.. 1991; Robins et al.. 1986; Yousef and FiSher,
1976; Cohen et al.. 1990) have provided clear evidence that phospholipids are
selectively synthesized as well as selectively remodelled. Consequently,
particular molecular species of phospholipids may be preferentially solubilized
in bile salt micelles. Biliary phospholipids tend to be primarily phosphati-
dylcholine containing 16:0 in the sn-1 position and 18:2(n-6) or 18:1(n-9) in the sn-
2 position (Yousef and Fisher, 1976; Robins et al, 1991). Robins et al (1986)
undertook studies to determine if selective secretion of PC in bile might reflect a
predominantly "physical process" in which intrahepatic Pes which were the
most hydrophilic were the most readily solubilized by bile salts and thus, the
most readily secreted into bile. When these authors chronically fed rats fatty
acids that were more or equally hydrophilic than the fatty acids that are
ordinarily prevalent in bile PC, bile became highly enriched in new molecular
species of PC that contained. the particular fatty acid that was fed. In contrast,
when a fatty acid was fed. that was less hydrophilic than those that ordinarily
comprise biliary PC, the composition of biliary PC was not changed
Biliary secretion of phospholipid appears to be dependent on the secretion
of bile acids. During bile formation, bile acids stimulate hepatocellular secretion
of PC and cholesterol from hepatocytes (Cohen et al, 1990). However, the
relationship between the biliary transport of phospholipids and cholesterol
remains unclear. Cohen and coworkers (1990) suggested that physical-d\emical
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mechanisms play a role in stimulating bile acids to select Pes with the
appropriate fatty acid profile from the hepatic pool. rn agreement, Yousef and
Fisher (1976) suggested that biliary secretion of phospholipids might involve the
physical dissection of phospholipids from the bile canalicular membrane by bile
acids being transported. across that membrane. Indeed, they demonstrated that,
in contrast to their effect on microsomes and plasma membranes, bile acids can
selectively solubilize from the bile canalicular membrane phospholipids whose
molecular species and fatty acid composition are similar to those present in bile.
In our study, when only examining the effects of prior diet, the major fatty
: acids in the biliary phospholipids of rats fed diets containing either com or fish
oil included 16:0, 18:0, and 18:2(n-6), a finding that partially supports the
evidence found by other researchers (Robins and Patton, 1986; Robins et al, 1991;
Yousef and Fisher, 1976; Cohen et al, 1990). These authors have shown that 16:0
and 18:2(n-6) are major fatty acids in bile but Robins and Patton (1986) reported
that biliary phospholipids have low amounts of 18:0. We found that 18:0 was a
significant component of these phospholipids, accounting for more than 10% of
the total fatty acid composition.
Furthermore, we also observed that the fatty acid composition of the
phospholipids in bile did reflect the diet. The MaxEPA fed animals had a higher
proportion of n-3 fatty acids whereas the com oil fed rats had more n-6 fatty
acids, particularly 20:4. Since com oil<antains 53% by weight of 18:2(n-6) and no
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2O:4{n-6), we expected to observe a higher percentage of 18:2(n-6) in the
phospholipids of the rats rece:iving com oil diet5, similar to the findings of
Balasubramaniam et a1 (1985) and Berr et al (1993) when they compared.
safflower oil fed and fish oil fed animals. However, there was no difference in
the proportion of 18:2(n-6) in the phospholipids of either treatment group.
Arachidonic acid (20:4. n-6) is an important component of phospholipids
contributing to the structural integrity of membranes and is the primary
precurSor of several classes of oxygenated derivatives with a variety of biological
activities (Vance and Vance, 1991). 'This fatty acid can be formed from 18:2(n-6)
by the alternating sequence of d6 desaturation, chain elongation to the 18:3(n-6)
intermediate, and ~ desaturation of 2O:3(n-6). It appears that the increase of n-3
fatty acids in the bile of fish oil fed animals that we observed. is probably at the
expense of 2O:4{n-6). Nassar et al (1986) demonstrated. that fish oil inhibits liver
a6- and as-desaturation of n-6 polyunsaturated fatty acids. It is probable that the
67'Yo reduction of 2O:4(n-6) in the MaxEPA oil fed rats seen in our study is due to
the inhibition of enzymes responsible for desaturation of the n-6 fatty acids.
We observed. a higher proportion of 18:1(n-9) in the MaxEPA group.
Balasubramaniam et al (1985) reported a similar finding after feeding rats
safflower oil containing diets. In addition. O1.oi and coworkers (1989) observed. a
similar phenomenon in the fatty acid compositions of liver microsomal PC in
young and adult rats fed. different fats. The reason for this higher proportion of
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18:1(n-9) is unclear. It is possible that more 18:1(n-9) is used in the synthesis of
biliary phospholipids to make up for the decrease in the total amount of n~ fatty
acids in the fish oil fed animals.
When we examined the effects of both the diet and the oil infused, we
found that 18:2(n-6) is a major constituent of biliary phospholipids regardless of
the type of fat in the diet or oil infused. This supports the concept that
phospholipids are selectively synthesized.
Not only the previous diet but also the fatty acid composition of infused
fat played a role in determining the fatty acid profile of phospholipids. The
results indicate an effect of prior diet and fat infused for 18:1(n·9), EPA, and
DHA. Furthermore, the fat infused had a significant effect on 20:4{n-6),
independent of prior diet.. As expected, MdMi had the highest proportion of
long chain n-3 fatty acids whereas CdCi had the most n-6 fatty acids until , at
least, the fifth hour of bile drainage. However, the infusion of com oil caused a
greater decline over time of n-6 fatty acids than the fish oil, regardless of the
former diet, for reasons unknown. Interestingly, when a bolus of com oil was
given to animals fed MaxEPA oil in their diets, EPA and DHA disappeared by
the second hour of bile flow, suggesting a relatively quick: turnover of these fatty
acids. Due to the small proportion the n~3 fatty acids represented. in bile
phospholipids, it is difficult to identify what fatty acid(s) replaced DHA and
EPA in the MdCi group. When l\IIaxEPA oil was infused into rats fed com oil
containing diets, there was no increase in the amounts of the n-3 fatty acids.
More than likely, the amount of EPA and OHA in the fish oil (Table 2.1) was not
sufficient to induce a change.
Robins and Patton (1986) have previowly reported that the contribution
of newly synthesized PCS to biliary secretion is only about 3% of the total PC
output. In a more recent study Robins et al (1991) contradicted this finding since
their results showed that when the liver is perfused with certain unsaturated
fatty acids, a number of new diunsaturated Pes may be formed in relatively
large amounts and these are preferentially secreted in bile. They suggested that
the most likely mechanism to explain this phenomenon is one that is dependent
on the physical characteristics of the particular hepatic Pes that are available for
biliary secretion when bile acid is being perfused. They concluded that when
new Pes were synthesized or when Pes are available from a preformed pool,
those with relatively short acyl chains are favoured for secretion in bile.
However, as stated earlier, we observed an appreciable amount of long chain n-3
fatty acids in the bile of rats fed MaxEPA oil, suggesting a greater supply of these
fatty acids available in the hepatic pool.
4.6.3 CONCLUSION
The results of the experiments described in this Otapter are outlined in
Table 4.5. We have shown that EPA is not selectively secreted into bile by the
liver compared to ORA in fish oil fed. rats. In addition, dietary fatty acid
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composition and infused fat can alter bile flow and composition. Specifically,
feeding a diet containing fish oil or infusing a meal of fish oil can increase bile
flow. Due to the greater flow in animals fed. fish oil containing diets, an
accompanying increase in total biliary lipid secretion was observed., although the
concentration of biliary lipids did not signifcantly change. Furthermore, a
reduction in the levels of biliary phospholipids and cholesterol was
demonstrated when a fat different than the one found in the diet was infused.
This effect was not seen for bile acids.
We also observed. a difference due to diet and oil infused on the fatty acid
composition of biliary phospholipids. The fatty acid composition of biliary
phospholipids in rats fed MaxEPA oil showed. enrichment with. n-3 fatty acids. It
is possible this change in fatty acid composition may be responsible for the
increased bile output, resulting in greater excretion of cholesterol in the form of
free cholesterol and in the form of bile acids. Further work is needed to
determine the significance for the changes in bile flow, whether the n·3 fatty
acids playa role in this increased output, and whether emptying the biliary pools
by infusing a fat meal different from the main fat in the diet has physiological
importance.
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Table 4.S 51111Ul\UY of Primuy and. Secondary Objectives and. Results for
Mechanism 13.
MedtWsmI3: EPAis re~ti.all
Ob'ectives
3.1 To investigate the biliary
secretion of EPA and DRA in
phospholipids from rats fed fish oil
containinst diets.
3.1.1 To determine whether the
composition of biliary phospholipids
could be altered by feeding rats diets
rich in either n~ fatty acids or n-3
fattY acids.
3.1.2 To determine whether diets rich
inn~ fatty acids or n-3 fatty acids
affect the rate of bile flow as well as
the biliary secretion of phospholipids,
cholesteroL and bile acids.
secreted mative to ORA in bile.
Result
No significant difference observed.
Rats fed a fish oil containing diet had
sigrUficant higher levels of 18:1(n-9), EPA
and DRA while rats fed com oil
containing diets had higher levels of
2O:4{n~).
Fish oil fed animals had significant
greater bile flow. The concentration of
biliary bile acids, cholesterol and
phospholipids did not change due to
diet. But fish oil fed rats had a greater
total secretion of lipids because of the
2reater bile flow.
3.1.3 To determine if feeding a meal The fatty acid profile of biliary
rich in n-3 or n~ fatty acids could. phospholipids; ie., 18:1(n-9), EPA and
induce short-teml changes in the fatty ORA, can be significantly altered by the
acid composition of biliary prior diet as well as the dietary fat
phospholipids after rats have been infused.
fed. diets containing either fish oil or
com oil.
·1
3.1.4 To determine whether diets rich
in n~ fatty acids or n-3 fatty acids
affect the rate of bile flow as well as
the biliary secretion of phospholipids,
cholesteroL and bile acids after an
infusion of fish oil and com oil
Over time, the prior diet and fat infused
can significantly alter bile secretion but
the infused fat did. not have an effect
when time was removed as a factor.
Prior diet and infused fat had a
significant effect on the levels of
cholesterol and phospholipids whereas
the effect of prior diet was independent
of infused fat for bile acids. In fact. there
was a reduction in the levels of
cholesterol and phospholipids when a fat
different than the one found in the diet
was infused.
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CHAFTER5J)
GENERAL DISCUSSION AND CONCLUSION
5.1 GENERAL DISCUSSION
The long chain n-3 fatty acids. DHA and EPA, have sparked a great deal
of interest since epidemiological and clinical evidence suggested that these two
fatty acids are responsible for various health benefits. The general hypothesis
that EPA is preferentially utilized relative to DHA may playa role in minimizing
the risk of cardiovascular disease. thrombosis as well as obesity. As a result,
investigators have been interested in determining whether both fatty acids
behave similarly or are metabolized differendy.
More OHA appears to be present in various mammalian tissues than EPA.
Even though both fatty acids are absorbed. to the same extent, several researchers
have demonstrated. that less EPA is stored. in adipose tissue than OHA (Sheppard
and Herzberg. 1992; Lin and Connor, 1990; Janadecek et al, 1991; Raclot and
Groscolas, 1994). Raclot and Groscolas (1994) found that adipose tissue stores
and releases n-3 fatty acids efficiently but differentially. They found that of their
total ingested mass 13% of EPA. 18% of 18;4{n-3). 220/0 of OHA and 32"0 of 22:5(n-
3) were stored in adipose tissue at the end of a 4 week feeding period. Thus. in
agreement with others (Herzberg and Sheppard. 1992; lin and COlUlOf. 1990;
Jandacek et ai, 1991), Raelot and Groscolas (1994) suggested that there was
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preferential storage of certain n-3 polyunsaturated fatty acids. Similar
differential storage was observed on a low fat diet as well as the fish oil based
diet. This finding supports the view that differential storage results from
intrinsic metabolic properties of individual n~3 fatty acids, and is unrelated to the
amount of dietary intake. In addition, Raclot and Groscolas (1994) were the first
to show that individual n-3 fatty acids are differentially released from two
adipose tissues differing by both their location and their size.
Accordingly, many investigators have questioned the reasons why EPA is
underrepresented in tissues such as adipose tissue relative to ORA. We
hypothesized that EPA is preferentially metabolized in muscle and thus, less of
this acid is available for storage. The three proposed. mechanisms investigated
to explain how EPA is preferentially utilized included; 1) EPA is oxidized at a
greater rate relative to ORA in skeletal and cardiac muscle, 2) EPA is
preferentially hydrolyzed from circulating triacylglycerols in muscle, and 3)
EPA is selectively secreted in bile by the liver.
From our data, we were able to conclude that the suggested mechanisms
may not be responsible for the preferential metabolism of EPA relative to ORA.
We did find that EPA was oxidized at a greater rate than OHA in soleus muscle
homogenates. However, when potentially more physiological models were
used. Le., cardiac myocytes or the intact skeletal muscle, there were no
differences in the oxidation of either of these fatty acids. Furthermore. we
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determined that EPA and OHA were reIeased from triacylglycerols in lymph-
derived chylomicrons at similar rates and. that both fatty acids were secreted in
bile to the same extent.
Other mechanisms have been proposed.. The following theories have been
suggested to explain why the ratio of OHA/EPA in the tissue exceeds the
amount that is absorbed from the diet; 1) EPA is preferentWly oxidized by the
liver compared to CHA. 2) EPA is amverted to OHA for storage. 3) EPA is
preferentially mobilized from storage, and/or 4) EPA is preferentially used for
the synthesis of membrane phospholipids.
5.2 OXIDATION OF EPA BY LIVER
Even though preferential oxidation of EPA relative to ORA was not
observed in skeletal and cardiac muscle, it has been speculated that EPA is
preferentially oxidized in the liver. Previous wode: has shown increased hepatic
ketogenesis and fatty acid oxidation upon fish oil feeding (Wong et ai, 1984;
Aarsland et ai, 1990). Two investigations in recent years have provided
evidence to support the supposition that EPA is oxidized at a greater rate in the
liver compared with ORA (Gavino and Gavino, 1991; Herzberg et ai, 1996).
Gavino and Gavino (1991) examined the activity of CPfo in liver
mitochondria. They found that CPfo had a higher activity with the fatty acyl
CoA of EPA than the fatty acyl CoA of OHA. These authors observed similar
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results when mitochondria were incubated with free fatty acids. These data
suggest that EPA is more readily available for fatty acid oxidation in liver.
In agreement, Herzberg et at (1996) found. a greater rate of ketogenesis
when hepatocytes were incubated with EPA compared to OHA. The
experiments with hepatoe::ytes were competition experiments because in each
incubation the radioactive label was in 18:1(n-9) regardless of which fatty acid
was added. Therefore. for the oxidation results, a lower apparent rate indicated
that the added fatty acid was oxidized at a greater rate than 18:1(n-9). Of the
added fatty acids only EPA was oxidized at a significantly greater rate than
18:1(n-9). This evidence that EPA was oxidized at a greater rate than the other
fatty acids. including OHA, is confirmed by the ketoacid production. Both
acetoacetate and 3-hydroxy butyrate syntheses were greater for added EPA than
any other added fatty acid including OHA. Consequently, these authors
provided evidence suggesting that EPA was oxidized at a faster rate in liver
compared to other fatty acids including CHA. Further investigative work is
needed to confum these studies. It would be of interest to determine the rates of
fatty acid oxidation using the labelled free fatty acid and to compare the results
to these competition studies.
5.3 INTERCONVERSION OF N-3 FATIY ACIDS
Interconversions of long chain n-3 fatty acids could potentially contribute
to their net differential storage. It ts possible that EPA could be converted to
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ORA since it is the precursor of OHA in the n-3 synthetic pathway and thus,
account for less EPA being stored. Consequently, OHA may serve as a reservoir
for EPA and when needed for eicosanoid synthesis or oxidation, OHA may be
retroconverted to EPA, resulting in the mobilization of EPA to the tissues of
need. Even though inten:onversions during absorption have been found to be
negligible (Nilsson et a.l, 1992; Chemenko et a.l, 1989), some interconversions
have been reported in such tissues as the liver and the retina (Gronn et a.l, 1988;
Voss et ai, 1991; Voss et a.l, 1992; Lin and Connor, 1990; Ouistensen et a.l, 1986).
However, the factors regulating these interconversions are poorly understood.
There is evidence supporting the conversion of EPA to OHA (Christensen
et ai, 1986; Anderson et a.1,. 1990, Un and Connor, 1990). Ouistensen et aI (1986)
observed rapid elongation of EPA to OHA in hepatocytes £rom fed but not fasted
rats. Un and Connor (1990) cited studies that demonstrated that when chicks
were fed EPA, the formation of ORA in the retina and brain resulted (Anderson
et al, 1990). Similar presumed conversion was observed. in adipose tissue and.
atherosclerotic plaques of humans fed fish oil (Rapp et ai, 1989; Leaf et ai, 1988).
Hagve and Christopherson (1984) studied the desaturation, chain elongation,
and esterification of 1-14(> EPA, 2O;4(n-6), 2Q-.3(n~), 18:3(n-3), and 18;2(n-6) in
isolated liver cells. Rats were fed diets containing 15% hydrogenated coconut oil,
15% hydrogenated marine oil, 15% soybean oil or standard pellets with 6% fat.
They found that the elongation to 22 carbon fatty acids was efficient with EPA.
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However, with 2O:4(n-6), there was little recovery of longer products. In
addition. this investigation revealed that EPA is rapidly esterified into
triacylglycerols and phospholipids and then liberated by hydrolysis and
converted to 22;S(n·3). The esterification of 1-14(: EPA in phospholipids
decreased in the order of marine oilxoconut oil>standard pe11et>soybean oil.
The specificity of lipases liberating 18:3(n-3) and EPA in preference to 18:2(n-6)
and 20:4(n-6) and specificity of elongation enzymes for EPA compared to 20:4(n·
6) are of importance for the biosynthesis of n-3 fatty acids, mainly to 22 carbon
fatty acids in animal tissues.
Hagve and Sprecher (1989) were unable to detect any products of
W\Saturation or chain elongation when appropriate n-6 and n-3 fatty adds were
incubated with myocytes or when the heart was perfused with [1_14(:]18:2(n-6).
Since heart is unable to elongate 18 carbon fatty adds to their corresponding 20
or 22 carbon fatty add, they suggested that heart phospholipid composition
must, in part, be regulated by specific mechanisms in removing fatty adds from
the circulation.
Animal and human studies have shown that ORA can be retroconverted
to EPA. Investigators suggest that the !i.etroconversion probably occurs via one
step of B--oxidation and then the saturation of the resulting trans double bond
(Schlenk, 1969; von Schacky and Weber, 1985; Fischer et al, 1987). Voss and
colleagues (1991) have shown that 22.:4(n-6), 22:5(n-6), 22:S(n-3), and DHA are all
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substrates for retroconversion to yield either 20;4(n-6) or EPA. Voss et a.1 (1992)
further stated that "since 2Q;4(n-6) and EPA are also metabolized to 22:5{n-6) and
ORA, it is apparent that a cycle exists for converting 20-22 carbon fatty acids as
well as the reverse process". Hagve and Ouistophersen (1986) provided
evidence for peroxisomal retroamversion of 22::4(n-6) and OHA to 2Q;4{n-6) and
EPA, respectively, in isolated. liver cells. Due to this evidence and the fact that
the retroeonversion is deficient in fibroblast cultures from patients with
peroxisomal diseases (Zellweger syndrome and neonatal adrenoleukodys-
trophy), Gronn and colleagues (1991) were convinced that retroeonversion in the
liver was a peroxisomal function. Subsequently, Gronn et at (1991) studied the
regulation of the retroeonversion of OHA to EPA and the metabolism of the EPA
formed in isolated. rat liver cells. They found that 200/0 of OHA was
retroeonverted to EPA in control cells by one cycle of Q.-oxidation with .6.4 enoyl
CoA reductase and.6.3,.6.2 enoyl CoA isomerase as auxillary enzymes (compared
to 10'Y0 in human fibroblasts) and commented that retroconversion was indeed a
peroxisomal fwu:tion. The resultant EPA was rapidly incorporated into
triacylglycerols, phosphatidykholine and phosphatidylethanolamine &actions.
During longer incubations EPA was removed. from phosphatidylcholine
&actions, chain elongated to 22:5(n-3) and this product was then incorporated
into triacylglycerols.
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Fischer et al (1987) demonstrated that ORA is retroconverted in man to
EPA, which is then quickly transformed to prostaglandin 13. In a 24 hour as well
as a week long dietary interVention study, purified. OHA or EPA ethyl ester were
given to healthy male volunteers. Endogenous prostaglandin formation of the
two and three series was then analyzed by measuring the main urinary
metabolites, prostaglandin I2-M and prostaglandin I3-M.. After the ingestion of
either fatty acid, a rapid formation of prostaglandin 13 was observed., implying
that OHA was retroconverted to EPA. Consequently, EPA was available for
prostaglandin synthesis. Furthermore, von Schacky and Weber (1985) found that
after the ingestion of purified OHA, EPA levels rose in the plasma of volunteers.
On the other hand, they observed that the consumption of EPA increased its own
level in phospholipids as well as its elongation product, 22:5(n-6). However,
further desaturation to OHA did not occur (Croset and Lagarde, 1986).
Yorek et al (1984) utilized the Y-79 retinoblastoma cell, a cultured human
line derived from the retina, as a model for investigating the metabolism of n-3
polyunsaturated fatty acids in neural tissue. Regardless of which fatty acid was
provided, 65-75% of the total uptake accumulated in phosphatidylethanolamine
and ethanolamine plasmalogen, suggesting that these phospholipids play an
important role in n-3 fatty acid metabolism. A small amount of DRA was
converted. to EPA, which was recovered in phosphatidylinositol and
phosphatidylserine. Therefore, theSe authors suggested that one metabolic
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function of DHA may be to serve as an intracellular storage pool for the
formation of EPA through. retroconversion. When any of the n-3 fatty acids were
available, the main fatty acid that accumulated. in cell phospholipids was OHA.
The extent to which ORA accumulated., however, depended on the particular n-3
fatty acid that was available. nus suggJsts that the ORA content of neural cells
and any cellular function dependent on ORA content, may be regulated by
changes in the type of n-3 fatty acids available to the nervous system. Other
systems in which retroconversion has been observed include human smooth
muscle cells as well as fibroblasts. These cells have been shown to convert
2O:3(n-6) to 18:3(n-6) ( Tinoco et ai, 1979) plus 22:4(n-6) to 2O:4(n-6) and 18:3(n-6)
(Gavino et al, 1981).
It would be interesting to conduct further studies on the interconversions
of the long chain n-3 fatty acids in adipose tissue and muscle tissue. Even though
Hagve and Sprecher (1989) did not find any elongation products when n-3 and
n-6 fatty acids were incubated with cardiac myocytes, it would be interesting to
see if the same phenomenon is observed with adipose tissues and skeletal
muscles.
5.4 SELECTIVE MOBIliZATION OF EPA
If differential mobilization of fatty acids from tissues exists, then this
could affect the qualitative supply of tissues and organs with fatty acids in the
post absorptive state and situations of negative energy balance such as fasting.
2m
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nus event might prove to be very significant in the case of 2O:4(n-6) and EPA.
since they are necessary for the integrity of cell membranes and for the
biosynthesis of eicosanoids.
Gavino and Gavino (1992) showed the preferential release of 18:3(n-3) and.
2O:4(n-6) over 16:0, 18:1(n-9), 18:2(n-6). Jones et al (1992) have shown that
polyunsaturated fatty adds are oxidized as fuel sources more rapidly and are
less stored than are saturated long chain fatty adds. Cunnane (1989)
demonstrated that there is selective utilization of EPA and selective retention of
ORA in liver triacylglycerols during fasting regardless of whether n-3 or n-6
fatty acids were the dominant essential fatty acids in the diet. However, the
mechanism remains to be determined.
Raclot and Groscolas (1993, 1994) have done extensive research in the area
of preferential storage as well as mobiJ.iz.ation of the n-3 fatty acids in adipose
tissue. FtrStly, they examined differential mobilization of white adipose tissue
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fatty adds according to chain length. unsaturation. and positional isomerism
24 carbon atoms, in unsaturation from zero to six double bonds, and including 23
cells. The in t1itro mobilization of 52 fatty acids ranging in chain length from 12-
l
that under conditions of stimulated lipolysis individual fatty acids are more
pairs of positional isomers was examined. From their results, they concluded
how, molecular structure of fatty adds influences their mobilization from fat
IJ (Raclot and Groscow, 1993). Their study aimed at determining whether, and
I
I
I
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readily mobilized from fat cells when they are short and unsaturated. and when
their double bonds are closer to the methyl end of the chain. Therefore, fatty
adds are not mobilized from fat cells in direct proportion to their content in
triacylglycerols, but differentially according concunently to chain length..
WlSatutation,. and positional isomerism.. Furthermo~, fatty adds with 22
. carbons were not preferentially released. Fatty adds were either preferentially
(20:5, 18:4), equivalently (22:5, 22:6) or lp.ss (20:1, 22:1) released. in comparison to
: total fatty acids. The authors stated that it is very likely that the basis of
differential mobilization of fatty acids is due to a differential aqueous solubility
i or, in more broad terms, a differential physiochemical property. From their
I results, Raclot and Groscolas (1993) commented that "Differential mobilization
!i probably affed:s the storage of individual fatty acids. This could partly explain
I the observation that the partitioning of dietary fatty acids between storage and
IIoxidation varies according to chain length and unsaturation".
: Further to their 1993 investigation. Raclot and Groscolas (1994) studied
I
whether dietacy n-3 fatty adds were selectively mobilized from stores with the
assumption that preferential mobilization of EPA could contribute to its
maintenance in the circulation after fish oil feeding. These authors investigated
storage in and mobilization from rat adipose tissue of EPA, DRA, 22:5(n-3), and
18:4(n-3). After fish oil feeding. substantial amounts of these fatty acids were
stored. The in moo relative incorporation (% in triacylglycerol/% in diet)
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increased significantly with EPA<18:4(n-3)<OHA<22:5(n·3). The in vitro relative
mobilization (% in free fatty acid/% in triacylglycerol) decreased significantly
with EPA>18:4(n-3»OHA>22:5(n-3). The majot" finding was that individual n-3
polyunsaturated. fatty acids characteristic of fish oil are efficiently but
differentially incorporated into and mobilized from various adipose tissues, i.e.,
the abdominal (retroperitoneal) and nonabdominal (subcutaneous) adipose
tissue. These authors suggest that the differential loss of n-3 fatty acids during
lipolysis, because of their differential mobilization, contributes to the explanation
of differential net storage. 'This possibility is further supported by the
demonstration of an inverse relationship between the relative mobilization of n-3
fatty acids in vitro and their relative incorporation in vivo.
More recently, Connor et al (1995, accepted for publication) studied the
relative mobilization of adipose tissue fatty acids under in vivo conditions. They
wanted to find out whether different fatty adds are mobilized into plasma
proportional to their concentrations in adipose tissue triacylglycerols. They fed
weanling rabbits a special diet to label the fat stores with a variety of dietary
fatty acids. The composition of the plasma free fatty acid fraction before and
after hormone-induced lipolysis and the fatty adds of adipose tissue
triacylglycerols were analyzed. Their results indicate that the mobilization of
fatty acids into plasma was not proportional to their content in adipose tissue,
but rather was influenced by their molecular structure. EPA and 20:4(n-6) were
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the fatty acids. with the highest mobilization into the plasma. Connor and
coworkers concluded that the preferential release of these two fatty acids is to
respond to the need for prostaglandins following the proposed stress. ORA was
among the most poorly mobilized. fatty adds. Since OHA is incorporated into
the membrane phospholipids of cells, these authors suggested that OHA would
not be expected to be utilized for energy purposes or in prostaglandin synthesis.
5.5 PREfERENTIAL INCORPORAnON OF EPA INTO PHOSPHOLIPIDS
The underrepresentation of EPA relative to OHA in triacylglycerols may
result frOm reIi.lOdeling prior to the synthesis of phosphatidic acid in the
common pathway of triacylglycerols and phospholipids. If more EPA is diverted.
to the synthesis of phospholipids than triacylglycerol synthesis, then this could
explain why less EPA is stored in triacylglycerols. Importantly, EPA is a
precursor of the eicosanoids like 20:4(n-6) and thus, could be diverted to the
pathway responsible for the synthesis of membrane phospholipids for
incorporation.
Benner et a1 (1990) studied the differential effects of 18:1(n·9) and EPA in
cultured rabbit hepatocytes on the synt:hesis of hepatocyte triacylglycerols and
phospholipids. They specula.ted that since EPA was a precursor for the
biologically potent eicosanoids, then EPA may be preferentially incorporated.
into phospholipids rather than stimulating hepatocyte triacylglycerol synthesis
and secretion. This concept could 'partially explain the mechanism for the
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decrease in triacylglycerol secretion and synthesis which is one of the
mechanisms proposed to explain the hypotriacylglyce.rolemic effect of fish oils.
Benner and his coworkers (1990) found that their data agreed with this
hypothesis, with EPA avidly incorporated. into phospholipids while 18:1(n-9)
predominantly became esterified in triacylglycerols. In addition, they observed
that in the presence of supplemental EPA, there was an increased synthesis of
22:5(n-3) and OHA. DHA was found particularly in the phosphatidylchoiine
fraction and not in phosphatidylinositol or phosphatidylserine. Furt:h.ermore,
they commented that '1t is possible that longer incubation of hepatocytes with n-
3 fatty acids, or long-term feeding experiments would result in more extensive
phospholipid replacement by n-3 fatty acids, including the chain-eiongation
products of EPA". This conversion of EPA to its longer metabolites further
supports the theory of interconversion of n-3 fatty acids presented in Section 5.3
and perhaps the view that DRA may act as a reservoir of EPA. However, when
von Schacky and Weber (19&5) gave volunteers 6 g of EPA, EPA appeared in
plasma free fatty acids and plasma phospholipids after four hours and was not
incorporated into platelet phospholipids (i.e., phosphatidylcholine and phospha-
tidyLethanolamine) until day six, suggesting that platelet fatty acid composition
does not inunediately reflect that of the surrounding plasma milieu, but rather
may be determined during megakaryocyte maturation. After dietary EPA,
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22;5(nM3) increased. in plasma and platelet phospholipids but OHA levels were
unalte<ed.
However, Yeo and Holub (1990) found that the enrichment of OHA
relative to EPA was even greater in hepatic phosphatidylcholine and
phosphatidylethanolamine than it was in the triacylglycerol pools. Enrichment
of DHA relative to EPA has also been observed in the plasma phospholipids of
humans fed cod liver oil (von Schacky et al, 1985). These findings add further
confusion and queries as to why EPA is lU\derrepresented in tissue
I triacylglycerol stores and to what pathways it is being directed. In contrast,
Harris et al (1982) demonstrated that proportionately more OHA compared to
EPA was folU\d only in plasma triacylglycerols and not phospholipids .in a study
.in which they gave volunteers salmon and salmon oil. Furthermore, Harris et at
(1989) conducted a dose response study in which 3-12 g of fish oUld were given
to hyperlipidemic patients for six months. They folU\d an increase in plasma
phospholipid EPA levels which reflected intake; however, OHA levels were less
affected.
Hagve and Sprecher (1989) studied the uptake and integrated metabolism
of n-3 and n-6 fatty acids in the isolated rat cardiac myocytes and in the perfused
heart. These authors stated that 'Tn rat hepatocytes the partitioning of labelled
fatty acids between phopholipid and triacylglycerol biosynthesis and oxidation
has been shown to be dependent 6n the chain length and the degree of
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unsaturation of the fatty acid substrate. Previously it has been shown that rat
heart mic:rosomes convert small amounts of 18:2{n~ to 18:3(n-6). It was not,
however, established whether this .o.6-desaturase activity was localized in
myocytes or other cells". In this investigation, Hagve and Sprecher (l989) were
unable to detect any products of desaturation or chain elongation when
appropriate n-6 and n-3 fatty acids were incubated with cardiac myocytes or
when heart was perfused with [1_14(:118:2(n-6). Heart appears to obtain its 20
and 22 carbon polyunsaturated. fatty acids from the circulation. This would lend
support to the idea that when needed these fatty acids are released from stores
such as adipose tissue and exported to other c:ells and tissues. These authors
conclude that '"heart phospholipid composition must in part be regulated. by
specificities in removing fatty acids from the c:ircu.lation since they lack the ability
to metabolize 18- carbon (n-6) and (n-3) polyunsaturated fatty acids to longer
polyenes". Our results did not show any selective release of any fatty acid by
heart LPL acting on circulating triacylglyc:erols.
Hagve and Christophersen (1983) studied 18:3(n-3) desaturation and chain
elongation and rapid hlmover of phospholipid n·3 fatty acids in isolated. liver
cells from rats fed a diet deficient in essential fatty acids. All n-3 fatty acids were
formed. EPA was found mainly in phospholipids whereas 22S{n-3) and DHA
were found in both phospholipids and triacylglycerols. During tong incubation
periods, continued after nearly all the 1-14(: 18:3(n-3) substrate had been
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metabolized either by esterification or by oxidation, the phospholipid content of
labelled 18:3(n-3) and 18:4{n-3) decreased while the content of EPA, 225(n-3),
and OHA increased markedly, suggesting a remodeling of the phospholipids' n-3
fatty acid content by a series of deacylation-reacylation reactions. The n-3 fatty
acid pattern in triacylglyerols changed little.
There are many discrepancies in the results regarding the preferential
incorporation of EPA into phospholipids compared to OHA. It is apparent that
more work is needed in this area to sort out this puzzle.
5.6 CONCLUSION
There is evidence for some of the alternative mechanisms to explain the
phenomenon that EPA is preferentially utilized relative to ORA. There is
support that EPA is preferentially oxidized relative to DHA in the liver, that it is
selectively mobilized from adipose tissue for export to other cells and tissues and
that interconversions of the n-3 fatty acids may enable DHA to serve as a storage
depot for EPA and thus, be retroconverted to EPA when there is a need for this
fatty acid for various metabolic processes. There are discrepancies in relation to
the hypothesis that there is preferential incorporation of EPA into phospholipids,
making it less available for storage and more available for its structural role in
the membrane and its role as a precursor for eicosanoids synthesis.
Raclot and Groscolas (1994) provided strong evidence that adipose tissue
stores and releases dietary n-3 fatty' acids efficiently but differentially. They
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provided support that differential mobilization is one of the mechanisms that
control the proportions in which exogenous fatty acids are stored. in adipose
tissue. Their results suggest structure-dependent discrimination of the n-3 fatty
acids for mobilization versus retention in adipose tissue, with EPA being stored
Less than OHA and mobilized to a greater extent. Thus, long term feeding of n-3
fatty acids, EPA and DRA, could influence n-3 fatty acid concentrations in
adipose tissue. The re;ervoir of these fatty acids could ensure their availability
for meeting the metabolic requirements of individuals during periods of need.
These findings may have physiological significance to the pathogenesis of
obesity as well as tbrombosi5. Jones (1988) reported that feeding dietary fish oil
to hamsters, compared. with com oil, favoured energy substrate oxidation
reducing the fraction of metabolized energy partitioned for storage.
Furthermore, Jones et al (1992) observed that, in obesity, whole-body
postprandial disposal of dietary fat was influenced by the long chain fatty acid
composition. These authors concluded that ovenveight individuals partitioned
less dietary saturated fat for oxidation postprandially, compared with
individuals of normal body weight. Thus, the fatty acid blend of dietary fat may
be an important determinant in altering energy substrate utilization and long
term body weight balance.
More investigative work is necessary to further study the incorporation of
EPA into phospholipids in variouS tissues and to affirm the differential
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metabolism in- liver. The role of EPA and oHA on major pathways of
phospholipid metabolism; Le., phospholipids in various liver membranes and
various fractions of serum lipoproteins, should be further studied. Studies on
the phospholipid turnover and exchange of phospholipids between membranes
and serum lipoproteins are profoundly important in ca.rdiova.scu.lar disease and
thrombotic disorders. It is important to increase our understanding to provide
iruJight into the control of the partitioning and channelling of fatty acids by
various tissues. Furthermore, it would. be interesting to determine the
availability of the n-3 fatty acids that are stored in tissue triacylglycerol when the
dietary source is no longer available.
rn addition, the suggestion of differential absorption to explain p~
ferential utilization of EPA relative to DHA should be revisited. rn section 1.4 of
Chapter 1.0, it was stated. that the undenepresentation of EPA relative to OHA
was "not due to differential intestinal absorption because it has been shown that
both of these fatty acids are absorbed to the same extent in rats (Otem.enko et at
1989)". However, a recent report by Degrace et at (1996) compared the lymphatic
absorption of a variety of oils including synthetic mixtures of OHA and. EPA in
rats. The data showed increased proportional mesenteric absorption of OHA
versus EPA from menhanden oU and cod liver oil, perhaps providing evidence of
enhanced intestinal availability of OHA at initial periods of absorption. The
higher frequency of OHA at the sn·2 poSition of triacylglycerols in these oils was
213
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cited as a reason for its improved absorption. It is possible then, that this is
evidence that differential absorption could contribute to the observation of
differential partitioning of these two fatty acids.
To explain the underrepresentation of EPA relative to DHA in tissue
triacylglycerols, several mechanisms have been proposed. We suggested that
EPA was preferentially utilized by skeletal and heart muscle, that EPA was
preferentially hydrolyzed from circulating triacylglycerols making it more
available for various metabolic processes in peripheral tissues, and that EPA was
selectively secreted in bile compared with OHA. Except for a twofold difference
in the rate of oxidation of EPA relative to OHA by soleus muscle homogenates,
there were no significant differences found with regards to the oxidation rates in
intact skeletal muscle or cardiac myocytes or with regards to preferential
hydrolysis in chylomicron triacylglycerols and selective secretion in bile. It is
apparent that the findings, except the data from the homogenate experiments,
invalidate our hypothesis. However, the results from the homogenate
experiments both in muscle and liver suggest that more investigative work in the
area of these proposed mechanisms should be explored before closing the book
on the overall hypothesis.
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